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 ABSTRACT 
 
Probiotics are live microorganisms including yeast and bacteria used as food supplements to 
offer health benefits. Currently available dosage forms of yeast probiotic products include 
powder and gelatine capsules, which are not most appealing to consumers. A new dosage 
form of tablets containing probiotic yeast is preferred, based on a market research 
commissioned by Lesaffre International, France. The aim of the present work was to study 
the physiological states of yeast cells and the effects of different formulation, processing and 
environmental conditions on cell viability with an intention to develop a new dosage form of 
probiotic yeast. Three different yeast samples: wet yeast (WY) directly from fermentation, 
active dried yeast granules (ADY) produced by drying wet yeast cells in a drum dryer and 
extrusion through a screen, milled yeast granules (MY) were received from Lesaffre. The cell 
culturability and the physiological states of yeast cells in different formulation, processing 
and environmental conditions were experimentally characterised by colony plate counting 
(CPC) and flow cytometry (FC) respectively. 
 
Cells in ADY and MY samples needed to be released from the granules before their 
culturability and physiological states could be characterised. Therefore, ADY was agitated in 
a homogeniser at different speeds. It was found that the number of cells released increased 
with the speed, but cells were vulnerable to the mechanical forces generated by 
homogenisation – when the speed was greater than 10000 rpm, which was considered to be 
the optimum speed for releasing yeast cells from the granules. The number of viable cells in 
WY sample was found to be higher than that in ADY, and the latter was greater than that in 
MY, which indicates the industrial drum drying and milling processes caused damage to the 
cells.  
 In order to choose an appropriate formulation for making the final dosage form, it is 
important to know whether yeast cells can survive in an acidic environment such as that in 
the stomach. Therefore, yeast cells from ADY were exposed to a simulated gastric and 
intestinal fluid of various pH (1 to 7) for two hours. It has been found that the fluid with pH 
greater than 2 had no significant effect on the cell viability, but the fluid with pH of 1 caused 
some damage to the cells although this pH is not typical in the stomach. A strong linear 
correlation between the number of viable cells obtained from FC and the number of 
culturable cells obtained from CPC for the different processing and environmental conditions 
and various homogenisation speed has been established which suggests that most of viable 
cells were culturable.  
 
Wet yeast cells were freeze dried before they were mixed with excipients to be compacted 
into tablets. In general, the number of viable cells decreased with freeze drying time. At a 
freeze drying time of 24 h without addition of protectants, the water activity (aw) and number 
of viable cells in CFU were 0.43 ± 0.02 and 8.1×109 ± 1.5×109 CFU/g respectively. Tablets 
containing a mixture of the freeze dried yeast (FDY) and microcrystalline cellulose (MCC) 
(50/50 weight ratio) resulted in a low tensile strength of 0.27 ± 0.03 MPa and a number of 
viable cells of 8.6×108 ± 2.5×108 CFU/g. The storage stability result of FDY in the 
formulation after 6 months at 4°C has revealed a 1.6 log loss.  
 
Wet yeast cells were encapsulated with pectin crosslinked with CaCl2 which formed calcium 
pectinate (CaP) beads in order to create a friendly microenvironment which can protect the 
cells during tableting and storage. The effects of pectin and CaCl2 concentrations on cell 
viability and encapsulation efficiency were examined. The formed CaP beads were freeze 
dried for 24 h in order to reduce their water activity to 0.22 ± 0.02. It was found that 
compacting a mixture of freeze dried beads with MCC (50/50 wt/wt) at a pressure of 90 MPa, 
 a tablet containing a number of viable cells of 9.0×108 CFU/g and a tensile strength of 1.09 ± 
0.03 MPa was achieved, which is highly desirable.  
 
The material properties of CaP beads were investigated by diametrical compression. Two 
types of material behaviours of CaP beads were found from ten tested beads. Three beads had 
no fracture and behaved elastically at small deformation with Young’s modulus of 312 ± 28 
MPa. Seven beads showed fracture points and irreversibly deformed with Young’s modulus 
of 162 ± 14 MPa. Finally, encapsulated cells in CaP beads were proved to be protected more 
from damage during compaction and show more resistance to environmental stress during 
storage than non-encapsulated cells. The material properties of CaP beads have been used to 
explain their protective benefits to yeast cells during compaction and storage. 
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CHAPTER 1 
 
INTRODUCTION 
 
An essential part of human well-being includes good physical health. The digestive system is 
one of the most important systems in animals including humans involving food consumption 
and assimilation. Digestion begins in the mouth by chewing and swallowing. After that food 
mixed with digestive juices and is passed through the digestive tract i.e. the stomach, small 
intestine and large intestine (“the gut”). Various enzymes help break down large molecules of 
food to smaller molecules. However, digestion is complete at the small intestine stage. In the 
large intestine, the liquid residue is absorbed and no breaking down of food takes place. 
 
In healthy individuals, the microflora in the intestinal gut remains relatively constant by 
maintaining a balance between pathogenic and non-pathogenic microorganisms. Once the 
intestinal gut microflora is disrupted, the host can be affected resulting in illness and 
discomfort. In recent years, many chronic digestive problems have been reported and caused 
to an unprecedented number of patients (Perrott, 1945, Mönnikes et al., 2001). Digestive 
disorders in the gut are affected by imbalances in both the internal and external environment 
and symptoms can become worse including heartburn, abdominal pain, diarrhoea and 
irritable bowel syndrome (IBS). All such disorders can be treated with drugs and antibiotics 
but the disadvantage is these treatments kill a number of beneficial as well as pathogenic 
bacteria. The integration of natural microorganisms known as probiotics and intestinal 
environment protection is a solution that increases the amount of active useful 
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microorganisms in the digestive system and maintains an adequate balance between 
beneficial and pathogenic bacteria. 
 
1.1 BACKGROUND AND SIGNIFICANCE 
 
Probiotics have been reported to have a number of benefits including improving well-being 
(Dugas et al., 1999, Klaenhammer, 2000) and to play an important role in the modulation of 
the intestinal immune system (Marteau and Rambaud, 1993), prevention of tumour 
development (Parodi, 1999), and suppression of cancer (Aso et al., 1995, Cross, 2002). 
Recently, various bacterial probiotics have been produced for the market in many 
formulations such as chewable tablets, yoghurt, liquid drinks and powders (Yamaguishi et al., 
2011, Czinn and Blanchard, 2009). However, bacteria are found to be susceptible in low pH 
such as the highly acidic conditions in the stomach so that many researches on other 
microorganisms have been undertaken. Yeast is one choice that is commonly thought of as an 
example of non-pathogenic eukaryotic microorganisms and has contributed to human welfare 
by maintaining and restoring the natural flora in the digestive system and therefore can be 
developed in order to pursue probiotic applications (Kumura et al., 2004, van der Aa Kühle et 
al., 2005).  
 
With yeast probiotics, it is important to develop a formulation that is rigid and contains an 
adequate amount of active microorganisms to be delivered to the human colon to offer 
probiotic benefits. Currently, there are several dosage forms of yeast probiotics which are 
widely available in the commercial market (Lourens-Hattingh and Viljoen, 2001, Graff et al., 
2008). However, the tablet dosage form is found to be easy to manufacture and administer 
whilst the oral route is also a convenient and safe way to administer such tablets. 
Chapter 1  Introduction 
_____________________________________________________________________________________ 
 
3 
Compaction pressure during tableting is a major challenge to overcome in probiotic tablet 
production because yeast cells are susceptible to such pressure and can easily be damaged. 
After these cells are exposed to such pressure, they can become injured and consequently die 
due to external stresses. It is thus essential to develop a method to protect yeast cells from 
compaction pressure and enhance cell survival during storage. A modified encapsulation 
method by extrusion could be applied to yeast cells by trapping them as core material with 
some biodegradable materials. However, so far there has been a lack of understanding of how 
the formulation, processing and environmental conditions associated with tableting, storage 
and passage via a gastrointestinal tract may affect physiology of probiotic yeast cells. Cell 
physiology can be investigated using flow cytometry, which will be extensively applied in 
this research.  
 
1.2 OBJECTIVES 
 
The main objectives of this research were: 
 
• To study the physiological states of yeast cells produced from various processing 
conditions i.e. drying and milling processes and also various environmental conditions 
i.e. low pH values in the GI tract (simulated in this work) using flow cytometry 
 
• To develop a tablet dosage form of yeast probiotic containing an adequate number of 
viable cells with long shelf life and enhanced consumer acceptability 
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• To reduce the number of damaged yeast cells in tablets by encapsulating them with 
some biodegradable materials before compacting the resulting beads into tablet 
dosage form  
 
• To investigate the mechanical properties of encapsulating beads and to understand 
how these beads behave under tablet compaction  
 
1.3 OUTLINES OF THESIS 
 
A brief summary of the chapters in this thesis is given below. 
 
Chapter 2 Literature review: Health benefits offered by probiotics and experimental 
techniques used to determine cell viability i.e. traditional techniques and flow cytometry are 
introduced. A literature survey includes the factors that may affect cell viability and the 
theory of flow cytometry which is used to study various physiological states of yeast cells. 
 
Chapter 3 Materials and methods: the equipment and chemicals used throughout this study 
are described. The methods to examine cell viability and bead characteristics are introduced. 
 
Chapter 4 Comparison of probiotic yeast viability produced from various processing and 
environmental conditions: viability of yeast cells produced from different processes is 
investigated by colony plate counting (CPC) and flow cytometry (FC). Some factors that 
have an impact on cell viability are described. The correlation between the number of 
culturable and viable cells in particular processing and environmental conditions is 
established. 
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Chapter 5 Freeze drying of wet yeast and compaction of them into tablet dosage form: yeast 
cells were freeze dried at various conditions before mixing with other excipients and 
compacting into tablets at different ratios and compaction pressures. Tablet properties i.e. 
tensile strength and water activity, and cell tablet storage stability results are described. 
 
Chapter 6 Encapsulation of yeast cells to improve their survival after tableting: yeast cells 
were encapsulated with two different biodegradable materials in order to maintain cell 
viability inside encapsulating beads and to protect cells from damage by external stresses. 
Physical properties of encapsulating beads as well as cell viability in the beads are presented.  
 
Chapter 7 Evaluation of calcium pectinate (CaP) bead properties and compaction of CaP 
beads into tablet form: mechanical properties of calcium pectinate beads were measured by 
diametrical compression tests. This chapter shows the results of cell viability in tablets 
containing CaP beads and other excipients produced at different compaction pressures, as 
well as cell storage stability in these formulations after 3 and 6 months. 
 
Chapter 8 Final conclusions and future work: the overall conclusions and recommended 
future studies are presented. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 INTRODUCTION 
 
In this chapter, the benefits of probiotic yeasts in animal nutrition are introduced. The 
measurement of cell viability by various methods is discussed, as well as the use of such 
measurements in investigations of factors influencing cell viability. By considering a number 
of recent studies concerning probiotic bacteria and yeast, the use of flow cytometry (FC) is 
summarized, together with some fluorescent dyes in the investigation of many aspects of 
yeast physiology. An overview of encapsulation technique to protect microorganisms from 
harsh conditions is introduced. Based on the review, encapsulation of yeast cells has been 
applied to protect yeast cells from tablet compaction pressure in probiotic and food 
supplement application. In addition, the material properties of single calcium pectinate (CaP) 
beads determined by diametrical compression are considered.  
 
2.2 PROBIOTICS AND THEIR USE 
 
At the beginning of the 20th century the grandfather of modern probiotics, Elie Metchnikoff, 
demonstrated the health benefits of lactic acid bacteria in yoghurt that helped digestion and 
improved the immune system in human bodies. This was explained by the possibility of 
modifying harmful microbes to useful microorganisms in the large intestine. It has taken over 
a century for his hypothesis to be proved and the term of “probiotics” to be defined. In 1965, 
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Lilly and Stillwell first claimed probiotics as ‘substances secreted by one organism which 
stimulate the growth of another’ (Lilly and Stillwell, 1965). Nine years later, a different view 
from Parker (1974) introduced probiotics as ‘organisms and substances which contribute to 
intestinal microbial balance’.  
 
The definition of probiotics which is now internationally accepted is “live microbial food 
supplements that beneficially affect the host by improving its intestinal microbial balance” 
(Fuller, 1989). More recently, probiotics have been known in prevention and treatment of 
infections, for example reduction of cholesterol, suppressing the growth of pathogens, 
stimulating the immune system and reduction in risk of cancer (Anderson and Gilliland, 
1999, Agerholm-Larsen et al., 2000, Kailasapathy and Chin, 2000, Gotcheva et al., 2002, 
Nomoto, 2005, Nguyen et al., 2007, Jones and Jew, 2007). 
 
2.2.1 Benefit of probiotics  
 
The selection of microbial strains for probiotics has been decided based on the amenability of 
the cells to industrial handling and their ability to remain viable until they reach the 
appropriate site in the body. However, there are differences in the composition of intestinal 
microflora in various host species, therefore this should be taken into account in selecting the 
strain of probiotic. There is some scientific evidence showing that particular species of 
bacteria such as Bifidobacterium, Lactobacillus and Streptococcus and particular strains of 
yeast such as Saccharomyces and Torulopsis have health benefits in human and animals 
(Tannock, 1995, Tannock, 1997, Berg, 1998). Beneficial effects of these bacteria include the 
regulation of the immune system, the balance of micro-flora and improvement of lactose 
digestion (Saad et al., 2013, De Vrese et al., 2001).   
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Saccharomyces boulardii and Saccharomyces cerevisiae are the most common yeast strains 
that have desirable properties used in probiotic products. They are resistant to antibiotics and 
reconstitute the intestinal microflora and thus, offer probiotic effects (Nousiainen and Setala, 
1993). Two strains of Saccharomyces isolated from infant faeces and Feta cheese have 
proved to have the ability to remove and assimilate cholesterol in the conditions found in the 
gastrointestinal (GI) tract (bile and low pH level of gastric juice) which is promising for their 
use as probiotics (Psomas et al., 2003). Moreover, some strains of dried yeast have been used 
for the prevention of vitamin B deficiency, the treatment of diarrhoea, lactose intolerance 
conditions, irritable bowel syndrome and those symptoms associated with Clostridium 
difficile colitis infection (Reynolds, 1982, Enache-Angoulvant and Hennequin, 2005, Marteau 
et al., 2001, McCullough et al., 1998). 
  
2.2.2 Viability of microorganisms within the GI tract 
 
The adverse environment in the GI tract, especially the low pH in the stomach, is the main 
problem for microorganisms to remain viable during their passage through the intestine. The 
survival of probiotics in the GI tract mainly depends on the strain and formulation of the final 
product (Holzapfel et al., 1998, Schillinger, 1999). It has been reported by Conway et al. 
(1987) that four strains of lactic acid bacteria had low survival when they were freely 
suspended in gastric juice but had the ability to survive and adhere to endothelial cells 
enhanced by the addition of milk. Similar results were obtained by Charteris et al. (1998) in 
that lactobacilli and bifidobacteria are bile-salt resistant but are sensitive to stomach acidity. 
However, the addition of milk and mucin helped protect them from acidic conditions in the 
upper gastrointestinal transit. 
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Several studies have claimed that it is not necessary that some probiotic strains remain viable 
whilst still offering health effects such as immune modulation and lactose tolerance condition 
(Ouwehand and Salminen, 1998, Salminen et al., 1999), which may be called prebiotics. 
Viable and non-viable lactic acid bacteria showed a health effect in the treatment of 
candidiasis and in reducing the duration of diarrhoea (Ouwehand and Salminen, 1998). 
Understanding prebiotic effects although interesting is not considered in this work.   
 
Moreover, it is thought that probiotic microorganisms have to be able to adhere to the 
intestinal endothelium and subsequently be capable of exerting probiotic effects (Tannock, 
1995, Tannock, 1997, Fuller, 1992). However, the effectiveness of the probiotics is affected 
by the varying levels of indigenous and exogenous microflora found in the GI tract (Freter, 
1992). Investigation of adhesion of probiotic cells on intestinal endothelium is out of the 
scope of this project. 
 
2.3 CULTURABILITY AND VIABILITY 
 
2.3.1 Colony plate counting 
 
Reproductive growth is one proof of life which is associated with cell viability. The 
characteristics which indicate viable cells are the presence of structure, changeable genetic 
information and metabolism or functional activity. Colony plate counting is a classical 
technique to measure cell culturability, which is used to indicate cell viability. This technique 
has limitations particularly when the cells are stressed or injured. Lack of reproduction on 
agar does not prove that cells are dead. Likewise, lack of culturability may be accounted for 
by several factors which include cells being in a dormant state, prolonged nutrient limitation, 
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or the culture plates not being incubated for long enough for the cells to adjust to the new 
environment and nutrient availability. 
 
2.3.2 Viable and non-culturable cells  
 
One of the factors indicating whether microbial cells are dead or alive depends on their 
capability to reproduce themselves. It is possible to define cells with reproductive capability 
as ‘viable’ (Bogosian and Bourneuf, 2001). Concerning bacteria, the authors showed that 
once the energy source in the medium is exhausted, the bacteria will lose their cytoplasmic 
membrane potential. If the nutrients are restored, such dormant bacteria may regain metabolic 
activity, membrane potential, and the capacity to grow. Cells with no cytoplasmic membrane 
potential but retaining cytoplasmic membrane integrity have the potential to become healthy 
and metabolically active once suitable conditions are restored. Such cells are considered as 
dormant or viable but non-culturable (VBNC). VBNC recognises the potential of dormant 
cells with an intact cytoplasmic membrane but no membrane potential (MP) to become 
healthy once again and thus fully function and possibly reproduce.  
 
The terms ‘viability’ and ‘culturability’ in microbiology have similar definitions, however the 
term viable but non-culturable has been applied to cells which failed to yield growth on solid 
media (Kell et al., 1998). It has been stated that VBNC is a survival strategy using the main 
control networks to regulate a genetically programmed sequence to enhance survival, hence 
these cells are capable of reversing this response and resuscitate to an actively metabolising 
state when the conditions for growth improve. The results in terms of public health studies 
indicate that these cells may not cause disease or be harmful. 
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2.4  FLOW CYTOMETRY 
 
A unique and powerful technique, flow cytometry, consisting of the words ‘flow’, ‘cyto’ and 
‘metry’, means the physical and/or chemical measurement across a wide range of single cells 
or biological/ nonbiological particles within a sample flowing in a liquid stream past a series 
of laser beam detectors. It allows quantitative investigation of whole cells and cellular 
compositions which have been marked by various fluorescent dyes, i.e. cell physiology. The 
advantage of flow cytometry is its ability to analyse both homogeneous and heterogeneous 
cell cultures within an enormously complex population of different cell types. This 
quantitative analysis technology describes the different characteristics of single cell 
populations as they flow in a liquid medium past an excitation light source of a laser beam 
with the capability of analysing up to 1,000 cells per second, providing real-time microbial 
analysis. Non-target cells are discriminated from target cells by using multi-fluorescence 
colour specific labelling to increase the information available (Vesey et al., 1994). 
 
2.4.1 History and background 
 
The history of flow cytometry began in Stockholm in 1930 when Caspersson and his 
colleagues pioneered microspectrophotometric measurement and obtained the apparatus for 
cytology automation (Shapiro, 2003). Moldaven proposed the concept of cell counting by 
flowing fluid through a capillary tube using a photoelectronic sensor, but this instrument has 
not hitherto been successfully built (Shapiro, 2003). Albert Coons was successful in applying 
the fluorescent antibody technique to mark specific cellular proteins (Radcliff and Jaroszeski, 
1998). A paper published by Gucker et al. (1947) accomplished the flow cytometric detection 
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of bacteria in aerosols using a laminar sheath stream of air. This work was done by analysing 
dust particles and airborne microbial spores used as biological agents.  
 
Crosland-Taylor (1953) adapted the sheath flow principle and attempted to count red blood 
cells in fluid flowing through a narrow tube. However, the experiment was described as 
suffering from some problems and found to be difficult due to the fluid being easily blocked 
in the tube. A wider tube was tried in order to overcome these drawbacks by allowing more 
particles to travel side by side, but this led to errors in counting (Shapiro, 1988). Kamentsky 
et al. (1965) performed an experiment to measure the nucleic acid content and light scattering 
of mammalian cells in a flow stream which can analyse 500-1000 cells per second. The 
applications of flow cytometry have been mainly used for the study of mammalian cells, 
particularly in the field of microbiology which is fully developed in the commercial market.  
 
Initial flow cytometry was limited by the size of the microorganism which had to be smaller 
than leucocytes. Improvements in optics technology led to obtaining the better fluorescent 
stains and were applied successfully to microorganisms thus allowing flow cytometry to be 
further developed. Hutter and Eipel (1979) investigated DNA contents in Saccharomyces 
cerevisiae by staining with propidium iodide (PI) and then using flow cytometry to obtain 
accurate results. This technique is able to discriminate between live and dead cells on the 
basis of the altered light scattering behaviour and can be used in large populations.  
 
2.4.2 Flow cytometry principles 
 
A cell suspension, prepared for analysis and introduced into a narrow tube, can be assessed 
by two types of physical phenomena: light scattering and fluorescence behaviour. A single 
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cell in suspension is hydrodynamically focussed through the flow cell, which forms a laminar 
flow across the surface in order to prevent mixing of sample and sheath fluid stream. Cell 
concentration is controlled at a low level of nearly zero to ensure that it contains a single cell. 
Some vibration within the flow cell takes place to make a uniform stream of the droplet 
through the flow cell (Davey and Kell, 1996). After cells of interest are fluoresced, the 
analysis of light scattering and fluorescence data are electronically assessed utilizing a 
computer and software following cell sorting procedure.   
 
In the beginning of cell counter operation, an electronic counter was produced to count 
thousands of cells per second by which the sample passes through the small hole at constant 
flow rate. The measurement system detects the output which goes above the threshold level 
and then the cells are counted. Before the cell counter was available in the market, people 
used a haemocytometer to count the blood cells under a microscope; therefore the precision 
of cell counter became a problem. 
 
2.4.3 Advantages and disadvantages  
 
The advantages of flow cytometry over the CPC technique (in section 2.3.1) are well 
described by Shapiro (1995) and Davey and Kell (1996). By using various mixtures of 
fluorescent dyes it is possible to study the physiological state of yeast cells beyond 
culturability in either homogeneous or heterogeneous populations. It is used to allow rapid 
data acquisition with direct methods for the detection of viable microorganisms in real time 
providing statistically accurate results.  
Disadvantages of flow cytometry include the high cost involved in a laser based system and 
instrument servicing. Flow cytometry is also inappropriate for the analysis of filamentous 
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organisms, or cells that have a tendency to aggregate resulting in coincidental events. It is 
intended to use an existing FC to characterise physiology of probiotic yeast cells, which can 
be well dispersed in a suspending liquid. 
 
2.5 DETERMINATION OF CELL VIABILITY BASED ON THE 
APPLICATION OF FLUORESCENT PROBES 
 
Fluorescent dyes function as viability probes to detect physiological metabolic changes of 
cells after a short period of exposure (Mason et al., 1994). When applied with flow 
cytometry, fluorescent dyes allow the detection of different applications such as metabolic 
activity, reproductive ability and membrane integrity in order to determine basic cell 
functions (Caron and Badley, 1995). The method characterizes cell populations based on light 
scattering and fluorescent dyes binding to the specific site of individual cells. Each of the 
fluorescing cells reacts by producing a light scattering signal and a fluorescent emission 
which varies depending on the specific properties of the individual cells. For example, 
propidium iodide (PI) and SYTO9 are used to measure membrane integrity which is achieved 
by binding to the DNA of the cell (Figure 2-1).  
 
A broad range of reviewed articles on fluorescent stains have been reported, which have 
subsequently been applied in further microbiological analyses. Many of them have emerged 
for flow cytometric studies of eukaryotic cells such as yeast by distinguishing the properties 
and measuring the activities of cells in artificial or natural mixtures (Carter et al., 1993, 
Davey and Kell, 1996, Deere et al., 1998).  
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Figure 2-1 Schematic diagram showing application of fluorescent probes to investigate 
cellular viability and cell physiology  
 
2.5.1 Cytoplasmic membrane potential 
 
Across the cytoplasmic membrane the cell generates an electrochemical gradient referred to 
as the membrane potential. It determines if the cells have selective permeability and active 
transport of charged molecules through the cytoplasmic membrane. The presence of 
cytoplasmic membrane potential is one of the most important characteristics of viability. 
Assessment of viability can therefore be based on the presence or absence of an intact 
polarised cytoplasmic membrane and the transport mechanisms across it.  
 
When exponentially growing cells are stressed by heat or energy starvation, they are 
particularly possessed by an active extrusion pump and become metabolically compromised 
before electrical depolarisation. At this stage, membrane potential is substantially decreased 
and the cells allow lipophilic dyes to pass through the cytoplasmic membrane easily and 
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accumulate due to the charges (Shapiro, 2005). Depolarisation can be measured with anionic 
probes known as Bis-(1,3-Dibutylbarbituric acid) Trimethine Oxonol (bis-oxonol, BOX, 
DiBAC4). This dye is allowed to access the permeabilised cytoplasmic membrane. When it is 
used together with PI, the culturability of the cells can be detected based on whether there is 
the presence of an intact fully energised cytoplasmic membrane (Davey and Kell, 1996, 
Hewitt and Nebe-Von-Caron, 2004).  
 
2.5.2 Membrane integrity (impermeant dye) 
 
Dead cells with a permeabilised cytoplasmic membrane can be identified with propidium 
iodide (PI), which fluoresces red and binds to nucleic acid and is unable to cross an intact 
cytoplasmic membrane. PI concentration in an extracellular medium must be maintained in 
excess due to the fact that the binding of PI to the DNA is reversible (King, 2000). Dead cells 
are also classified as those without an intact cytoplasmic membrane. The membranes of dead 
or dying cells are permeabilised and unable to maintain the cytoplasmic membrane potential; 
hence the internal structures are freely exposed to the environment. Additionally, the 
indication of dead cells can be noticed from a reduction of ATP or energy in the cytoplasmic 
membrane. Therefore, another characteristic of dead cells is an increase of cell permeability 
of the cytoplasmic membrane. 
 
2.5.3 Membrane integrity (permeant DNA stain) 
 
The permeant DNA stain, SYTO9, has been combined with PI in a commercially-available 
viability stain (FungaLight, Molecular Probes). This green fluorescent nucleic acid stain has 
the ability to penetrate and label all yeast cells with intact membranes and damaged 
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membranes. When used with the red fluorescent nucleic acid stain PI (see section 2.5.1), PI 
only penetrates to the DNA of those cells with damaged membranes where it displaces 
SYTO9, reducing the green fluorescence. Therefore, yeasts with intact cell membranes stain 
fluorescent green and those with damaged cell membranes stain fluorescent red. Zhang and 
Fang (2004) quantified the viability of Saccharomyces cerevisiae using flow cytometry by   
staining cells with SYTO9 and PI.  
 
2.6  FACTORS INFLUENCING YEAST VIABILITY 
 
2.6.1 Processing conditions 
 
2.6.1.1  High pressure homogenisation 
 
There are a number of reports on studying the effect of high pressure homogenisation on cell 
viability of gram positive and gram negative microorganisms (Lanciotti et al., 1994, Guerzoni 
et al., 1999, Vannini et al., 2004). The pressure from homogenisation influenced cell viability 
at different temperatures where cell viability of Saccharomyces cerevisiae decreased when a 
homogenisation pressure over 1000 bar was used at 20-30 °C (Guerzoni et al., 1999). Shear 
from high pressure homogenisation (Kleinig and Middelberg, 1998) and cavitation from ball 
valves have been identified as the primary mechanisms to cause cell disruption in yeast 
(Middelberg, 1995). Cell disruption is not of interest in this work, but the effects of 
mechanical forces generated in various processing steps including tableting on cell 
physiology is worth being investigated. 
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2.6.1.2   Drying process 
 
Microorganisms for various products such as food, pharmaceuticals and beverages are 
produced by fermentation in aqueous solution. Preservation by desiccation is therefore an 
important process used to prolong the stability of microorganism for long-term storage. The 
preservation of the suspension should contain high initial cell concentration as the majority of 
cells died during the drying process (Bozoǧlu et al., 1987). Adverse temperatures, poor 
choice of protectant and rehydration methods are the causes of cell death in drying.  
 
Labuza et al. (1972) investigated the effects of drying conditions in spray and drum drying on 
yeast cell viability. When cells were exposed very rapidly to high temperatures even with a 
short residence time, this caused small damage to cells (Labuza et al., 1970). These studies all 
demonstrate the drying temperature and time had a negative impact on cell viability.  
 
2.6.1.3  Milling process 
 
Interest in the reduction of the particle size of freeze dried probiotic products, especially by 
jet milling and ball milling, has been rising, mainly for preparing powder in small sizes for 
microencapsulation applications (Gèze et al., 1999, Hayakawa et al., 1993). Picot and Lacroix 
(2003) reported that reduction in particle size of freeze dried bacterial products caused 
additional damage to cells, and that cells were then more susceptible to other stresses.  
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2.6.2 Environmental conditions 
 
Several studies have reported an insufficient number of microorganisms in commercially 
available probiotic products (Kailasapathy and Chin, 2000, Varnam and Sutherland, 2001). 
Not only the processing conditions cause reduction of bacteria survival, but also 
environmental conditions i.e. highly acidic fluid in the stomach. The environmental 
conditions during storage can decrease product shelf life even with storage at low 
temperature (Lee and Salminen, 1995). Due to such environmental effects, probiotic 
organisms might be in some physiological state that the colony plate counting (CPC, section 
2.3.1) cannot detect, but these cells might still be able to adhere to the intestine or target site 
and offer probiotic effects to the host (Kell et al., 1998). 
 
However, little information regarding the effects of processing and environmental conditions 
on yeast cells is currently available in the literature. Therefore, one of the main objectives of 
this thesis is to investigate the survival of S. cerevisiae in different processes and a simulated 
gastric liquid with varying pH.  
 
2.6.3 Residual moisture during storage 
 
Regarding the effects of the drying process in section 2.6.1.2, it is important for probiotic 
products to contain the minimum possible level of moisture in order to extend product shelf 
life. However, the determination of water content or moisture content is not sufficient for 
reliably predicting microbial responses and chemical reactions in materials because its 
definition and measurement does not inform if the water in the product is bound or free. The 
molecules in bound water are firmly packed and the density is greater than that of free water 
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so bound water can only be frozen at low temperature. Therefore, the determination of water 
activity is a more accurate indication of how tightly water is bound within the material 
(Mathlouthi, 2001). Water activity (aw) is a parameter that affects product quality and safety 
especially in food and pharmaceutical products. It influences colour, odour, flavour, texture 
and shelf life of the products and is also related to the stability with respect to chemical and 
biochemical reaction rates and physical properties (Troller and Christian, 1978, Duckworth, 
1975, Beuchat, 1981). In this thesis, the required water activity value (aw) of probiotic tablets 
should range between 0.1 and 0.3 in order to maintain probiotic storage stability (Dr Peter 
Jüsten, Lesaffre, France, Personal communication). 
 
2.6.4 Direct compression of probiotics into single tablets  
 
There are numerous routes by which drug substances can be administered. Oral dosage forms 
are the most widely used for the administration of small or organic drugs. They allow ease 
transportation, absorption to the large surface area of the small intestine and circulation in the 
body. Oral dosage forms include tablets, suspensions, capsules and solutions.  
 
2.6.4.1 Advantages and disadvantages of the tablet dosage form 
 
In the pharmaceutical industries, oral dosage is the most natural and easiest method to 
administer drugs to adult patients. The advantages of tablets are easy to administer and 
transport, economical to produce, accurate to control the dose, able to contain more than one 
therapeutic ingredient and can have a pleasant appearance. However, the disadvantages of 
tablet dosage form include the complexity of the manufacturing process, physiological factors 
during the absorption of active ingredient from tablets i.e. gastric emptying rate and the tablet 
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size which is likely to be problematic for children (Turkoglu and Sakr, 2009, Banker et al., 
2002). Overall, it is appealing to develop probiotic yeast in tablet dosage form if an adequate 
number of active cells can be incorporated into the tablet and their viability can be 
maintained.  
 
2.6.4.2 Direct compaction  
 
Direct compaction of powders into tablets has been widely used compared to the wet 
granulation process due to the elimination of some drying steps. Its advantages are lower 
labour costs, less processing stages and lower energy consumption (Jivraj et al., 2000, 
Rubinstein, 1988, Armstrong, 1997). The formulation of tablets prepared by direct 
compaction contains many excipients e.g. diluent, binder, lubricant and disintegrant. The 
mixing step is very important because of the differences in density of these substances and 
thus, segregation of the powder blend before compression is problematic. However, a 
solution to avoid segregation is to select the excipients having similar particle sizes. 
 
Microcrystalline cellulose (MCC) has been commonly used as filler or binder because of its 
good binding property, low bulk density, high dilution potential and lubricating property 
(Reier and Shangraw, 1966, Bolhuis and Waard, 2011). Many studies have explained the 
good compactibility properties of MCC over other fillers (Bolhuis et al., 1979, Williams et 
al., 1997). During compaction, the pressure increased with punch displacement and the 
particles will rearrange themselves causing volume and porosity reduction as shown in Figure 
2-2. After MCC undergoes stress, it deforms plastically, its molecules come in contact, and 
their physical and chemical interactions lead to formation of a rigid tablet (Bolhuis et al., 
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1979). At low stress, MCC is slightly elastic (Aulton et al., 1974) but at high stress, plastic 
deformation can occur permanently (Reier and Shangraw, 1966). 
 
 
Figure 2-2 Process of deformation mechanism during compaction (Stasiak et al., 2010) 
 
2.6.4.3 Effect of compaction pressure on cell death 
 
Several studies have shown the effects of compaction pressure on the reduction of the number 
of viable microorganisms (Chesworth et al., 1977, Plumpton et al., 1986b, Schiller et al., 
1968). The results indicated that cell death may be caused by shear or heat during 
compression (Chesworth et al., 1977). Blair et al. (1991) and Yanagita et al. (1978) claimed 
that larger microorganisms were ruptured by shear rather than heat. In addition, the authors 
also reported that plastically deforming materials at low stress compaction caused greater cell 
rupture than fracturing materials. For compaction of S. cerevisiae, lethal effects were 
influenced by pressure (shear), particle size of dried yeast and heat sensitivity (Plumpton et 
al., 1986b, Plumpton et al., 1986a). Added to this, Fassihi and Parker (1977) demonstrated 
that cells were killed due to shear stress at a low compaction pressure but at high pressure cell 
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disruption was attributed to local heat. One of the aims in this study was to investigate the 
effect of compaction pressure on yeast cell viability using colony plate counting (CPC; 
section 2.3.1) and flow cytometry (section 2.4) by varying compaction pressures during 
tableting. 
 
2.7  DRYING MICROORGANISMS 
 
Drying technologies have been applied to production of food and drug in bulk quantities, and 
also found to be the preferable preservation method (Morgan et al., 2006).Interest in drying 
methods has been shown in numerous industries including food and pharmaceuticals 
(Morgan et al., 2006). The dried form of microorganisms, produced via water removal 
presents many advantages in that it is light, compact and does not require subzero 
temperatures for storage and transport (Chan, 2002). There are numerous available drying 
methods, from which the ideal technique is selected based on the requirements of the sample 
in the final application. 
 
2.7.1 Freeze drying 
 
Freeze drying involves the separation of water from a wet solid product, with the use of 
freezing and vacuum drying, resulting in the material in its anhydrous state (Franks, 1998). It 
involves heat and mass transport respectively. It can be scaled up for manufacturing 
(Tsinontides et al., 2004). Freeze drying is considered as the most convenient and successful 
method and widely used as a dehydration method for cell preservation (Chan, 2002, Abadias 
et al., 2001b) and enhances cell survival during storage in comparison with other drying 
methods (King and Su, 1994, Chávez and Ledeboer, 2007, Fu and Chen, 2011). Materials to 
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be dried are initially frozen (at temperatures between -10°C and -30°C), followed by a 
sublimation of ice in a high vacuum (Chambers, 1949). Following the freeze-drying process, 
dried yeast cells generally remain unchanged morphologically and physiologically (Kirshop 
and Snell, 1984). 
 
Freeze drying enables heat sensitive materials to be dried without decomposition and it 
results in a product which can be rehydrated more easily. The water activity in the product 
can be very low therefore the storage stability of freeze-dried material is seen to be good 
(Chambers, 1949). However, some loss in cell viability can occur in the freeze-drying 
method. One of the main causes of cell viability reduction is the freezing stage, specifically 
the freezing rate, if not correct, can be detrimental to cell viability. After freeze drying, the 
cell survival rate can be as low as 0.1% (Atkin et al., 1949, Abadias et al., 2001a, Morgan et 
al., 2006) but for Saccharomyces, the average cell viability obtained after freeze drying is 5% 
according to National Collection of Yeast Cultures (NCYC) (Kirshop and Snell, 1984). Poor 
performance of yeast survival may be attributed to the larger size of cells compared with 
bacteria (Kirshop and Snell, 1984). The damage from the freezing stage often takes the form 
of injury to the protoplasmic membrane, possibly as a result of intracellular ice formation or 
due to the production of high concentrations of solutes. Morgan et al. (2006) found that 
damage to the fragile cell membrane is caused by the formation of large ice crystals which 
cannot be repaired thus reducing cell viability. It is ideal to employ a higher freezing rate to 
enable smaller ice crystals to form in order to minimize cell damage. A further disadvantage 
of freeze dried encapsulated products is the open porous structure in the final products (Fyfe, 
2011), the possibility of contamination and volume limitations within the freeze drying 
container. The variations in volume changing can have detrimental effects on the viability 
and appearance of freeze dried products.  
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Freeze drying has also been known to cause some adverse effects to proteins that appear to be 
denatured as well as causing damage to the cell membrane and cell wall. In this thesis, wet 
yeast was freeze dried as explained in section 3.10.1. In order to reduce these detrimental 
effects, numerous additives providing protection have been investigated in order to increase 
cell viability (Abadias et al., 2001a, Chan, 2002, Morgan et al., 2006). 
 
2.7.2 Protective agents 
 
During drying, microorganisms are more susceptible to an increase of osmotic stress as the 
water activity begins to decrease (Morgan et al., 2006). Completion of freezing is dictated 
when more than 99% water is removed from the initial dilute solution, and so as a result, 
rapidly increasing the total concentration of solute (Franks, 1998). One way in which 
microorganisms respond to this stress is by counteracting the osmotic stress and maintaining 
osmotic balance between concentrated extracellular and the more dilute intracellular 
environment. The solutes in the protective media facilitate the cells by aiding to stabilize the 
proteins and cell membrane during osmotic stress conditions (Morgan et al., 2006). The 
components of the protective media have two main functions in preserving cell viability. A 
dry residue with a definite physical structure behaves as a support medium and receptor in the 
rehydration step. The other function is to protect microorganisms biochemically from damage 
(Abadias et al., 2001a).  
 
There are a variety of simple and complex compounds that have been tested for their 
protective actions including polyols, saccharides or sugars, polymers, vitamins and minerals 
(Abadias et al., 2001a, Chan, 2002, Morgan et al., 2006). Coutinho et al. (1988) stated that an 
addition of 10% trehalose can maintain cell viability in yeast suspensions before drying. 
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Berny and Hennebert (1991) found that the viability of Saccharomyces cerevisiae increased 
from 30% to 98% by using an appropriate protecting medium containing 10% skimmed milk 
in the freeze-drying process. When selecting a suitable protective agent, it is important to 
note that the protection provided varies from strain to strain and can also be affected by the 
residual moisture content (Chan, 2002). 
 
2.8 ENCAPSULATION 
 
Encapsulation is a method involving physicochemical and/or mechanical processes in 
protecting a core substance from adverse environments (Champagne and Kailasapathy, 
2008). The core material is entrapped by a shell material, and capsule sizes range from 
nanometres to a few millimetres (Chen and Chen, 2007) and capsules can also be in different 
shapes (Shahidi and Han, 1993). In food and drug applications, the shell/coating materials are 
required to be biodegradable such as chitosan, alginate and pectin, which also does no harm 
to bioactive core components (yeast cells in this work) and the cells are maintained in a 
favourable environment whist the capsule passes through the GI tract.  
 
The main purpose of encapsulation of probiotic products is to protect the microorganisms 
from adverse environments and deliver adequate numbers of viable cells to the GI tract in 
order to offer probiotic benefits (Picot and Lacroix, 2004). For probiotic bacteria, there are 
various types of adverse environment i.e. high acid and bile salt conditions. For probiotic 
yeast in tablet dosage form, the compaction pressure is also likely to be an issue. Cell 
viability in the encapsulated matrix is dependent on various parameters such as the 
physicochemical properties of the matrix, initial concentration of cells, particle size and shell 
material (Chen and Chen, 2007). Kim et al. (2008) have reported the benefits of 
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microencapsulation of bacteria against acidic medium and enhancing the product storage 
stability. However, bacterial cells entrapped in a Ca-alginate matrix were not protected from 
acidic conditions due to the porosity of the matrix which allowed diffusion of acidic fluid to 
the cells (Sultana et al., 2000). Nevertheless, it is not known how yeast cells are susceptible to 
low pH liquid environment. The effects of suspending liquid with different pH on cell 
viability will be investigated. Moreover, the potential for increasing cell survival by 
encapsulating probiotic yeast with some biodegradable materials to provide favourable 
environments and thus to maintain cell survival rate during tableting and storage needs to be 
exploited. 
 
2.8.1 Extrusion method 
 
Numerous encapsulation techniques have been developed and applied to microorganisms in 
food and drug applications. Extrusion is the most common and oldest encapsulation method 
involving in forcing the cell suspension through a small capillary or syringe into a 
crosslinking solution which hardens the coating material to trap the core material in a form of 
solid particle (Sara, 1995, King, 1995). This technique was first patented and developed by 
Swisher (1957) and later on applied in the manufacture of unstable and volatile flavour using 
carbohydrate matrices (Gunning et al., 1999, Reineccius, 1989) where shelf lives of up to 5 
years were reported (Schultz et al., 1956). The active ingredient encapsulated by the extrusion 
method is surrounded by the coating material, but the disadvantage of this method is the 
resultant large particle size and defective structures i.e. thin wall and pores after processing 
(Westling et al., 1988, Kailasapathy, 2002, Wampler, 1992).  
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2.8.2 Biopolymers for encapsulation of microorganisms  
 
Some desirable characteristics of the carrier materials to encapsulate microorganism are: no 
activity or reaction with the cells, easy to handle and able to provide good protection of the 
active ingredients (Shahidi and Han, 1993). As the active ingredients in probiotic applications 
are microorganisms which are easily susceptible to damage in adverse environments, they 
require biocompatible and food-grade coating materials in order to maintain cell viability and 
exhibit appropriate physical properties for engineering processing leading to final use. The 
most suitable type of material for coating with the extrusion method is carbohydrate, water-
soluble and water-insoluble polymers (Desai and Jin Park, 2005, Anal and Singh, 2007). 
Encapsulation in an alginate matrix is the most popular system for bacterial cells 
(Champagne et al., 1994, Jankowski et al., 1997). Chandramouli et al. (2004) and Sheu et al. 
(1993a) found that cell survival in calcium alginate beads increased with an increase of bead 
size and alginate concentration when the beads were exposed to acidic conditions. However, 
Hansen et al. (2002) claimed that alginate microspheres larger than 1 mm have an adverse 
effect on the quality and texture in food applications but and small beads less than 100 µm 
did not give protection to cells exposed to acidic conditions.  
 
2.8.2.1  Shellac 
 
Shellac is a biodegradable, renewable purified product of natural polymer resulting from the 
secretion of the insect Kerria lacca (Coccoidea) which mostly are found on trees in Asian 
countries i.e. India, Thailand and China (Cockeram and Levine, 1961, Chambliss, 1992). 
Shellac has been used as an enteric coating material in food and drug application due to its 
low water permeability and excellent barrier properties in gastric fluids (Sheorey et al., 1991, 
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Pearnchob et al., 2004). However, shellac has the disadvantages in low solubility and stability 
in neutral pH solutions and therefore, the slow dissolution of shellac in intestinal fluids is a 
major problem. Pearnchob et al. (2003b) have reported the benefits of shellac as a moisture 
barrier, taste masking and high stability coating in tablet dosage form. Tablets coated with 
shellac resulted in extended drug release which is potentially useful in pharmaceutical 
applications. Limmatvapirat et al. (2008) have developed shellac as an excipient in the tablet 
for oral controlled drug delivery. Recently, a novel method using shellac as an encapsulating 
material of carbamide peroxide for tooth whitening has been introduced (Xue and Zhang, 
2008).  
 
In addition to the applications mentioned above, the use of shellac with microorganisms 
(bacteria) in probiotic application is a promising application to protect the cells against acidic 
pH and achieve controlled release in the GI tract as discussed by Stummer et al. (2010a). 
However, there has been no work on encapsulation of yeast cells Saccharomyces cerevisiae 
with shellac. 
 
2.8.2.2  Pectin 
 
Pectin is an anionic heterogeneous and water soluble polysaccharide found in the cell walls of 
most plants. It is non-toxic substance and can totally degrade by colonic bacterial enzyme 
(Cummings et al., 1979). Pectin contains a linear chains of (1→4) linked D-galacturonic acid 
and can easily be cross-linked with calcium ions in mild conditions. The carboxyl groups of 
this acid are esterified with methanol, which are naturally presented as methyl esters. Low 
degree of esterification (DE <50%) pectin forms more rigid gels with a cross-linking between 
galacturonic acid and calcium ion (Rolin, 1993).  
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Many authors have reported the benefits of pectin as a drug delivery to the colon (Rubinstein 
et al., 1990, Rubinstein and Radai, 1991, Munjeri et al., 1997) and as a carrier for sustained 
drug release (Aydin and Akbugˇa, 1996, Sriamornsak and Nanthanid, 1998a, Sriamornsak 
and Nunthanid, 1999a). Pectin has been used as a carrier of protein (BSA) for oral delivery 
since it can react with calcium ions and form calcium pectinate gel beads (Sriamornsak, 
1998). The author also reported the effects of bead size, the amount of protein added, 
entrapment efficiency, drying condition and calcium concentration on the release of BSA in 
calcium pectinate gel beads (Sriamornsak, 1998, Sriamornsak, 1999).  
 
Probiotic bacteria are found to be susceptible to pH in the GI tract, whilst a poor survival rate 
is also evident during product shelf life until point of consumption (Charteris et al., 1998, 
Conway et al., 1987, Holzapfel et al., 1998, Wang et al., 2004). Many studies have reported 
the improvement of cell viability by encapsulation of bacteria cells with some biodegradable 
and food-grade polymer such as alginate (Yoo et al., 1996, Jankowski et al., 1997, Sultana et 
al., 2000) and whey protein (Picot and Lacroix, 2004). More examples of probiotic bacteria 
encapsulated by the extrusion method are shown in Table 2-1. A few have reported 
encapsulation of yeast cells with alginate (Mahmoud et al., 1990, Cheong et al., 1993, Choi et 
al., 2007), chitosan (Raymond et al., 2004) and gellan gum (Tan et al., 2011). To the best of 
my knowledge, there has been no report concerning the encapsulation of yeast cells with 
pectin as a physical barrier in order to protect cells from severe environments, so that an 
adequate number of active cells can be released at appropriate sites and provide beneficial 
effects for the host. A major challenge of manufacturing probiotic yeasts in tablet dosage 
form is that yeast cells are exposed to compaction pressure so they might easily be damaged 
or become vulnerable to damage.  
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Table 2-1 Probiotic strains and encapsulation materials 
Probiotic strain Materials Reference 
Bifidobacterium infantis Gellan/Xanthan gum Sun and Griffiths (2000) 
Lactobacillus acidophilus, 
Bifidobacterium infantis 
Ca-alginate Krasaekoopt et al. (2004) 
Lactobacillus acidophilus Alginate-chitosan Urbanska et al. (2007) 
Lactobacillus casei Alginate/pectin Sandoval-Castilla et al. (2010) 
Lactobacillus rhamnosus Whey protein Reid et al. (2007) 
 
2.9 MECHANICAL PROPERTY DETERMINATION BY 
DIAMETRICAL COMPRESSION 
 
One of the important characteristics of excipients used for tablets made by compaction is to 
know their mechanical properties (e.g. brittle or ductile) in order to produce formulations that 
will result in rigid tablets. The investigation of mechanical properties of excipients in 
pharmaceutical applications by diametrical compression has been widely used to measure the 
strength of the materials (Fell and Newton, 1970, Stanley and Newton, 1977, Pitt et al., 
1988). This technique has been used with brittle materials and large particles (>200 µm) 
exhibiting plastic deformation (Bonollo et al., 1994, Procopio et al., 2003). For small 
biological and non-biological particles (20-90 µm), a micromanipulation technique was 
developed for the determination by diametrical compression (Andrei D et al., 1996, Zhao and 
Zhang, 2004, Zhang et al., 1992). 
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2.9.1 Hertz analysis 
 
Hertz theory has been used to determine the mechanical behaviour of spherical particles 
(Hertz, 1882). Firstly, some assumptions to be used with this analysis are valid for (1) 
material having small deformations up to 30% at high compression speed (Andrei D et al., 
1996), (2) materials are linear elastic and isotropic, (3) the contact interface between two 
solid materials is perfectly smooth. Later on, this analysis has been developed to use with 
various types of contact interfaces and material shapes (Stanley, 2001).    
 
In a different study, Zhao and Zhang (2004) determined the mechanical properties of two 
biocompatible micro-particles using a micromanipulation technique by compressing at 
different speeds. Wang et al. (2005) compressed single calcium alginate microspheres with 
diameters ranging between 80-130 µm using the same technique before mechanical 
behaviour for small deformation up to 30% was determined by an elastic model (Hertz, 
1882).  
 
2.9.2 Viscoelastic analysis 
 
Viscoelastic characteristics of a material can be explained by some mechanisms that occur 
during relaxation. The process involves either the transport of water from inside the 
microsphere or changes in the polymer network. In the case of a dried microsphere, transport 
of water is negligible. Yan et al. (2009) evaluated the mechanical properties of agarose 
microspheres by diametrical compression using micromanipulation. The authors also 
presented a modified Hertz equation which was used to determine the viscoelastic material 
behaviour from the experimental force-displacement data. For a more detailed review of 
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mechanical characterization of particles, beads and cells see Mercadé-Prieto and Zhang 
(2012). 
 
Although a number of developed techniques used in studying compaction behaviours of 
spherical particles e.g. Kawakita (Kawakita and Lüdde, 1971) and Heckel (Heckel, 1961) 
have been reported, only few studies have reported the correlation between the mechanical 
properties of single particles of pharmaceutical excipients and their compaction behaviour 
(Yap et al., 2006, Yap et al., 2008). In a tablet containing various excipients, individual 
particles have different mechanical properties and this may affect their compactability. 
Therefore, it is essential to understand how the individual primary particles behave and 
deform under compaction.  
 
Chapter 2  Literature Review 
____________________________________________________________________________________ 
 34 
2.10 CONCLUSIONS 
 
The benefits of probiotic yeast in animal nutrition and a development of a yeast probiotic in 
tablet dosage form were introduced in this chapter. Two well-known methods to examine cell 
viability: colony plate counting (CPC) and flow cytometry (FC) were reviewed. The factors 
that influence cell viability i.e. drying, milling, pH and compaction pressure were 
summarised. 
 
Therefore, the first objective in this study is to examine cell viability of yeast cells produced 
from various processing conditions by CPC and FC methods. Since yeast cells can be 
categorized into three physiological states after they are stained with propidium iodide (PI) 
and bis-oxonol (BOX), it is interesting to establish the correlation between the number of 
viable cells obtained from FC and the number of culturable cells obtained from CPC.  
 
Next objectives in this study are to examine the effects of freeze drying on yeast cells and to 
make tablets containing freeze dried yeast and other excipients with sufficient tablet strength, 
the number of active cells and product shelf life.  
 
The encapsulation technique offers some protection to core material to some extent. In this 
study, yeast cells are encapsulated with some biodegradable materials in order to protect 
yeast cells from tablet compaction pressure and to maintain cell viability during storage. Next 
objective is to minimize yeast cell damage during compaction with the help of encapsulation 
technique before producing tablets containing encapsulated yeast cells in beads and other 
excipients.   
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The beads with yeast cells embedded are subjected to pressure during tableting and therefore, 
the final objective is to understand the mechanical behaviour and deformation of these beads 
by diametrical compression tests. 
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CHAPTER 3 
 
MATERIALS AND METHODS 
 
3.1 INTRODUCTION 
 
Yeast cells were provided by Lesaffre, France, which were mainly in two forms: embedded in 
dried granules and wet yeast cells directly from fermentation. In order to make rigid tablets 
with a sufficient number of viable cells, a series of experimental works have been conducted, 
including homogenisation of the yeast granules using different speeds to release cells from 
them, and exposure of yeast cells to artificial gastric/intestinal fluid of different pH to identify 
suitable formulations. Wet yeast cells were encapsulated into a matrix and then dried using 
different methods. Yeast granules or encapsulated and dried yeast cells were mixed with 
various industrial excipients, which were then compacted into tablets using different 
pressures. The tablets with yeast cells were then stored under ambient conditions to 
investigate their stability. 
 
The cell viability of yeast in each form was determined by two main methods. One was a 
traditional method, colony plate counting (CPC) in which the number of culturable cells is 
counted after a certain period of incubation. The other method was flow cytometry (FC), 
which is more accurate and allows more detailed investigation of cell physiological state.  
 
The main objectives of this study were: to use CPC and FC to determine the viability of 
probiotic yeast S. cerevisiae produced in various forms, to establish a correlation between the 
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number of viable cells obtained from FC and CFU/g data from colony plate counting method, 
and to maximize the number of viable yeast cells in rigid tablets by producing them using 
minimum compaction pressure. Special attention has been paid to encapsulation of yeast cells 
in a biocompatible matrix to form beads, which can create a micro-friendly environment and 
provide certain protection to cells when they are compacted into tablets. It is hypothesized 
that the beads with cells should possess certain mechanical properties in order to protect the 
cells. Therefore, their mechanical properties have also been characterized. 
 
Additionally, scanning electron microscopy (SEM), image analysis (QICPIC) and particle 
sizing (Mastersizer) were used to study the physical properties of the beads with yeast 
embedded. Other measurements include water activity (aw) of dried cells, dried beads, and 
excipients used for compaction and dry cell weight (DCW). The details of these methods are 
described below. 
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3.2 COLONY PLATE COUNTING (CPC) 
 
3.2.1 Buffers and solutions 
 
TS buffer was prepared by dissolving 1 g of Bacto tryptone (BD Bioscience, UK) and 8.5 g 
of NaCl (Sigma Aldrich, UK) in 1 L distilled water. Oxytetracycline solution was prepared 
by stirring 1 g of oxytetracycline dihydrate (Sigma Aldrich, UK) in 100 mL of distilled water 
for 30 min before 2 mL of 0.2 M HCl solution was added and the mixer was stirred for 
another 30 min. The mixture was filtered by a sterile 0.25 µm membrane filter and kept at 
4°C in a dark place. 
 
Phosphate buffered saline solution was made by dissolving one PBS tablet (Sigma Aldrich, 
UK) in 200 mL distilled water, and autoclaved for 15 min at 121°C and 1 atm. 
 
Aseptic technique was applied in all experiments to prevent contamination by other 
organisms, particularly bacteria. Distilled water was used in all experiment unless stated 
otherwise. 
 
3.2.2 Yeast strain and samples  
 
Saccharomyces cerevisiae was originally received from Lesaffre International, France (Table 
3-1) in the forms of (1) wet yeast (WY) i.e. yeast cake harvested from a fed batch 
fermentation then centrifuged and filtered using a rotary vacuum drum, (2) active dried yeast 
granules (ADY): yeast cake which was processed in a drum dryer at 40-42°C for total drying 
time of 10-20 h and (3) milled yeast (MY): ADY with the granule size reduced by a 
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comminutor before discharge through a 30 mesh (≈590 µm) screen. d50 of MY is 403 µm. 
Before use, ADY and MY were kept at 4°C in vacuum packaging.  
 
Table 3-1 Three different forms of yeast - ADY, MY and WY received from Lesaffre, France 
with description of process conditions and yeast characteristics used in this research. 
 
Sample Code Process condition Description 
Wet yeast WY Fed batch fermentation/filtration Suspension (27-32% DCW) 
Active dried 
yeast 
ADY Drum dryer at 40-42°C for 10-20 
h 
Spherical granules (~ 92 % 
DCW), d50 = 1252 µm 
Milled yeast MY Comminutor/30 mesh screen Rod shapes (~ 95% DCW), 
d50 = 403 µm 
DCW: dry cell weight 
 
3.2.3 Cell viability determination 
 
In this study, three different methods were used to determine cell viability. Colony plate 
counting (CPC) to determine colony forming units (CFU) has been used to evaluate the 
viability of yeast cells based on serial dilution and the number of colonies that can grow on 
an agar medium after a certain incubation time (Postgate, 1969). Cells stained by methylene 
blue and counted using haemocytometry is another method to determine the number of alive 
and dead cells based on a principle of the blue to penetrate the wall and membrane of dead 
cell (Richard, 1932). The third method which not only measures cell viability but also 
physiological state is flow cytometry as described in section 3.8. 
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3.2.3.1    Yeast suspensions 
 
The preparation of yeast suspensions was based on the protocol adapted from Lesaffre 
International, France (Appendix 1) by dissolving 1 g of yeast in 100 mL of TS buffer and 
homogenising at 10-000 rpm using a T-25 Ultra-Turrax homogeniser (IKA, UK) for 3 min. 
This is equivalent to a dilution of 100 fold (initial concentration x 10-2).  
 
3.2.3.2   Agar plate preparation and cell enumeration  
 
Yeast malt extract agar (YME) was purchased from Sigma Aldrich, UK and an agar stock 
was prepared from 4.1 g of YME agar and 100 mL distilled water which were mixed together 
thoroughly, autoclaved for 15 min and then left until the temperature cooled to 48°C before 1 
mL of oxytetracycline solution was added. The agar stock was poured into a Ø90 mm petri 
dish and solidified at room temperature for approximately 30 min. Each cell suspension after 
homogenisation was serially diluted and 100 µL of each dilution was spread onto the YME 
agar plates by a sterilized spreader (Figure 3-1). The plates were incubated at 25°C for 72 h 
and at appropriate dilution, plates resulting in 30 to 300 colonies were counted (Appendix 1). 
This experiment was conducted in triplicate and the results were expressed as mean ± 95% 
CI. A statistical method (t-test) was used to determine whether or not data were significantly 
different at a confidence interval 95%.  
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Figure 3-1 A schematic diagram showing how serial dilutions were made from a yeast sample 
(initial dilution 100 fold i.e. 10-2). 1 mL of each sample was mixed into 9 mL of water and 
dilutions were made from 10-3 to 10-8.  100 µL of each dilution was plated onto YME agar 
and the plates incubated at 25°C for 72 h. 
 
 
3.3 PARTICLE SIZE DISTRIBUTION 
 
The size of yeast cells in ADY and MY suspension was determined by integrated light 
scattering using a particle size analyzer (Mastersizer 2000, Malvern Instruments Ltd., 
Malvern, UK) as shown in Figure 3-2. The analyzer was fitted with a laser beam which 
measured the angular variation in intensity of light scattered when a dispersed sample passed 
through the beam. The scattering data were then analyzed to calculate the size of the particles 
based on a volume equivalent sphere model. According to this calculation, optical properties 
such as refractive index of the sample and dispersant are required. In the experiment, the 
refractive index (RI) of yeast cells was set at 1.53 and that for water as a dispersant was 1.33 
(Smith et al., 2000). 
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Figure 3-2 Image of Mastersizer 2000 (Malvern Instruments Ltd., Malvern, UK) 
 
3.4 DRY CELL WEIGHT 
 
Dry cell weight (DCW) means the weight of a sample after water removal by drying in an 
oven. A certain weight of given sample was placed on a glass plate at 80°C for at least two 
days or until dried mass was constant. Dried weight was calculated accordingly based on the 
difference in the weight before and after drying and expressed in g/L or % dry cell weight. 
Dried cell weight determination of each sample was carried out in duplicates and the average 
of dry cell weight was presented with standard errors.   
 
3.5 Cell viability test based on staining by methylene blue and 
counting using haemocytometry  
 
A haemocytometer with methylene blue dye was used to determine yeast cell viability and 
the number of cells per mL in a suspension (Lehrer and Cline, 1969). The number of counted 
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cells in a given volume was converted to cell/mL by Eq. 3-1 and the percentage of cell 
viability was calculated by Eq. 3-2. Methylene blue was used to stain cells where dead cells 
with damaged cell walls allow methylene blue to penetrate into them resulting in a dark blue 
colour. In contrast, live or healthy cells remain unchanged. 0.9 mL of methylene blue staining 
solution (Sigma Aldrich, UK) was added to 0.1 mL of yeast suspension (of a known 
concentration), which was agitated for 1 min. One drop of this mixture after a 1000 fold 
dilution was placed onto the chamber covered with a cover slip and viewed under an optical 
microscope (Leica Microsystem Ltd, Milton Keynes, UK). Higher cell concentrations tend to 
create the blockage of light from the microscope. The counting chamber was thicker than a 
standard microscope slide and therefore it was necessary to use a 40x lens to give a clear 
image and avoid scratching the surface of the objective lens. At least 600 live and dead cells 
in 5 from 25 grids (see Figure 3-3) on 0.2 mm2 of the haemocytometer surface were counted 
separately through the microscope and recorded, as described in Richard (1932).  
 
 
Figure 3-3  Haemocytometer showing 5 grids from 25 where live and dead cells were 
counted 
 
 
4105 ×××= dilutioncountedcells
suspension
cellsofNumber
              (Eq.3- 1) 
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%100% ×
+
=
countcellDeadcountcellLive
countcellLive
viabilitycell
          (Eq.3- 2) 
 
3.6 EFFECT OF HOMOGENISATION SPEED 
 
1g of ADY or MY was dispersed in 100 mL of PBS and homogenised using a T-25 Ultra-
Turrax homogeniser (IKA, UK) at a speed between 6,000 and 15,000 rpm for 3 min prior to 
cell viability determination by CPC and FC analysis. Yeast suspension (initial dilution 10-2) 
was serially diluted according to section 3.2.3.2 before plated onto YME agar and incubated 
for 72 h. For FC analysis according to section 3.8, yeast suspension at dilution 10-4 was 
stained with PI & BOX and SYTO9 & PI respectively. CFU/g (based on dry basis) and the 
numbers of healthy, injured and dead cells were plotted against homogenisation speed with 
standard errors. Flow cytometric dot plots of two dual stains were also generated 
corresponding to different homogenisation speeds. 
 
3.7 EFFECT OF ENVIRONMENTAL CONDITIONS ON CELL 
VIABILITY 
 
3.7.1 Simulated gastric fluid preparation 
 
Acidic fluids of pH 1.2 and pH 2 were prepared by initially making up 0.2 M HCl and 0.2 M 
NaCl solution and then mixing these in different ratios depending on the required pH value 
(Table 3-2). Other acidic fluids were prepared by dissolving PBS tablets (pH 7) in distilled 
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water and then adjusting the pH by adding 0.2 M HCl. The pH of the solution was checked 
with a pH meter (Coming, pH meter 240, UK). All fluids were autoclaved for 15 min at 
121°C and 1 atm before use.  
 
Table 3-2 Preparation of simulated gastric fluid with different pH values  
(BP, Appendix XII B) 
pH 0.2 M HCl (mL) 0.2 M NaCl (mL) 
1.2 425 250 
2 65 250 
 
 
3.7.2 USP apparatus and in-vitro dissolution study 
 
In vitro cell release and dissolution studies of tablets were performed using an apparatus-I 
USP rotating basket (Figure 3-4a), which is equipped with eight vessels, a temperature bath, 
shafts and a standard British Pharmacopoeia (BP, 1999) rotating cylindrical basket. The 
samples/tablets were placed in the cylindrical basket (40 mesh, welded seam, Fig. 3-4b) held 
with the motor shaft (Fig. 3-4C) and rotated in a cylindrical vessel containing the dissolution 
medium. This was carried out in a constant-temperature water bath at 37 ± 0.5 °C for 2 h 
throughout each run. The rotation speed of the shaft was set at a constant speed of 100 rpm 
throughout the study.  
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(a)  
 
(b)  
 
(c)  
 
Figure 3-4 (a) USP dissolution apparatus containing eight vessels, equipped with a rotating 
shaft and operated in a constant temperature bath set at 37 ± 0.5 °C (b) rotating cylindrical 
basket (40 mesh) which is held by (c) a motor shaft during operation 
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3.8 FLOW CYTOMETRY ANALYSIS 
 
A BD Accuri C6 flow cytometer (MI, USA) (Figure 3-5) equipped with a 488 nm argon-ion 
laser for propidium iodide (PI) and bis-oxonol (BOX) excitation was used in this study. The 
red emission from PI (FL3) was collected with a 670 nm longpass filter. The green emission 
from BOX (FL1) was collected through a 533/30 nm band-pass filter. SYTO9, nucleic acid 
stain, emitting green fluorescence at 480/500 nm was combined with PI and used as a 
conventional direct-assay to measure viability based on membrane integrity. Yeast samples 
stained with single or dual dyes were passed through the flow cytometer and the data were 
collected. The acquired data of individual cell population combined with statistical data were 
plotted in histograms (frequency distribution) (Figure 3-6A) or dot plots (Figure 3-6B) which 
are the most common graphic representation. 
 
 
Figure 3-5 Accuri C6 flow cytometer (Ann Arbor, MI, USA) connected with CFlow software 
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(A)   (B)  
Figure 3-6 Flow cytometry data illustration (A) histogram (B) dot plot 
 
 
3.8.1 Flow calibration and fluid calibration 
 
Prior to flow cytometry experiments, it is necessary to validate the performance of the flow 
cytometer by using two default validation beads which are a 6 peak and 8 peak bead samples 
(Accuri C6, BD). These pre-diluted validation beads were stored at 4°C in the dark room and 
were used to analyze the fluorescence channels. The data of validation beads should look like 
the defined number of peaks as shown in Figure 3-7 (Accuri C6 user guide). Eight 
discernable peaks in FL1-H are shown for the validation of 8 peak beads and six discernable 
peaks beads in FL4-H are shown for the validation of 6 peak beads. If there was an indication 
of fewer peaks caused by an error of any of four fluorescence channels, the troubleshooting 
validation is needed (CFlow Accuri user guide).   
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(a)   (b)      
Figure 3-7 Validation data of 8 peak beads shown in FL1-H (a) and 6 peak beads shown in 
FL4-H (b) 
 
 
3.8.2 Threshold setting and fluidics rate  
 
Threshold is used to eliminate light scatter or fluorescent signals caused by debris or 
undesired events in cell samples. All the thresholds in BD Accuri C6 are set on the height 
signal for any given parameters. In this study, a primary threshold of 80,000 was set for yeast 
cells on FSC-H where given yeast cells can be collected and electronic noise in the system 
can be gated out (CFlow Accuri user guide). Any event not meeting the threshold criteria will 
not be acquired. 
 
The software of the system (BD Accuri C6 software) can accommodate an upper limit of 
10,000 events/sec where three different fluid speeds (low, medium and fast) can be adjusted. 
Fluidic rate setting which is recommended to acquire all samples is set at a low speed of 
2,500 events/sec or less to ensure the best data resolution. If not stated, fast fluidic rate was 
used i.e. during performing flow cleaning or running decontaminant fluids.  To analyze the 
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sample, gates can be drawn to the region where populations of interest are shown. The 
examples in Figure 3-8 show a gating of P1 and P2 population where cells of interest are. 
Cells presented in dot plots are selected based on the drawn gate and accordingly analyzed 
the physiological states. 
 
 
Figure 3-8 Flow cytometry data showing a gate of selected cell analysis within P1 and P2 
population 
 
 
3.8.3 Preparation of fluorescent dyes 
 
PI and BOX were obtained from Molecular Probes, Europe BV, Leiden, Netherlands. PI at a 
working concentration of 200 µg mL-1 made in distilled water and stored at 4°C was used to 
stain nucleic acid within the cells (Hewitt and Nebe-Von-Caron, 2001). For the case of the 
membrane potential dye, BOX, a working concentration of 10 µg mL-1 was made from 10 mg 
mL-1 stock solution in DMSO and stored at -20°C. For dual staining, 20 µL PI and 1 µL BOX 
were added into each sample, which was incubated for 5 min prior to flow cytometry 
analysis.  
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SYTO9, the green fluorescent nucleic acid stain, as a part of the LIVE/DEAD FungaLight 
yeast viability kit (Life Technologies Ltd, UK) has been used together with PI to determine 
yeast viability (Tanja et al., 2013, Zhang and Fang, 2004). The combination of 3.34 mM of 
SYTO9 and 20 mM PI were used together in a 1:1 mixture in 1 mL cell suspension. Samples 
were incubated at room temperature (37°C), protected from light for 15-30 min prior to flow 
cytometry analysis without cell washing. The data of the desired populations based on green 
and red fluorescent plot are shown in Figure 3-9.   
 
Figure 3-9 Yeast cell suspension containing a mixture of both live and dead cells stained with 
SYTO9 and PI and analyzed by FC 
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3.8.4 Control studies 
 
For flow cytometry, it is important to do control studies in order to discriminate between live 
and dead cells in population plots. 1 mL of yeast suspension as described in section 3.2.3.1 
was used as a population of healthy cells. To prepare a dead cell population, 1 mL of healthy 
cell suspension was added in an Eppendorf tube (Sigma Aldrich, UK) and centrifuged at 
5,000 rpm for 5 min. The supernatant was removed and 100% v/v ethanol was added to 
healthy cell pellet and left for at least 15 min to kill all cells present. After that, cells were 
washed and centrifuged with PBS solution twice before being re-suspended in PBS solution. 
 
3.8.5 Sample analysis 
 
Cell suspensions were serially diluted before staining or were used without staining with 
fluorescent dyes. 1 mL of sample at a known concentration was added in the polypropylene 
test tube and placed on a sample introduction probe (SIP, Figure 3-10). Data were collected 
and saved on an empty well in BD Accuri C6 software collect tab (Figure 3-11). In the BD 
Cflow plus software, the rate (events/ µL) was shown as default (Figure 3-11), in which the 
actual number of cells can be converted to a known concentration. 
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Figure 3-10 Sample introduction probe (SIP) and sample stage (Accuri C6 instrument 
manual) 
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Figure 3-11 BD Accuri C6 software showing empty wells to save the data, fluidic rate, 
threshold and run setting 
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3.9 CORRELATION BETWEEN CFU AND FC DATA 
 
In PI and BOX plots, cells which do not uptake PI are considered to be viable cells (healthy 
and injured cells). In order to determine the correlation between viable, healthy and injured 
cells and the number of culturable cells (CFU/g) obtained from CPC, the data in three 
different conditions: (1) three yeast samples (2) ADY suspensions homogenised with varying 
speed and (3) ADY suspensions exposed to a fluid of different pH were investigated. These 
data were fitted in a linear relationship by plotting the mean values with standard errors of 
two observed variables in a scatter plot and log scale. CFU/g is presented as the dependent 
variable on the ordinate and the number of viable, healthy or injured cells as the independent 
variable on the abscissa. Best fit straight lines and the corresponding linear equations were 
generated by Excel software. The correlation coefficient (R2) and slope were presented. 
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3.10 COMPACTION OF FREEZE DRIED YEAST INTO TABLET 
DOSAGE FORM 
 
3.10.1 Freeze drying condition 
 
WY was placed in a freeze dryer (Edwards, EF03, Crawley, UK) for 24 h and at 0.6-0.7 mbar 
(Figure 3-12). The initial temperature of its refrigeration unit was switched on until it reached   
-50 °C and then the drying temperature was maintained at 25°C to minimize residual water 
content until the end of the process. In case of adding protective agent, 10% (w/v) of 
skimmed milk (Berny and Hennebert, 1991, Abadias et al., 2001a) was added to WY prior to 
freeze drying (Figure 3-13).  
 
 
Figure 3-12 Freeze dried yeast (FDY) after freeze drying at 0.6 mbar for 24 h  
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Figure 3-13 Freeze dried yeast with addition of 10% skimmed milk after freeze drying at 0.6 
mbar for 24 h  
 
3.10.2 Particle size distribution (QICPIC) 
 
After 24 h freeze drying time, FDY (and MCC) was collected and milled by a food processor 
(Kenwood, FP260 series, UK) for 3 min. Particle size distribution was carried out using an 
image analyzer (QICPIC, Sympatec GmbH Inc., Clausthal-Zellerfeld, Germany) equipped 
with a dry dispersing unit GRADIS/L as shown in Figure 3-14. The minimum number of 
particles used to measure the mean diameter was 400 in order to give statistically 
representative results. Dried particles were fed into a high-speed dry disperser, which was 
connected to a Venturi tube. During the process, the dried beads were dispersed by the 
gravity disperser and centrifugal force caused by velocity gradients. The images of particles 
were captured by a high-speed camera and recorded by the image sensor therefore; the size 
and shape of particles were analyzed using Windox 5.0 software. The results of particle size 
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presented were based on triplicate experiments and expressed as mean ± 95% CI. The graph 
was plotted between density distribution and diameter (mm). 
   
 
               
Figure 3-14 QICPIC particle size and shape analysis (Sympatec, GmbH, Germany) 
 
Dispersing unit 
Venturi tube 
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3.10.3 Water activity 
 
To determine water activity of FDY particles, a disposable cup was filled to not more than 
half full with them. A Pawkit water activity meter (Figure 3-15) was used by placing it on the 
level surface of the disposable cup at room temperature.   
 
Figure 3-15 Portable water activity measurement system (Pawkit, Decagon Devices Inc, PA, 
USA) 
 
 
 
 
3.10.4 Preparation of excipients 
 
In this study, microcrystalline cellulose powder (MCC or Avicel Ph102, FMC Biopolymer, 
UK) as a widely used filler for direct compaction (Shangraw R and Demarest D, 1993) and 
magnesium stearate (Mg Stearate) (Sigma Aldrich, UK) as a lubricant (Armstrong, 1988) 
were introduced in all tablets. MCC was mixed with 1% w/w of MgSt using a double cone 
Gardner Laboratory Mixer (Kemutec Manufacturing Division, UK) for 2 min. MgSt has a 
lubricating property and helps preventing ingredients from sticking the die during 
compression process. The tablet total weight in this research was 1 g, which contained active 
ingredient (FDY), MCC and MgSt in particular ratios (Table 3-3). 
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Table 3-3 The amount of ingredients used in a one gram tablet 
  Amount (g) in one tablet 
90/10 80/20 50/50 
Filler MCC 0.09 0.19 0.49 
Active ingredient FDY/CaP beads 0.9 0.8 0.5 
Lubricant MgSt 0.01 0.01 0.01 
  
 
3.10.5 Tableting by direct compaction 
 
A Zwick/Roell Z030 universal testing machine (Herefordshire, UK) equipped with a 50 kN 
load was used for all compression studies (Figure 3-16a). A punch, 13 mm die and base plate 
manufactured from toughened stainless steel were used to make all tablets (Figure 3-16b). 
Compaction velocity was 30 mm min-1 and three tablets of each formulation were 
compressed. Aseptic technique and conditions by using Virkon (multi-purpose disinfectant) 
to eliminate other microorganisms were applied throughout the compression process. 
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(a)  
 
(b)  
 
Figure 3-16 (a) Zwick/ Roell Z030 universal testing machine for compressive and tensile 
strength of materials, force ranging 10 mN to 30 kN (b) tablet die with a diameter of 13 mm 
and base plate 
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3.10.6 Diametrical compression test for tablets 
 
The tensile strength of tablets was determined by diametr ical compression to their failure 
and typically it was evaluated not more than 24 h after compaction. A Zwick/Roell Z030 
equipped with a 50 kN load was set up as shown in Figure 3-17. The diameter and thickness 
of each tablet were measured accurately by a digital caliper micrometer gauge (Mitutoyo, 
U.K). Compaction velocity was 0.01 mm s-1 and three tablets of each formulation were 
compressed. Single tablets were placed upright at the middle of a base plate and compressed 
vertically. The plunger was moved downward and stopped once the tablet failure was 
detected. The force required to break the tablet was recorded and tensile strength (σT) was 
calculated by the following formula (Eq. 3-4): 
 
dT
F
T ∏=
2σ
                                                       (Eq.3- 3) 
 
Where;   σT is tensile strength (MPa) 
F is maximum force needed to break the tablet (N) 
d is diameter of tablet (mm) 
T  is thickness of tablet (mm) 
 
 The experiments of measuring tablet tensile strength were performed in triplicate and the 
results are expressed as mean ± 95% CI. 
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Figure 3-17 Zwick machine set-up equipped with a 50 kN load for measuring tablet tensile 
strength 
 
 
After compression, it was evident that a tablet showed a crack towards the end on the 
compaction direction. There was also a flat part of the tablet towards the crack as shown in 
Figure 3-18. Tensile strength can be calculated as defined in Eq.3-4.  
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Figure 3-18 A tablet containing calcium pectinate bead and MCC after the diametrical 
compression test 
 
 
3.10.7 Scanning electron microscope (SEM) 
 
SEM visualization of materials in this research was kindly assisted by Mrs. Theresa Morris, 
School of Metallurgy and Materials, University of Birmingham. Some specimens of tablets 
containing FDY and MCC were cut with a steel blade through the center to examine the 
cross-sectional internal structure. Samples were coated with a 30 nm layer of gold and then 
observed at an accelerating voltage of 10 keV prior to analysis. Morphological characteristics 
and images of samples were obtained using a scanning electron microscope (Philips XL-30 
SEM). 
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3.10.8 Tablet storage stability test 
 
Stability testing is used to establish a shelf life of a product before consumer handling. 
Tablets containing FDY and MCC in 50/50 (wt/wt) ratio, resulting from compaction at 75, 90 
and 105 MPa, were placed in a plastic container and stored in a cool place at 4°C ± 1°C, 
(69%RH ± 5%RH) for 3 and 6 months prior to storage stability test. These tablets were 
immersed in PBS buffer for 2 h using a USP apparatus (section 3.7.2) and homogenised at 
10,000 rpm for 3 min prior to colony plate counting and FC analysis. The experiments were 
performed in triplicate and the results are expressed as mean ± 95% CI. 
 
3.11 ENCAPSULATION OF YEAST CELLS WITH SHELLAC BY 
EXTRUSION 
 
Shellac (Marcoat 125) was provided by SYNTAPHARM Harke Group, Germany which had 
been produced by a solvent extraction method (Buch et al., 2009). This shellac solution with 
a dissolved solid content of 25% and pH ~7.5 was a clear, slightly amber and quite stable 
aqueous solution known as an ammonium salt. As it did not contain any preservatives, it 
could be diluted or mixed with any ingredients to the required concentration. Calcium 
chloride was acquired from Sigma-Aldrich (Dorset, UK) and of analytical grade. They were 
used as received without further purification. 
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3.11.1 Preparation of core material and cross-linking solution 
 
The core material was prepared by homogenizing 5 g of ADY in 100 mL of PBS for 3 min. 
The suspension was aseptically transferred into 50 mL centrifuge tubes and centrifuged at 
3,000 rpm for 10 min. The supernatant was removed and yeast cell pellet was collected and 
used as the core material in the encapsulation process. The pellet was washed thoroughly 
with 40 mL sterilized TS buffered solution. Afterwards, the pellet was resuspended in 20 mL 
of ammonium shellac to produce a suspension with a concentration of 20% (w/v). This 
suspension in a 250 mL beaker was stirred for 30 min with an overhead stirrer (Eurostar, 
IKA, Germany) at a high speed of 1,500 rpm and left for 15 min to remove bubbles before 
further usage. 
 
For preparing the cross-linking calcium chloride solution, 1.5 g of calcium chloride 
(CaCl2·2H2O) was dissolved in 100 mL sterilized distilled water. During capsule formation, 
the cross-linking solution was stirred constantly to avoid the aggregation of the prepared 
capsules. When the core material in droplets came into contact with calcium chloride 
solution, there was diffusion of calcium ions to shellac molecules, resulting in formation of 
the beads. The encapsulation process using different concentrations of CaCl2 was to study the 
mechanical properties of beads and the effect of CaCl2 concentration on yeast cell survival in 
tableting.    
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3.11.2 Production of calcium shellac bead  
 
The cell suspension containing cell pellet and shellac solution after stirring for 30 min was 
filled in a glass syringe and extruded through a Nisco Encapsulation unit (model Var J1, 
SPA-00195, Nisco, Zurich, Switzerland) with an inner diameter of 0.4 mm (Figure 3-19) by a 
syringe pump at a flow rate 120 mL h-1 before the droplets were dripped into a cross-linking 
solution bath for gelation. The distance between the nozzle and cross-linking solution was set 
at 2 cm. Calcium shellac beads containing cells prepared by this extrusion method, were 
formed instantly, which were allowed to immerse in CaCl2 for 15 min for hardening before 
being rinsed three times with sterilized distilled water.  
 
 
Figure 3-19 A Nisco encapsulation unit model VAR J1, SPA-00195 
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3.12 ENCAPSULATION OF YEAST CELLS WITH PECTIN  
 
GENU pectin type LM 101 (DM 36%) was generously supplied by Copenhagen Pectin, 
Denmark. These are low methylester pectin extracted from citrus peel which is suitable for 
pharmaceutical applications. The product has light colour and relatively fine particle size 
(100 mesh or 149 µm). Calcium chloride was acquired from Sigma-Aldrich (Dorset, UK) and 
used as supplied. 
 
3.12.1 Preparation of core material  
 
Pectin powder was dispersed in distilled water to a concentration of 5% w/v unless a different 
concentration is stated in Table 3-4 in order to determine how the mechanical strength of 
calcium pectinate beads affects viability of yeast cells in tablets produced at different 
compaction pressures.  
 
Table 3-4 The preparation of core material at different concentrations 
Pectin concentration (%w/v) Amount of pectin (g) Water (mL) 
3 1.5 50 
4 2 50 
5 2.5 50 
 
For encapsulation of yeast cells with pectin, core material was prepared by 10 g of wet yeast 
(WY) mixed with 50 mL of each pectin concentration in a 250 mL beaker and stirred with an 
overhead stirrer (Eurostar, IKA, Germany) for 30 min at a high speed of 1,500 rpm, which 
was left for 15 min to remove bubbles before further usage. 
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3.12.2 Production of calcium pectinate beads using a G23 needle 
 
The suspension of pectin and wet yeast as described in section 3.12.1 was pumped through a 
glass syringe and extruded through a G23 needle (0.33 mm in diameter) using a syringe 
pump. Droplets containing yeast were dripped into a bath of calcium chloride cross-linking 
solution for gelation at room temperature. The distance between the dripping tip and the 
gelling bath was at 7 cm (Chan et al., 2009). Magnetic stirring was used constantly in the 
cross-linking solution in order to avoid the aggregation of calcium pectinate beads. When the 
core droplets came into contact with the calcium ions, the beads were formed, which were 
further hardened in the same CaCl2 solution for 30 min. They were washed with distilled 
water twice before they were filtered and dried in a freeze dryer (Edwards, EF03, Crawley, 
UK) for 24 h.  
 
3.12.3 Optimization of calcium chloride concentration 
 
The concentrations of calcium chloride solution in the encapsulation process were varied to 
be 1%, 1.5%, 2% and 2.5% in order to determine whether calcium ion has an effect on 
viability of cells in entrapped beads by leaving them hardening in the solution for 30 min. 
 
3.12.4 Freeze drying of calcium shellac/pectinate beads 
 
Calcium shellac/pectinate beads prepared using the procedures described in section 3.11.2 
and 3.12.2 were freeze-dried in the freeze dryer (Edwards, EF03, Crawley, UK) before they 
were compacted into tablets. The beads were placed on a petri dish and subsequently put in 
the drying chamber. The refrigeration unit was switched on until the temperature reached -50 
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°C and the beads were dehydrated at 0.6-0.7 mbar for 24 h. The drying temperature was 
maintained at 25°C until the end of the process when the pressure was at 2.5-3.5 mbar.  
 
3.12.5 Characterization of beads with encapsulated cells 
 
Cell encapsulation efficiency and the properties of calcium shellac and pectinate beads 
obtained from the encapsulation process described above i.e. water activity value, particle 
size distribution and internal structure were studied. 
 
3.12.5.1 Particle size analysis 
 
The sizes of dried calcium shellac/pectinate beads were analyzed using an image analyzer 
(QICPIC, Sympatec GmbH Inc., Clausthal-Zellerfeld, Germany) as described in section 
3.10.2. The minimum number of particles measured to determine the mean diameter was 400 
beads in order to give statistically representative results.  
 
3.12.5.2 Water activity  
 
To determine water activity of the dried calcium shellac/pectinate beads, a disposable cup 
was filled to not more than half full with them. A Pawkit water activity meter (Figure 3-15) 
was used by placing it on the level surface of the disposable cup at room temperature.  
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3.12.5.3 Viability of cells entrapped in beads/tablets 
 
Calcium shellac or calcium pectinate beads with cells entrapped were homogenised in 100 
mL of PBS solution at a homogenisation speed of 10,000 rpm using a T-25 Ultra-Turrax 
homogeniser (IKA, Germany) for various times to fully release cells from the beads. Cell 
viability by CPC and FC was performed as described in section 3.2 and 3.8 respectively. 
 
0.5 g of calcium shellac beads was compacted into tablets using a Zwick/Roell Z030 
universal testing machine (Herefordshire, UK) as described in section 3.10.5. These tablets 
were immersed in PBS solution using the USP apparatus (see section 3.7.2) and cell viability 
was performed by CPC and FC as described in section 3.2 and 3.8 respectively. 
 
3.12.6 Optimizing calcium chloride concentration 
 
The effect of calcium chloride as a cross-linking molecule on cell viability was studied by 
varying its concentration at 1%, 1.5%, 2% and 2.5% (w/v). Cell viability in CaP beads made 
in each concentration was determined by CPC and FC together with PI and BOX and SYTO9 
and PI respectively (see section 3.2 and 3.8). The numbers of healthy, injured and dead cells 
against CaCl2 concentration with standard errors were obtained from FC analysis after cell 
suspension being stained with fluorescent dyes. 
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3.12.7 Encapsulation efficiency (EE) 
 
The encapsulation efficiency (EE) was calculated based on the initial number of yeast cells 
and those encapsulated in calcium pectinate beads (see Eq.3-5).  
 
%100)(
)(
×=
INPUTWYincellsofnumberTotal
OUTPUTbeadsCaPincellsofnumberTotalEE
 
      (Eq.3- 4) 
 
The number of cells in calcium pectinate beads was determined after they were freeze dried 
at 0.6 mbar for 24 h and it is assumed that there was no loss of cells during the drying 
process. Prior to determination of encapsulation efficiency, the beads with cells trapped must 
be completely dissolved before their total number can be counted. Firstly, 1 g of the beads 
was disintegrated in 100 mL PBS solution (pH 7) by using a USP apparatus operated at 37 °C 
and 100 rpm for two hours. 1 mL of pectinolytic enzyme was added in order to help degrade 
calcium pectinate beads. The use of the enzyme was to mimic the enzyme in human colon 
(Rubinstein et al., 1993, Ashford et al., 1994). After that, this suspension was homogenised 
for 3 min before the total number of cells was measured using flow cytometry.   
 
Another measurement to determine encapsulation efficiency based on number of culturable 
cells (%) of the beads was calculated using Eq 3-6 which was based on one gram of bead and 
WY.  
  
      %100)(
)(
×=
INPUTWYofCFU
OUTPUTbeadsCaPinCFU
cellsculturableofnumberonbasedEE  (Eq.3- 5) 
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3.12.8 Varying pectin concentration 
 
The concentrations of pectin were varied at 3%, 4% and 5% in order to investigate if high 
concentration of pectin solution could offer more protection to encapsulated yeast cells. It had 
been found that no spherical calcium pectinate beads could be formed when pectin 
concentration lower than 3% was used. The suspensions of yeast cells mixed with pectin 
concentration higher than 5% were very turbid and it was difficult to form the beads through 
a 23G needle and a syringe pump.   
 
3.12.9 Viability test under fluorescence microscope 
 
Cell suspensions of calcium shellac and pectinate beads were stained with SYTO9 and PI for 
30 min, a part of LIVE/DEAD FungaLight yeast viability kit, before they were observed 
under a fluorescence microscope (Olympus, AX70, Tokyo, Japan) equipped with a camera 
(Olympus DP70). The images obtained from the fluorescence microscope was analysed to 
determine live cells stained in green and dead cells stained in red.   
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3.13 EVALUATION OF CALCIUM PECTINATE (CAP) BEAD 
PROPERTIES AND COMPACTION OF CAP BEADS INTO 
TABLET FORM 
 
3.13.1 Diametrical compression test for CaP beads 
 
In order to study the mechanical properties and estimate the Young’s moduli of calcium 
pectinate beads, diametrical compression was performed using a 100 N load connected to 
Zwick/Roell machine as shown in Figure 3-20. At least ten calcium pectinate (CaP) beads 
were compressed. Firstly, one CaP bead was placed under a 100 N load. The maximum 
compression force used was set to be 95 N when the platen stopped compressing. The 
compression speed was set at 0.01 mm s-1 with/without holding time while the load and 
displacement data were recorded. The force-sampling time data for compressing single 
calcium pectinate beads were examined by the data acquisition software testXpert V9.01 
which had been installed in a computer directly connected to the Zwick machine. A typical 
force-displacement curve was plotted as shown in Figure 3-21.  
 
Nominal rupture stress is one of the parameters used to determine the mechanical strength of 
the particle (Yap et al., 2008). It is defined as the ratio of the rupture force at failure to the 
initial cross sectional area of the microparticle.  
 
 
Chapter 3  Materials and Methods 
____________________________________________________________________________________ 
 
75 
 
 
Figure 3-20  Zwick machine set-up with a 100 N load for measuring the mechanical 
properties of single calcium pectinate beads 
 
 
 
Figure 3-21 Typical load and unloading-displacement curve of a single CaP bead (2.3 mm in 
diameter) performed at a speed of 0.01 mm s-1  
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Young’s modulus of single calcium pectinate beads for the case of small deformation was 
calculated by Hertz equation (Hertz, 1882) (Eq 3-7). This equation is valid for deformation of 
CaP beads up to 30% nominal deformation or 10% strain (Andrei D et al., 1996). A Poisson 
ratio (ν) of 0.5 was chosen as the material was presumed negligible water loss and might be 
close to incompressible material (Wang et al., 2005).   
  
2/3
2 )1(3
2
∆⋅
−
=
ν
RE
F
                                    (Eq.3-6) 
 
Where  E  = Young’s modulus (MPa) 
  F = applied external force (N) 
  ∆ = total displacement of the moving platen (mm) 
  R = radius of calcium pectinate bead (mm) 
  ν = Poisson’s ratio 
 
3.13.2 Force relaxation 
 
In order to identify whether the beads were viscoelastic, single dried CaP beads were 
compressed by a 100 N load at a speed of 0.01 mm s-1 and then held at constant deformation 
for 3 min to allow force relaxation. Since there was no water loss under compression, any 
force relaxation during the holding can be considered to be due to their viscoelasticity.  
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3.13.3 Compaction of CaP beads into tablet 
 
Dried calcium pectinate beads (as described in section 3.12.4) were mixed with MCC and 
MgSt in different ratios as shown in Table 3-3. Every tablet weighed 1 g which contained 1% 
of MgSt to help prevent ingredients from sticking the die during compression process. 
Tablets were compacted using a Zwick/Roell machine (section 3.10.5) at a compaction 
velocity of 30 mm min-1.  
 
3.13.4 Storage stability test 
 
Tablets containing CaP and MCC in 50/50 (wt/wt) ratios compacted at 75, 90 and 105 MPa 
were stored in a cool place at 5 ± 1°C, (69%RH ± 5%RH) for 3 and 6 months. Tablets 
compacted at 90 MPa were also stored in a desiccator (45% RH ± 3%RH) at 5 ± 1°C in order 
to determine if relative humidity has an impact on cell viability. The average CFU/g tablet 
and FC data were plotted against compaction pressures. Flow cytometric dot plots of cells 
stained with PI and BOX and, SYTO9 and PI respectively were presented.  
 
Chapter 3  Materials and Methods 
____________________________________________________________________________________ 
 
78 
3.14 CONCLUSION  
 
This chapter details the materials and methods used to investigate the viability and 
physiological states of probiotic yeast cells in a range of processes related to preparation of 
samples from fermentation, compacting dry cells with excipients into tablet dosage form and 
their storage including encapsulation of them in biocompatible matrixes with an aim to 
improve cell survival in tableting and storage. The following chapters will present the 
detailed results with associated discussions. 
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 CHAPTER 4 
 
COMPARISON OF PROBIOTIC YEAST VIABILITY PRODUCED FROM 
VARIOUS PROCESSING AND ENVIRONMENTAL CONDITIONS 
 
4.1 INTRODUCTION 
 
Three different samples of yeast (as shown in Table 3-1) received from Lesaffre International 
(France) have been used to investigate cell viability by measurements techniques, i.e. colony 
plate counting (CPC) (Jayapal et al., 1991), haemocytometry with methylene blue (Richard, 
1932) and flow cytometry (Pore, 1991, Wenisch et al., 1997). Working at the single cell level, 
flow cytometry (FC) combined with a variety of fluorescent dyes e.g. propidium iodide [PI] 
(Ramani and Chaturvedi, 2000) and bis-(1,3-dibutylbarbituric acid) trimethine oxonol 
[DiBAC4(3) or BOX] (Dinsdale et al., 1995) has been used to assess microbial physiological 
states (Hewitt and Nebe-Von-Caron, 2001). PI is used to investigate DNA content and 
distinguish between live and dead cells. Dead cells with permeabilised cytoplasmic membrane 
or injured membrane can be stained with PI, which binds to nucleic acid but is unable to cross 
an intact cytoplasmic membrane. A membrane potential (MP), an electrical potential difference 
across the cytoplasmic membrane of a cell is required for energy production in the form of ATP 
during nutrient uptake. The lipophilic anionic dye known as BOX has been used to detect 
changes of MP by producing green fluorescence when the cytoplasmic membrane is 
depolarised or fully energised (Caron and Badley, 1995, Hewitt and Nebe-Von-Caron, 2004). 
The use of BOX combined with PI allows allocation of cells into three physiological states: (a) 
intact polarized cells without staining (b) injured cells with no membrane potential or 
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depolarized cytoplasmic membranes and (c) dead cells with permeabilised membranes (Davey 
and Kell, 1996, Hewitt and Nebe-Von-Caron, 2001). Another commercial viability kit, 
FungaLight, has previously been developed only for bacteria (Hope and Wilson, 2003, 
Lehtinen et al., 2003) and recently it has also been used to quantify yeast viability (Zhang and 
Fang, 2004, Tanja et al., 2013). 
 
FC is much more powerful microbiological technique than the traditional method of colony 
plate counting (CPC). It has the ability to discriminate between cells in a mixed population or 
heterogeneous suspension and can be used to resolve rapidly the physiological and metabolic 
state of single cells including those that are not culturable (Pore, 1991, Wenisch et al., 1997). 
Nevertheless, some characterization of cultures is best done by plate counting if one’s interest 
is limited to only those cells that have the ability to grow on solid media (Caron and Badley, 
1995). This method requires colonies to be visualized under a microscope after dilution plating 
of 109 to 1012, depending on the initial cell concentration (Jayapal et al., 1991). It assumes that 
the diluted sample is a homogeneous suspension of cells so that each colony grows from a 
single cell. However, the CPC method has always had drawbacks e.g. it is time-consuming and 
labour intensive because it involves solid media preparation, as the plates require incubation 
time and manual counting is often used.  
 
In this work, the size distribution of yeast suspension homogenised at different speeds was 
studied and hence, the effects of homogenisation speed on cell viability were evaluated. The 
factors influencing yeast cell viability i.e. heat from drying process, size reduction by milling 
process, compaction pressure from tableting and various pH values in the GI tract (simulated) 
were also investigated. Preliminary results of tablet dissolution time were examined by 
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dissolving a tablet in a USP apparatus for two hours. This was to determine whether all active 
ingredients from the tablet can be released within the limit of disintegration test (B.P).  
 
The aim of this study was to use both CPC and FC to determine the viability of probiotic 
Saccharomyces cerevisiae produced from various processing conditions and to study the effect 
of simulated GI tract conditions (pH values between 1.7 and 6.1) on such cells. It was also 
intended to correlate the number of viable cells obtained from flow cytometry and the number 
of cultural cells from CPC, and such a correlation may lead to the determination of how the 
stress level from either processing or environmental conditions affects yeast cell viability. 
 
4.2 RESULTS AND DISCUSSION 
 
4.2.1 Particle size analysis 
 
As the yeast samples (ADY and MY) received from Lesaffre was in the solid granule form, it is 
necessary to disperse them in a buffer using homogenisation and hence, to optimize the 
homogenisation speed which can release the maximum amount of yeast cells but generate 
minimum damage to them. Particle size data of ADY and MY suspension in Figure 4-1 and 
Figure 4-2 show a sharp peak ranging from 3-8 µm in size, which corresponds to the typical 
size of yeast cells (Jorgensen et al., 2002). It appears that after 3 min homogenisation, higher 
homogenisation speeds enhanced the number of cells released from the granules, as might be 
expected. The particle size distribution data of WY suspension (data not shown) show only one 
peak at all homogenisation speeds. This might be because WY received from fermentation did 
not contain other excipients. Viability of ADY cells released after applying different 
homogenisation speeds was determined (more detail in section 4.2.3.1) and it was found that in 
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this experiment, the maximum CFU/g and number of viable cells were found when a 
homogenisation speed of 10 000 rpm was used, hence this speed was applied in consequent 
experiments.   
 
 
Figure 4-1 Particle size distribution of ADY suspension after being homogenised for 3 min 
using a T-25 Ultra-Turrax homogenizer at various speeds. 
 
 
Figure 4-2 Particle size distribution of MY suspension after being homogenised for 3 min using 
a T-25 Ultra-Turrax homogenizer at various speeds. 
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4.2.2 Dry cell weight  
 
Since CFU calculation was based on dry cell mass, dry cell weights of ADY, MY and WY 
were obtained as shown in Figure 4-3. MY sample had a mean DCW of 95.6 ± 0.4 %, which 
contained the least amount of water among the three samples. WY harvested after fermentation 
contained the highest amount of water with an average of 26.1 ± 0.4 %. These DCW values 
were used to calculate true values of CFU/g dry cell mass.  
 
 
Figure 4-3 Percentage of dry cell weight comparison between ADY (91% ± 3%), MY (95.6% ± 
0.4%) and WY (26.1% ± 0.4%) after being left in the oven for 48 h; results are obtained from 
two measurements (n=2) and presented with standard errors 
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4.2.3 Viability determination  
 
In order to determine whether processing conditions have an effect on cell viability, studies 
were conducted on ADY, MY and WY. Cell viability was determined by FC using dual 
staining of PI and BOX. Three physiological states of cells were detected as described in Table 
4-1. The fluorescent emissions of BOX and PI represent green and red respectively. Moreover, 
two groups of dead cell population as shown in top right quadrant of PI and BOX staining 
(Figure 4-6; upper row) and in lower gating of SYTO9 and PI staining (Figure 4-6; lower row) 
were observed. Furthermore, when these populations of dead cells were sorted based on 
forward scatter/side scatter plots (FSC/SSC), the results can be explained by the presence of 
doublets which have two different sizes of dead cells (flow dot plots are not shown). 
 
Table 4-1 Distinct physiological states of S. cerevisiae after stained with PI and BOX 
 
Characteristics Staining pattern Quadrant 
Healthy BOX-, PI- Lower left 
Injured BOX+, PI- Upper left 
Dead BOX+, PI+ Upper right 
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4.2.3.1 Effect of homogenisation speed on yeast cell survival  
       
Suspensions of ADY were prepared at different homogenisation speeds for 3 min. The 
homogenisation speed was varied between 6,000 to 15,000 rpm. Cell viability was determined 
by FC using dual staining of PI and BOX and SYTO9 and PI. At low homogenisation speeds 
(<10,000 rpm), it appears that a large number of dead cells at granule surfaces were released 
which are thought to be cells damaged by heat (40-42 °C) in the drying process (Lesaffre, 
France) as shown in Figure 4-4. It can be noticed that similar results from using the two dual 
stains were obtained at homogenisation speeds from 6000 to 15000 rpm (Figure 4-6). At high 
homogenisation speeds, it is presumed that cells were vulnerable due to mechanical forces 
generated in the homogeniser.  
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Figure 4-4 CFU/g and the number of healthy, injured and dead cells of yeast suspension (based 
on 1 g of ADY) homogenised at different speed for 3 min and stained with BOX and PI. Data 
are obtained from triplicate studies (n=3) with standard errors 
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Figure 4-5 The number of total and viable cells measured by FC vs. CFU/g in CPC of ADY 
suspension at various homogenisation speeds 
 
 
Based on the data finding in Figure 4-5, CFU decreased when yeast granules were 
homogenised from 10,000 rpm to 15,000 rpm. At a speed of 10,000 rpm, the maximum number 
of viable cells measured by FC was 1.4×10+10 ± 0.5×1010  cells which corresponded to colonies 
of 1.3×10+10 ± 0.3×1010 CFU/g. The colonies on the agar plates are thought to be the number of 
single cells that are able to grow at the particular condition i.e. enough nutrients in the medium. 
Some cells that are determined as viable but unable to be cultured on the solid medium are 
typically called viable but nonculturable (VBNC) cells (Hewitt and Nebe-Von-Caron, 2001, 
Oliver, 2005). However, the number of culturable cells or CFU/g always underestimates the 
number of viable cells present as CFU/g measures the capability to reproduce rather than a true 
measurement of viability. A correlation between the number of viable cells and CFU/g data at 
different homogenisation speeds is described in section 4.2.4. 
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Figure 4-6 Flow cytometric density plots of ADY suspension homogenised at different speed, stained with BOX and PI (upper row) and with SYTO9 and 
PI (lower row). Green and red fluorescence are presented on the ordinates and abscissae axes respectively. 
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4.2.3.2  Viability of three yeast samples 
 
Flow cytometric dot plots in Figure 4-7 present the physiological states of healthy, injured 
and dead cells after being stained with PI and BOX. It can be seen that WY showed the 
maximum percentage of healthy cells at 98.4 ± 0.2 % among the three samples. Consistent 
data of the percentage of live and dead cells in SYTO9 and PI plots (Figure 4-8) can be 
observed. The definition of a live cell in this paper is a cell with an intact polarized 
cytoplasmic membrane as proposed by Caron and Badley (1995) including healthy and 
injured cells in the PI and BOX plots. The percentage of live cells in WY was approximately 
27.1 ± 2.5% and 41.2 ± 0.1% more than that in ADY and MY respectively. Cell viability loss 
in ADY which was drum dried at 40-42°C for 10-20 h (Lesaffre, France) is thought to be due 
to the effect of adverse temperature during the drying process which can cause cell death. 
This is in agreement with Labuza et al. (1970) and Bozoǧlu et al. (1987) who reported 
considerable viability loss in spray and drum drying at short residence time.  
 
In ADY production, the granules were extruded through the wide extrusion screen resulting 
in a particle sizes between 500 and 2000 µm. FC results of ADY from two dual stains show 
the average percentage of viability of 71 ± 2% which is higher than 57% of MY (D50  ̴ 400 
µm). This slight decrease in viability of MY suggests that the milling process had a small 
adverse effect on cell viability. The present findings seem to be consistent with other research 
which reported particle size reduction can cause additional damage to cells and these cells are 
then more susceptible to other stresses (Picot and Lacroix, 2003). 
 
Chapter 4               Comparison of Probiotic Yeast Viability  
__________________________________________________________________________________ 
 
89 
 
Figure 4-7 Flow cytometric dot plots of WY, ADY and MY suspensions discriminating 
healthy, injured and dead cells after being stained with PI and BOX 
 
 
 
Figure 4-8 Flow cytometric dot plots of WY, ADY and MY suspensions discriminating live 
and dead cells after being stained with SYTO9 and PI 
 
The numbers of healthy, injured and dead cells of each yeast sample after staining with PI 
and BOX are plotted with CFU/g in Figure 4-9, and all data are based on 1 g dry cell weight. 
It can be seen that WY contained the maximum number of healthy cells, which was more 
than ADY and MY by 1 and 1.5 log respectively. WY displayed the minimum number of 
dead cells/g DCW, which was significantly less than those in ADY and MY (p ≤ 0.05). 
Differences between means of CFU/g between three yeast samples were significant. In 
addition, CFU/g value was consistent with FC data where CFU/g of WY was almost one log 
higher than that of ADY. Relative correlation between the number of viable cells measured 
by FC and CFU data of various yeast samples is described in section 4.2.4. 
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Figure 4-9 The number of healthy, injured and dead cells of three different samples: WY, 
ADY and MY after being stained with BOX and PI. Data shown are based on 1 g dry cell 
mass basis with standard errors.  
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4.2.3.3  Effects of pH on cell viability 
 
In the GI tract, pH can vary between 1.7 and 6 due to food consumption and various enzymes 
(Blanquet et al., 2004). A study was conducted in order to investigate whether environmental 
condition of pH during the digestive system has an effect on cell viability. ADY suspensions 
with different pH were tested using a USP apparatus operated at 37°C and a speed of 100 rpm 
(as explained in section 3.7.2). Each sample was taken after two hours after the cells were 
exposed to a fluid with a given pH before cell viability was determined by CPC and FC. The 
numbers of healthy, injured and dead cells in different pH fluids are presented in Figure 4-10. 
The number of healthy cells dramatically decreased in strong acid whereas that injured cells 
slightly fluctuated. Figure 4-11 shows that the number of viable cells after exposure to fluids 
with different pH was all higher than 109 CFU/g except the number corresponding to the fluid 
of pH 1 in which the viable cell number dropped to approximately 108 CFU/g. This was 
consistent with FC data when cells were stained with PI and BOX. The loss of viability when 
cells were exposed to a simulated gastric fluid (SGF) of pH 1 might be caused by the high 
acidity and osmotic pressure of pH 1 fluid (Appendix 2). It was found that viability loss of S. 
cerevisiae after being exposed in hypertonic solution caused the reduction of cell volume, 
therefore cells were osmotically responsive (Morris et al., 1986) and cell membranes were 
subjected to cell shrinkage by mechanical constraints (Beney et al., 2000). Although yeast 
was found to be susceptible in pH 1 fluid, pH in the human stomach is rarely as low as 1 
(typically it is pH 1.6) and tends to increase after food consumption, so the effect of pH on 
yeast cell viability is not significant in practice.   
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Figure 4-10 CFU/g and the number of healthy, injured and dead cells of yeast suspension 
(based on 1 g of ADY) homogenised at a speed of 10,000 rpm for 3 min and stained with 
BOX and PI. Data are obtained from triplicate measurements (n=3) with standard errors. 
 
 
 
The number of viable cells as shown in Figure 4-11 is a summation of healthy and injured 
cells which are cells without PI staining. When comparing viable cells and culturable cells 
(CFU), it can be noticed that CFU/g values were always underestimated. This is because 
CFU/g measures the reproductive capability rather than a true measurement of viability. 
 
Another cell viability measurement of yeast exposed to various pH fluids for 2 h by using a 
haemocytometer and methylene blue was made. The data also show that the number of alive 
cells in pH 1 fluid was significantly less compared to those exposed to other pH values 
(Figure 4-12), which is consistent with data obtained from CPC and FC.  
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Figure 4-11 The number of total and viable cells of ADY measured by FC when they were 
stained with PI and BOX vs. CFU/g measured by CPC, after being exposed to a fluid of 
varying pH. Data shown are based on 1 g of ADY with stand errors. 
 
 
 
 
Figure 4-12 The number of total, alive and dead cells of ADY suspension after being exposed 
to various pH fluids for 2 h, stained with methylene blue and counted by a haemocytometer. 
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4.2.3.4  Effect of compaction pressure on cell viability 
 
In order to determine the effect of compaction pressure on cell viability, MY and MCC were 
mixed in a 50/50 (wt/wt) ratio (Table 3-3) and compacted into tablets using a compression 
pressure in a range of 75-135 MPa (see section 3.10.5). These tablets were dissolved in PBS 
for two hours using a USP apparatus (see section 3.7.2). The results of the number of healthy, 
injured and dead cells are shown in Figure 4-13 and compared with MY as a controlled 
experiment. Higher compaction pressure caused more dead cells and resulted in less number 
of healthy cells. It can be noticed that there was no significant difference in the number of 
cells when compaction pressures higher than 120 MPa were used. 
 
 
Figure 4-13 The number of healthy, injured and dead cells in tablets made by MY /MCC in 
50/50 (wt/wt) ratio compacted at different compression pressure and exposed to PBS for 2 h. 
Data shown are based on 20,000 cells as measures by FC with standard errors. 
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Similar experiment to study the effect of compaction pressure on cell viability was performed 
with tablets made with ADY/MCC in 50/50 (wt/wt) ratio and compacted with a pressure 
ranging between 75 and 150 MPa. Cell viability in terms of CFU/g tablet is shown in Figure 
4-14 in comparison with control experiment (before compaction) and a targeted CFU/g in one 
tablet. There was no significant difference in CFU/g when compaction pressures up to 105 
MPa were used, however CFU/g dropped significantly when compaction pressures beyond 
105 MPa were used. If the data in Figure 4-13 and Figure 4-14 are compared, the results are 
consistent where the optimized compaction pressure giving satisfactory CFU/g tablet was 105 
MPa. Later on, however, it was confirmed by a fellow student that these formulations failed 
in tensile strength (Shriya Pancholi, Chemical Engineering, Birmingham, Personal 
communication). 
 
 
Figure 4-14  CFU/g tablet of tablets containing ADY/MCC in 50/50 (wt/wt) ratio and 
compacted at different compaction pressure. Error bars represent the 95% confidence limit 
from three measurements (n=3). The green line demonstrates target CFU/g tablet (Lesaffre’s 
specification) whereas the red line represents CFU/g ADY before compaction. 
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4.2.3.5  Tablet dissolution time and the corresponding cell viability 
 
The dissolution time of the produced tablets and the corresponding cell viability were studied 
by dissolving a tablet in PBS using a USP apparatus and the samples were collected every 20 
min before being stained with PI and BOX. It was observed that a tablet started to 
disintegrate immediately after it was placed in a liquid medium. The results in Figure 4-15 
show that all active ingredients from the tablet were released between 20 and 40 min. This 
did not comply within a limit of disintegration time of uncoated tablet (15 min) according to 
the B.P. (1998). The total numbers of cells were constant after 40 min of dissolution time. 
  
 
Figure 4-15 Number of total, healthy, injured and dead cells of a tablet containing MY/MCC 
in 50/50 (wt/wt) ratio and compacted at 105 MPa during dissolution studies by dissolving in 
PBS. Data are obtained from triplicate studies (n=3) with standard errors 
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4.2.4 Correlation between CFU and FC data 
 
The number of healthy, injured and viable cells obtained from FC under different conditions 
(three yeast samples, ADY suspensions homogenised with varying speed and ADY 
suspensions exposed to a fluid of different pH) and the number of culturable cells obtained 
from CPC (see section 3.2.3.2) were compared. The numbers of healthy and injured cells are 
those which do not uptake PI by intracellular constituents, and their sum is defined as the 
total number of viable cells. In Figure 4-16 to 4-18, CFU/g (Table 4-2) is presented as the 
dependent variable on the ordinate and the number of injured, healthy or viable cells (Table 
4-2) as the independent variable on the abscissa. Best fit straight lines and the corresponding 
linear equations were generated by Excel software.  
 
It can be seen that CFU/g and the number of healthy cells had a strong linear correlation with 
an R2 of 0.76 where a poor correlation between CFU/g and the number of injured cells with 
an R2 of 0.39 was displayed. However, as shown in Figure 4-18, a correlation coefficient (R2) 
of 0.95 was found between CFU/g and the number of viable cells, indicating an excellent 
agreement. In addition, the slope of the linear equation in Figure 4-18 was 0.95 which 
suggests that most viable cells were culturable. 
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Table 4-2 The number of viable cells and CFU/g under different processing and environmental conditions (mean ± CI 95%, n=3) 
 
Condition 
 
Healthy (H) Injured (I) Viable (V) CFU/g 
Three yeast samples 
WY 8.7×1010 ± 0.2×1010 8.1×109 ± 0.3×109 9.5×1010 ± 0.2×1010 6x1010 ± 1×1010 
ADY 1.4×1010 ± 0.3×1010 6×109 ± 1×109 2.0×1010 ± 0.3×1010 1.3 x1010 ± 0.4×1010 
MY 3×109 ± 1×109 2×109 ± 1×109 5.6×109 ± 0.3×109 2 x109 ± 1×109 
 
ADY suspensions 
with varying 
homogenisation 
speed (rpm) 
6000 6×109 ± 1×109 3×109 ± 1×109 9×109 ± 1×109 5×109 ± 1×109 
8000 1.1×1010 ± 0.3×109 2.7×109 ± 0.4×109 1.3×1010 ± 0.1×1010 1.1×1010 ± 0.1×1010 
10000 1×1010 ± 1×1010 2×109 ± 1×109 1×1010 ± 1×1010 1.3×1010 ± 0.3×1010 
12000 5.9×109 ± 0.1×109 3.9×109 ± 0.3×109 9.8×109 ± 0.4×109 1×1010 ± 1×109 
15000 7×109 ± 1×109 1.9×109 ± 0.2×109 9.3×109 ± 0.3×109 5×1010 ± 1×109 
 
ADY suspensions 
exposed to a fluid of 
different pH 
pH 7 10.0×108 ± 0.2×108 4×109 ± 1×109 4.9×109 ± 0.2×109 3×109 ± 1×109 
pH 4 4.8×108 ± 0.1×108 4×109 ± 1×109 4.7×109 ± 0.3×109 3×109 ± 1×109 
pH 3 2.9×108 ± 0.3×108 2.4×109 ± 0.4×109 2.7×109 ± 0.1×109 3×109 ± 1×109 
pH 2 8×107 ± 1×107 7×109 ± 1×109 7×109 ± 1×109 4×109 ± 2×109 
pH 1.2 3×106 ± 1×106 8.8×108 ± 0.3×108 9×108 ± 1×108 7×108 ± 1×108 
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Figure 4-16  Correlation between CFU/g and number of healthy cells of yeast under three 
different conditions  
 
 
 
Figure 4-17 Correlation between CFU/g and number of injured cells of yeast under three 
different conditions 
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Figure 4-18 Correlation between CFU/g and number of viable (healthy plus injured) cells of 
yeast under three different conditions 
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4.3 CONCLUSIONS 
 
This study has demonstrated the effects of processing and environmental conditions on yeast 
cell viability by using flow cytometry in conjunction with fluorescent dyes which has enabled 
an in-depth understanding of physiological state of individual cells. Cell viability of yeast 
cells in terms of culturability was determined using a traditional method of colony plate 
counting (CPC) and compared to flow cytometric data. Correlations between CFU/g from 
CPC and the number of healthy, injured and viable cells obtained from flow cytometry (in 
section 4.2.4) were sought. A strong correlation between CFU/g and the total number of 
viable cells determined by FC has been found (R2 = 0.95) and this suggests that most viable 
cells were culturable. Therefore, the correlation might be useful to estimate cell culturability 
from total viable cell number determined by FC for other processing and environmental 
conditions. 
 
High homogenisation speeds enhanced the release of yeast cells from ADY and MY granules 
(as explained in section 4.2.3.1). Moreover, homogenisation speed had an influence on cell 
viability of ADY where a speed of 10000 rpm produced the highest CFU/g. At a 
homogenisation speed of 15000 rpm, it is speculated that yeast cells became injured by the 
generated shear force and had lower culturability (lower CFU/g). WY obtained from 
fermentation contained a very high number of viable cells while drying process, milling 
process (section 4.2.3.2) and tableting of yeast with MCC using high compaction pressure 
(section 4.2.3.4) had negative effects on cell viability. It was also found that cell viability 
reduced when yeast was exposed to a simulated gastric fluid of pH 1 (section 4.2.3.3) which 
might be due to cell shrinkage in highly acidic and high osmotic pressure fluid. In the 
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dissolution test, all the cells were fully released from the tablets containing ADY and MCC 
which disintegrated within 40 min after being exposed to the liquid medium (section 4.2.3.5). 
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 CHAPTER 5 
 
FREEZE DRYING OF WET YEAST CELLS AND COMPACTION OF 
THEM INTO TABLET DOSAGE FORM 
 
5.1 INTRODUCTION 
 
In addition to processing and environmental conditions (in the GI tract), storage conditions 
can also have negative effects on probiotic microorganism survival. Using drying technology 
has been the preferred method for the preservation of microorganisms in many industrial 
applications enabling long term storage in bulk quantities. Freeze drying or lyophilisation 
(Costa et al., 2000, Miyamoto-Shinohara et al., 2000a) is one of the drying technologies used 
for the preservation of microorganisms. It works by freezing them and creating a vacuum to 
remove water by sublimation. Miyamoto-Shinohara et al. (2000a) have reported that yeast 
Saccharomyces cerevisiae cell viability only dropped by 10% after freeze drying and no 
further loss of viability occurred over the subsequent 10 years storage. It has been suggested 
that a high initial cell concentration should be used for freeze drying in order to maintain a 
relatively high number of viable cells afterwards (Bozoglu et al., 1987). In this study, 
therefore, wet yeast was used since it contains a higher number of viable cells per gram than 
active dry yeast (ADY) or milled yeast (MY) since the latter contains other ingredients. 
Although freeze drying is the preferred method for preserving microorganisms, during the 
freezing process large ice crystals can form leading to cell membrane and cell wall damage, 
and therefore a reduction in cell viability. It has been found that cryoprotectants in the 
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medium can reduce the damage, for example, Costa et al. (2000) have found that when non-
fat skimmed milk was used as a protective medium when freeze drying, a higher cell 
recovery was achieved. Carvalho et al. (2004) reported that the survival of the freeze dried 
cells depended on both the protective medium and the strain of microorganism.  
 
In the research described in this chapter, wet yeast was dehydrated using a freeze dryer with 
and without a protective medium -skimmed milk. The effect of drying time on the loss of 
viable cells and the resulting water activity of cell powders was determined. Freeze dried 
yeast (FDY, subjected to an optimal freeze drying time) was mixed with MCC in different 
ratios before being compacted into tablets (target ≥ 6.67×108 CFU per 1 g tablet or, 2×109 
CFU/day and maximum 3 tablets per day, specified by Lesaffre, France) and the effects of 
formulation and compaction pressure on the tensile strength of the formed tablet and cell 
survival were evaluated. MCC was chosen to make tablets because tablets containing MCC 
had the higher tensile strength compared with those containing starch or HMPC (Wu et al., 
2005). Moreover, the size distribution of MCC and FDY particles and the internal structure of 
the formed tablets were studied. The viabilities of cells in tablets containing FDY and MCC 
with different ratios were assessed by flow cytometry (FC) and colony plate counting (CPC) 
methods (Postgate, 1969). Two dual stains of PI and BOX (Hewitt and Nebe-Von-Caron, 
2001) and SYTO9 and PI (Tanja et al., 2013, Zhang and Fang, 2004) were used together with 
FC to determine cell physiological states.  
 
To examine their storage stability, cells in tablets made using a particular formulation 50/50 
(wt/wt) were placed in a plastic bag and stored at 4 °C for 3 and 6 months. The storage time 
was partially limited by the duration of the study but the data collected may still be useful for 
indicating the storage stability of yeast in tablet to a certain extent. CFU and FC data of 
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tablets containing FDY before and after storage were evaluated against the existing 
correlation established in section 4.2.4. 
 
5.2 RESULTS AND DISCUSSION 
 
5.2.1 Particle size distribution 
 
Freeze dried yeast (FDY) (see section 3.10.1) was milled using a food processor (Kenwood, 
FP260 series, UK) for 3 min.  The particle size distribution of FDY was determined by 
QICPIC (as described in section 3.10.2) and the result is shown in Figure 5-1. The number of 
FDY particles observed in three successive measurements ranged between 80,000 and 
150,000 particles. The result shows a wide distribution with a mean size of 0.85 ± 0.1 mm.  
The maximum particle size was 2.55 mm but it was thought that a longer milling time to 
cause further reduction in particle sizes could also cause some damage to cells. 
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Figure 5-1 Particle size distribution measured by QICPIC of FDY after freeze drying at -
50°C and 0.6-0.7 mbar for 24 h and milling for 3 min.  
 
 
Particle size of MCC was also determined by QICPIC (as described in section 3.10.2) and the 
data are shown in Figure 5-2: MCC particles showed a moderately wide distribution with an 
average particle size of 0.19 ± 0.01 mm which are approximately 5 times smaller than FDY 
particles. Three successive measurements were taken, as with FDY particles, and the data 
were generated based on 200,000 to 250,000 particles.  
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Figure 5-2 Particle size distribution of MCC measured by an image analyser (QICPIC).  
 
5.2.2 Effect of freeze drying time on cell survival and water activity (aw) of 
remaining powders 
 
To determine the effect of freeze drying on the water activity of remaining cell powders, 
which can affect cell long term stability during storage, the freeze drying time (at -50°C and 
0.6-0.7 mbar) was varied between 12 h and 48 h. Cell viabilities every 12 h were then 
measured by CPC (Figure 5-3) and FC (Figure 5-4).  
 
WY containing 6.5×1010 ± 1.1×1010 CFU/g initially was used in this experiment. At 12 h of 
freeze drying time, CFU/g decreased to 1.2×1010 ± 1.4×109 CFU/g FDY corresponding to 
0.73 log loss and had aw of 0.64 ± 0.02. It can clearly be seen that cell viability decreased 
with freeze drying time where 0.90, 1.02 and 1.29 log loss were observed at 24, 36 and 48 h 
of freeze drying time respectively. This indicates that a longer freeze drying time had a 
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deleterious effect on CFU/g. However, the aw values at 36 and 48 h were constant at 0.38 ± 
0.02 but the extra drying caused further reduction in CFU/g FDY. Added to this, aw of FDY 
obtained at  a 24 h freeze drying time was 0.43 ± 0.02 which was still higher than the value of  
0.3 desired for long term storage stability (Dr Peter Jüsten, Lesaffre, France, Personal 
communication). 
 
 
Figure 5-3 CFU/g FDY as measured by CPC and water activity (aw) at different freeze drying 
times (n=3)  
 
 
Cell viability at different freeze drying times was further investigated by FC. Flow cytometric 
dot plots can be seen in Figure 5-4 and show various states of FDY suspensions with dual 
stains of BOX and PI and SYTO9 and PI at various freeze drying times. Clear discrimination 
of healthy, injured and dead cells was achieved by monitoring the extents to which yeast cells 
accumulated PI and BOX. The number of healthy cells (PI- and BOX-) showed a subtle 
fluctuation during exposure to freeze drying. 
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FC using SYTO9 and PI reagents (LIVE/DEAD FungaLight) cannot distinguish the overall 
health of cells, i.e., identification of the three physiological states – healthy, injured and dead 
- as PI and BOX staining can (Bunthof and Abee, 2002). In this study, the results of two dual 
stains were consistent in that the highest number of live cells and lowest number of dead cells 
were discovered at 12 h of freeze drying time. The number of dead cells detected in SYTO9 
and PI plots appeared higher than those in PI and BOX plots. This is because the relative 
concentration of PI used in FungaLight (20 mM) was considerably higher than the one in PI 
and BOX staining (200 µg mL-1) (Soejima et al., 2009).  
 
The numbers of healthy, injured and dead cells determined by FC employing fluorescent 
staining with PI and BOX are presented in Figure 5-5. A decreasing trend of healthy cells in 
conjunction with an increase of injured and dead cells with freeze drying time was observed. 
A clear reduction in the number of viable cells (corresponding to healthy and injured cells 
together) indicated loss of culturability of cells, which is consistent with a declining trend of 
CFU/g FDY. Viability reduction during freeze drying can likely be attributed to membrane 
permeabilisation resulting in an increase of dead cells which could be caused by dehydration 
during drying (Rault et al., 2007, Meng et al., 2008, Fu and Chen, 2011). Injured yeast cells 
with membrane potential loss might be manifested by an inability of such cells to be 
culturable i.e. able to form colonies on the solid medium. However, the cells may regain 
normal function under appropriate conditions e.g. adequate nutrients (Mazur, 1965, Mazur, 
1966, Novo et al., 2000). Taking aw and cell viability determined by CPC and FC into 
account, FDY obtained after 24 h freeze drying was selected for further experiments.  
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(a)  
 
(b)   
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(c)  
 
(d)  
 
Figure 5-4 Flow cytometric density plots showing the percentage of healthy, injured and dead 
cells after staining with PI and BOX (left) and SYTO9 and PI (right) at various freeze drying 
times: (a) 12 h (b) 24 h (c) 36 h and (d) 48 h. 
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Figure 5-5  Number of healthy, injured and dead cells of freeze dried yeast (FDY) at various 
freeze drying times after being stained with PI and BOX and sorted by FC. Data shown are 
based on 1 g of FDY 
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5.2.3 Freeze dried yeast with protective agent 
 
Many papers have reported that the addition of cryoprotectant to microorganisms before 
freeze drying enhanced cell viability by protecting cell membranes and maintaining protein 
stability (Benaroudj et al., 2001, Leslie et al., 1995, Zhao and Zhang, 2005). It was found that 
Lactococcus lactis had more than a 60% survival rate after adding skimmed milk and sucrose 
into microorganisms before freeze drying (Berner and Viernstein, 2006). In addition to this, 
freeze drying Candida sake at -20°C was better than using liquid nitrogen since in the latter 
case the water was removed too fast and resulted in cell damage (Abadias et al., 2001a). In 
this work, addition of skimmed milk on protection of yeast during freeze drying was 
investigated. 
 
In the experiments described in this section, 10% (w/v) of skimmed milk without any sugar 
was added to WY prior to freeze drying (see method section 3.10.1) (Blanquet et al., 2005). 
The flow cytometric plots of various physiological states of FDY with and without the 
addition of skimmed milk are shown in Figure 5-6. The addition of 10% skimmed milk 
suspended in WY gave a 5% increase in viability as observed in SYTO9 and PI plots and 
exhibited a 2% cell viability increase in PI and BOX plots.    
 
During freeze drying, yeast cells are faced with increasing osmotic stress as the water activity 
begins to decrease (Morgan et al., 2006). A cryoprotectant is a substance that aids the 
protection of microorganisms from cell damage during the freeze drying process and helps 
maintain viability by reducing the osmotic pressure between the cells and the external 
environment (Capela et al., 2006, Kets et al., 1996), stabilizing the proteins and cell 
membrane during osmotic stress conditions (Morgan et al., 2006). Survival rates of S. 
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cerevisiae after freeze drying were variable due to differences of yeast strain and drying 
conditions such as volume of suspension and initial cell concentration (Blanquet et al., 2005). 
Results in this study are in accordance with those of Blanquet et al. (2005) who reported the 
cell survival rate was improved by only 1% after 5% w/v of milk protein was added to yeast 
suspension prior to freeze drying, whereas higher survival rates of 13% were obtained when a 
mixture of milk protein and trehalose were added. Similar protective effects on cell viability 
were observed with another strain of yeast: Candida sake (Abadias et al., 2001a) showed an 
increase of 29% survival rate when trehalose and skimmed milk were used. Many reports 
claimed the addition of protective agents such as a mixture of sugar and skimmed milk was 
found to improve cell viability of lactic acid bacteria and yeast (Berner and Viernstein, 2006, 
Berny and Hennebert, 1991, Capela et al., 2006, Hsi-Chia et al., 2006). In this section, 
skimmed milk was added without the addition of carbohydrate (hence sugar was not available 
to form hydrogen bonds with the protein from denaturation when water was removed) so the 
influence on yeast viability was very marginal. Previous research found that cryoprotectant 
only helped some strains of probiotic to survive during freeze drying (Rybka and 
Kailasapathy, 1995) by acting on cell membrane integrity or protein structure (Carvalho et 
al., 2004). Subsequent experiments were therefore carried out without the addition of 
skimmed milk to reduce process complexity. 
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(a)  
 
(b)  
 
Figure 5-6  Flow cytometric plots showing various physiological states of (a) FDY without 
skimmed milk and (b) FDY with the addition of 10% skimmed milk, after being stained with 
PI and BOX (left) and SYTO9 and PI (right). 
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5.2.4 COMPACTION OF FREEZE DRIED YEAST 
 
5.2.4.1 Tablet formation containing freeze dried yeast 
 
A preliminary experiment showed that FDY could not be compressed into rigid tablets, which 
can withstand handling, by direct compression with a pressure up to 105 MPa (data not 
shown). Therefore, FDY without the addition of skimmed milk and freeze dried for 24 h was 
mixed with MCC in ratios of 90/10 and 80/20 (wt/wt) (see Table 3-3) before compaction into 
tablets. The results of tablets made with FDY and MCC in 90/10 (wt/wt) ratio and compacted 
at 105 MPa are shown in Figure 5-7. These tablets were of cylindrical shape with a diameter 
of 13 mm and thickness of 7.2 ± 0.1 mm. A similar thickness of tablet made with FDY and 
MCC in 80/20 (wt/wt) ratio at 7.2 ± 0.2 mm was observed at the same compaction pressure. 
High thickness of the tablet could be caused by poor compressibility of FDY particles. In 
addition to this, due to the difference in FDY and MCC particle sizes, a clear segregation of 
MCC and FDY was observed on different sides of the tablet. This is thought to affect the 
mechanical strength of tablet, which was investigated further in the work described in section 
5.2.4.3. 
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(a)  
 
(b)  
 
 
Figure 5-7 A tablet containing FDY and MCC in 90/10 (wt/wt) ratio after compaction at 105 
MPa (a) side view (b) top view 
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5.2.4.2 SEM analysis 
 
In order to see the arrangement of FDY and MCC particles, the tablet was cut across its 
cross-sectional area and a SEM analysis (see section 3.10.7) was carried out as illustrated in 
Figure 5-8. During tablet compaction, there was a deformation mechanism of powder 
excipients which resulted in the rearrangement of a tablet. SEM images highlight a difference 
in particle sizes between FDY and MCC, which might cause poor tablet compressibility. In 
addition, void spaces and high porosity of the tablet may adversely affect tensile strength 
(Wu et al., 2005) which will be explained more in the next section. 
 
 
(a)  
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(b)  
 
(c)  
Figure 5-8 SEM images of a tablet containing FDY and MCC in 90/10 ratio compacted at 90 
MPa showing some void spaces between FDY and MCC at different scales (a) 200 µm (b) 
100 µm and (c) 10 µm 
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5.2.4.3  Cell viability and tablet tensile strength at different compaction 
pressure  
 
Cell viability in tablets containing FDY and MCC in 90/10 and 80/20 (wt/wt) ratios was 
studied and the results are shown in Figure 5-9. It was found that a tablet compressed at 
higher compaction pressure was stronger than one compressed at lower pressure but resulted 
in lower cell viability. An increase in the amount of filler (MCC) by 0.1 g exerted a slightly 
positive effect on the tablet strength as MCC demonstrated its properties of high 
compressibility and plasticity. No significant change in cell viability between 90/10 and 
80/20 formulations at the same compaction pressure was observed. This finding is not 
consistent with Klayraung et al. (2009) who claimed cells are better protected from stress 
factors when a tablet contains higher cell loading due to cell-cell interactions. Interestingly, 
cell viability of a formulation (80/20) compacted at 90 MPa was higher than that of a 
formulation (90/10) compacted at 105 MPa although the former contained less FDY. From 
this it can be concluded compaction pressure might have a more significant impact on cell 
survival compared to the amount of active ingredient.  
 
Tensile strengths of the tablets containing FDY and MCC in 90/10 and 80/20 (wt/wt) ratios 
were also determined (Figure 5-9). It was found that tablets containing FDY/MCC in 90/10 
ratio exhibited tensile strength of 0.11 ± 0.01 MPa and 0.24 ± 0.02 MPa when compacted at 
90 and 105 MPa respectively.  A similar increase of tensile strength from 0.22 ± 0.03 MPa to 
0.29 ± 0.01 MPa was obtained from a formulation (80/20) when 0.1 g of MCC content was 
added. The results showed that tensile strength increased when compaction pressure and the 
amount of filler increased. Nevertheless, tensile strengths of these formulations were 
significantly less than 1 MPa (Lesaffre’s specification).   
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Figure 5-9 CFU/g tablet versus tensile strength of tablets containing FDY and MCC in 90/10 
and 80/20 (wt/wt) ratio after compacted at 90 and 105 MPa. The green line demonstrates the 
target CFU/g tablet (Lesaffre). The red circle represents the target tablet tensile strength 
(Lesaffre) 
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5.2.4.4  Survival of cells in tablets made of different amounts of cells and 
excipient and their tensile strength  
 
The tablet formulations containing FDY and MCC in a ratio of 90/10 and 80/20 shown in the 
previous section appeared to be thick and brittle. It has been reported that increasing filler 
concentration can decrease porosity and pore size in a tablet, leading to higher tablet strength 
(Chan et al., 2011). Accordingly, decreasing the amount of FDY and increasing the amount 
of MCC was attempted in this study. The new formulation of FDY and MCC in 50/50 ratio 
was produced at 90 MPa, and typical tablets are shown in Figure 5-10. The mean thickness of 
this formulation based on measurements from three tablets was 6.98 ± 0.02 mm which was 
slightly less compared to those made in 90/10 and 80/20 (wt/wt) ratio. This might be because 
a 50/50 ratio tablet had better tablet compressibility.  
 
 
 
Figure 5-10 Tablets containing FDY and MCC in 50/50 (wt/wt) ratio and compacted at 90 
MPa 
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Table 5-1 Cell survival and tensile strength of tablets containing FDY/MCC at different ratios 
and compaction pressures 
Formulation 
Compaction 
pressure 
(MPa) 
CFU/(g tablet) Tensile 
strength 
(MPa) 
Log loss Before 
compaction 
After 
compaction 
WY*  6.5×1010  8.1×109  0.90 
90/10 90 7.29×109 2.27×109 0.11 0.51 
90/10 105 7.29×109 6.71×108 0.26 1.06 
80/20 90 6.48×109 1.84×109 0.22 0.55 
80/20 105 6.48×109 5.63×108 0.29 1.08 
50/50 75 4.05×109 9.34×108 0.15 0.64 
50/50 90 4.05×109 8.60×108 0.27 0.67 
50/50 105 4.05×109 5.43×108 0.36 0.87 
*CFU/g was calculated based on WY before and after freeze drying for 24 h 
 
Table 5-1 shows CFU/g tablet before and after compaction, tensile strength and log loss 
depending on the formulation and tablet compaction pressure. The new formulation of tablet 
containing FDY and MCC in 50/50 ratio compacted at 90 MPa had an average tensile 
strength of 0.27 ± 0.03 MPa which was slightly higher than those made with 90/10 and 80/20 
ratios (0.16 and 0.05 MPa respectively). This highlights that increasing filler content to 50% 
improve tablet tensile strength significantly but such tablets still did not meet the required 
specification in term of tensile strength. In addition, increasing the compaction pressure 
might produce significant deformation of MCC particles (Denny, 2002). Despite increasing 
the quantity of MCC and using a higher compaction pressure of 105 MPa, the tensile strength 
only increased slightly to 0.36 ± 0.03 MPa (Table 5-1) which is still less than 1 MPa 
(Lesaffre’s specification).  
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The number of viable cells in tablets containing FDY and MCC in 50/50 ratio which were 
formed by compaction at different pressures was also considered (see Figure 5-11). To 
produce a 50/50 formulation, the amount of FDY was decreased by 44% from the 90/10 
formulation and 37.5% from the 80/20 formulation. Therefore, less CFU/g tablet was to be 
expected in both cases due to less amount of FDY content. At 90 MPa, viable yeast cell 
numbers decreased by 0.51, 0.55 and 0.67 log after tablet compaction of 90/10, 80/20 and 
50/50 ratio formulations. An increase of MCC offered stronger tablets but more excipient 
particles might interfere with cell surfaces resulting in cell destruction (Klayraung et al., 
2009).  
 
At a compaction pressure of 105 MPa, viable yeast cell numbers reduced by 1.06, 1.08 and 
0.87 log after tablet compaction of 90/10, 80/20 and 50/50 ratio formulations which the losses 
at 105 MPa in all formulations were greater than those at 90 MPa. Loss of viable cell 
numbers has also been found by other authors to increase with compaction pressure 
(Plumpton et al., 1986b, Stadler and Viernstein, 2003). It should be noted that in all cases the 
final CFU/g tablet was lower than Lesaffre’s specification which was 6.67×108 CFU/g tablet.  
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Figure 5-11 CFU/g tablet and tensile strength of tablets containing FDY and MCC in 50/50 
(wt/wt) ratio after compaction at 75, 90 and 105 MPa. The green line demonstrates the target 
CFU/g tablet (Lesaffre). The red circle represents the target tablet tensile strength (Lesaffre) 
 
 
 
The flow cytometric results of cell physiological states of yeast in tablets containing 
FDY/MCC in 50/50 (wt/wt) ratio compacted at different compaction pressures are presented 
in Figure 5-12. The results show significant changes in the number of healthy, injured and 
dead cells between tablets produced at different compaction pressures. When increasing 
compaction pressure during tableting, the gradual decrease in number of injured cells (i.e., 
those cells with diminished membrane potential) was observed as revealed by BOX staining. 
Bunthof and Abee (2002) define injured cells as “intact and metabolically active but not 
culturable”. Therefore, it is important to examine whether injured and/or healthy cells 
contributed to the number of viable cells in tablets containing FDY and if such cells were 
culturable, which will be presented in section 5.2.4.6. 
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Figure 5-12 CFU and the number of healthy, injured and dead cells in 1g tablets containing 
FDY and MCC in 50/50 (wt/wt) ratio after compaction at 75, 90 and 105 MPa before storage. 
The red line demonstrates the minimum required CFU/g tablet (Lesaffre). 
 
 
5.2.4.5  Storage stability of yeast in tablets 
 
Storage stability tests on yeast in tablets containing FDY/MCC in 50/50 (wt/wt) ratio 
compacted at 75, 90 and 105 MPa were also conducted.  Three tablets were placed in a 
plastic bag and stored at 4 ± 1°C (69% ± 5% RH) for 6 months. These tablets at each 
compaction pressure were tested at 3 and 6 months. However, the tablets were not placed in a 
desiccator where the moisture level could be maintained. Therefore, it is conceivable that 
cells could have been affected by unknown fluctuations in moisture and light during storage.   
 
Viable cell numbers for the 50/50 ratio tablets after 3 and 6 months storage were determined 
by the FC technique (Figure 5-13, Figure 5-14, Figure 5-15) and colony plate counting 
(Figure 5-16, Figure 5-17, Figure 5-18). Based on the PI and BOX stain plots, tablets before 
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storage contained relatively high percentages of both healthy and injured cells. Such cells 
corresponded to the dense spread of live cells where healthy cells (gated in blue) and injured 
cells (gated in pink) are shown in the SYTO9 and PI stain plots. Therefore it is plausible that 
differing levels of SYTO9 penetration may depend on the health of individual cells.  After 
three months storage, a high number of healthy cells appeared to have been injured, which 
might be due to changes in cell structure and function caused by exposure to stress factors 
such as moisture and oxygen (Miyamoto-Shinohara et al., 2000b). This is consistent with a 
loss of cell viability by membrane permeabilisation due to relative moisture content and light 
in the fridge which led to changes of proteins and nucleotides in cells functionality (Morgan 
et al., 2006, Santivarangkna et al., 2007). The total number of cells in these tablets 
determined by FC remained constant during 3 and 6 months storage (data not shown). 
Therefore, cell lysis can be considered to have been negligible. 
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Figure 5-13 Flow cytometric dot plots showing various physiological states of yeast cells for 
tablets containing FDY and MCC in 50/50 (wt/wt) ratio compacted at 75 MPa (10 kN) after 3 
and 6 months storage at 4°C and being stained with PI and BOX and SYTO9 and PI. 
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Figure 5-14 Flow cytometric dot plots showing various physiological states of yeast cells for 
tablets containing FDY and MCC in 50/50 wt/wt ratio compacted at 90 MPa (12 kN) after 3 
and 6 months storage at 4°C and being stained with PI and BOX and SYTO9 and PI. 
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Figure 5-15 Flow cytometry dot plots showing various physiological states of yeast cells for 
tablets containing FDY and MCC in 50/50 wt/wt ratio compacted at 105 MPa (14 kN) after 3 
and 6 months storage at 4°C and being stained with PI and BOX and SYTO9 and PI. 
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Figure 5-16 shows the number of healthy, injured and dead cells in tablets containing FDY 
and MCC in 50/50 ratio as well as CFU/g tablet after storage at 4 ± 1°C (69% ± 5% RH) for 
3 months. After storage, the number of healthy cells significantly decreased and the number 
of dead cells increased while the number of injured cells slightly fluctuated with compaction 
pressure. It can be seen that the number of healthy cells alone was more than the CFU value 
but not all healthy cells were able to form colonies. The declined trend of such cells with 
compaction pressure is consistent with that before storage but demonstrates less culturability 
when exposed to the adverse effects of storage.  
 
 
Figure 5-16 CFU and the number of healthy, injured and dead cells in 1g tablets containing 
FDY and MCC in 50/50 (wt/wt) ratio compacted at 75, 90 and 105 MPa after 3 months 
storage at 4⁰C. The red line demonstrates the minimum required CFU/g tablet (Lesaffre). 
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The data of cell viabilities after being stored for 6 months are shown in Figure 5-17. There 
was a significant loss in CFU/g tablet (p < 0.05) at all compaction pressures compared with 
tablets that had been stored for 3 months. There is also a decrease in the numbers of both 
healthy and injured cells (as more cells died) as storage time increased. Decreased stability of 
tablets containing FDY after storage could be due to the adverse effects of moisture, light 
and/or oxygen during storage. Since the tablets were not stored in a vacuum package they 
were exposed to oxygen in the plastic bag during storage and the loss of culturable cells at 
4°C might be caused by the extent of oxygen induced cell injury following protein 
denaturation (Morgan et al., 2006, Ghandi et al., 2012). Besides exposure to oxygen, moisture 
level may also affect viability during storage especially since FDY with aw of 0.42 ± 0.02 was 
used to produce the tablets. The water activity value is thought to influence the phase 
transition of the cell membrane leading to cell deterioration and structural collapse 
(Kurtmann et al., 2009). Therefore, it is suggested tablets should be stored at a high level of 
desiccation or vacuum packaged to maintain high cell viabilities. 
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Figure 5-17 CFU and the number of healthy, injured and dead cells in 1g tablets containing 
FDY and MCC in 50/50 (wt/wt) ratio compacted at 75, 90 and 105 MPa after 6 months 
storage at 4⁰C. The red line demonstrates the minimum required CFU/g tablet (Lesaffre). 
 
 
Figure 5-18 CFU in 1g tablets containing FDY and MCC in 50/50 (wt/wt) ratio compacted at 
75, 90 and 105 MPa before and after 3 and 6 months storage at 4⁰C. The red line 
demonstrates the minimum required CFU/g tablet (Lesaffre).  
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Table 5-2 Cell viability loss in log scale during tablet compaction and after storage at 4°C 
over a 3 and 6 month period for tablets containing FDY/MCC in 50/50 ratio 
Compaction 
pressure (MPa) 
Cell viability log loss 
After 
compaction 
After storage for* 
3 months 6 months 
75 0.64 0.79 1.28 
90 0.67 0.93 1.55 
105 0.87 0.94 1.38 
* cell loss data after storage was calculated based on cell viability data after compaction 
 
After 3 months storage at 4 ± 1°C (69% ± 5% RH), all tablets produced at three different 
compaction pressures had approximately 1 log loss of cell viability which reduced further 
after 6 months storage to 1.6 log loss (Figure 5-18). This finding is consistent with findings 
from Klayraung et al. (2009) who reported 1 log loss of freeze dried Lactococcus lactis after 
being stored for 6 months at 30⁰C . These results further support the observation of Brennan 
et al. (1983) and King and Su (1994) that cell viability loss rapidly decreased during the early 
stage of storage. When comparing cell viability loss during tablet compaction and storage, 
FDY had a higher survival rate during tablet compaction than those stored for 3 and 6 
months. Table 5-2 shows a summary of losses of viable cell number during tablet compaction 
and storage (based on the CFU values). Storage at 4⁰C was found to have a greater impact on 
cell viability loss in comparison with cells that were subjected to tablet compaction pressure; 
this might be due to the duration and conditions of storage. Many factors i.e. moisture, light 
and oxygen during storage were detrimental to cells (FDY) in tablets, hence they had 
negative effects on cell survival (Porubcan and Sellars, 1979). There are very few studies on 
maintaining cell viability during storage but the available literature suggests use of high 
barrier bags that can control levels of oxygen, moisture, light and temperature better than low 
barrier bags (Costa et al., 2002). In a previous study ascorbic acid was found to protect 
Lactobacillus delbrueckii spp. bulgaricus cells which were stored at 4⁰C and then spray dried 
(Teixeira et al., 1995). The addition of an antioxidant such as ascorbic acid could be used to 
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diminish lipid oxidation in cell membranes, which typically occurs during storage and is 
responsible for cell death. In addition, there was more survival of microorganisms in 
fermented soymilk after being freeze dried than being spray dried. After 4 months storage in 
a vacuum package, cell survival at 4⁰C was higher than that at 25⁰C (Wang et al., 2004). 
Therefore, superior storage data at 4⁰C can be used to predict cell viability for products 
stored at 25⁰C according to an Arrhenius equation (Ishibashi et al., 1990).  
 
5.2.4.6  Correlations of yeast cells in tablets containing FDY   
 
The correlations between CFU/g and healthy, injured and viable cells of tablets containing 
FDY and MCC in a 50/50 (wt/wt) ratio before storage and after being stored for 3 and 6 
months were plotted with the correlation in section 4.2.4 as shown in Figure 5-19, Figure 5-
20 and Figure 5-21 respectively. It can be seen that the storage data (outlined in red) were 
plotted in the lower positions in all figures which weakened the linear correlation coefficients 
shown in Figure 4-16 to 4-18. Therefore, it can be concluded that the correlation in section 
4.2.4 cannot be applied to the storage stability data of tablets containing FDY. This might be 
due to some different stress factors affecting cell viability between storage and processing 
conditions and exposure to simulated fluids with different pH as presented in Figure 4-16 to 
4-18.  
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Figure 5-19 Correlation between CFU/g and number of healthy cells established in section 
4.2.4 plotted with data of tablets containing FDY and MCC in 50/50 (wt/wt) ratio before and 
after storage (outlined in red). A new correlation line was weakened with R2 of 0.25. 
 
 
 
 
Figure 5-20 Correlation between CFU/g and number of injured cells established in section 
4.2.4 plotted with data of tablets containing FDY and MCC in 50/50 (wt/wt) ratio before and 
after storage (outlined in red). A new correlation line was weakened with R2 of 0.004. 
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Figure 5-21 Correlation between CFU/g and number of viable cells established in section 
4.2.4 plotted with data of tablets containing FDY and MCC in 50/50 (wt/wt) ratio before and 
after storage (outlined in red). A new correlation line was weakened with R2 of 0.23. 
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5.3 CONCLUSIONS 
 
Flow cytometry has been shown to be a useful technique to determine the individual 
physiological state of yeast cells. Using a flow cytometric method in conjunction with PI, 
SYTO9 and BOX, it is possible to characterize cells into separate groups based on membrane 
potential and membrane integrity which is beyond culturability explored by the colony plate 
counting method.  
 
The effects of freeze drying time on cell survival and water activity have been explored using 
FC and demonstrated in greater detail. The study in section 5.2.2 has shown a declining trend 
of viable yeast cells with increased freeze drying time which might be caused by dehydration. 
Such reduction of viable cells is attributed to membrane permeabilization resulting in PI 
uptake and consistent with a decline trend of CFU/g FDY. The addition of skimmed milk 
without a carbohydrate source (sugar) had a very small influence on the cell viability by 
which the number of viable cells increased by 5% in SYTO9 and PI plots and 2% in PI and 
BOX plots. 
 
Compression of FDY and MCC into tablets was found to disrupt the cytoplasmic membrane 
of some cells by diminishing membrane potential as revealed by BOX staining. These tablets 
have shown high porosity from SEM analysis and resulted in low tensile strength (section 
5.2.4.2). Increasing the amount of MCC in a tablet reduced segregation which slightly 
improved the tensile strength of the tablet (section 5.2.4.4). Attention is also drawn to the 
primary particle size of FDY and its properties which reflected poor binding properties within 
a tablet formulation.  
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According to Lesaffre’s CFU specification, two tablet formulations which contained FDY 
and MCC in 50/50 (wt/wt) ratio and compacted at 75 and 90 MPa can meet the minimum 
required CFU of 6.67×108 CFU/g tablet. Nevertheless, these two formulations could not form 
rigid tablets having in low tensile strength (Figure 5-11).  
 
The storage stability at 4°C of the formulation compacted at 90 MPa revealed approximately 
1 and 1.6 log loss after 3 and 6 months storage respectively. Significant cell viability loss 
during storage could potentially be caused by tablet sensitivity due to moisture, oxygen, light 
and temperature. Therefore an additional cell protection by an encapsulation technique could 
potentially be applied to reduce cell viability loss during tableting and storage. The 
correlation between CFU/g and viable cells as explained in section 4.2.4 could not be used to 
estimate the culturability of cells which have been stored for 3 and 6 months. However, a 
strong correlation between healthy cells and CFU/g has proved that healthy cells were the 
main contribution to the number of viable cells but not all healthy cells were culturable. 
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 CHAPTER 6 
 
ENCAPSULATION OF YEAST CELLS TO IMPROVE THEIR 
SURVIVAL AFTER TABLETTING  
6.1 INTRODUCTION 
 
In the previous chapter, some formulations of tablets containing freeze dried yeast (FDY) and 
microcrystalline cellulose (MCC) exhibited an adequate number of viable cells at low 
compaction pressure for tableting, but they were vulnerable to high compaction pressure. The 
low compaction pressure resulted in tablets with low tensile strength, and it is presumed they 
could not stand further processing and handling. Moreover, during storage, FDY cells in 
tablets appeared to be vulnerable to moisture, oxygen and light resulting in lower CFU/g 
tablet. In addition, cell viability loss during storage for these tablets proved greater than the 
losses from compaction.  
 
Stummer et al. (2010a) reported that dried bacteria cells coated with shellac were protected in 
acidic conditions and cell survival rates were maintained for four months after storage at 5°C. 
Since shellac has low permeability, it is suitable as a taste masking coating (Pearnchob et al., 
2003b) or protective coating against moisture for water sensitive materials including 
microorganisms (Phan The et al., 2008). In addition, shellac is suitable as an enteric coating 
material to prevent some types of active ingredients from being released in acidic conditions 
when they pass through the stomach (Ravi et al., 2008a, Ravi et al., 2008b). Sandoval-
Castilla et al. (2010) reported that Lactobacillus casei entrapped in pectin beads were 
protected after exposure to simulated gastric fluid and bile salts. Pectin is also used as a 
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carrier for oral drug delivery (Chung and Zhibing, 2003) and a carrier for sustained release 
(Sriamornsak and Nanthanid, 1998a, Sriamornsak and Nunthanid, 1999a). It is, therefore, 
hypothesized here that encapsulation of cells can protect them from being damaged by 
compaction to a certain extent and enhance their storage stability.  
 
From many available encapsulation techniques, the extrusion method (droplet method) is the 
longest established and most common approach due to its low cost and mild operating 
conditions (King Alan, 1995, Sara, 1995). Previous works have shown viability of bacterial 
cells encapsulated in various beads produced by the extrusion method was up to 80-95% 
(Audet et al., 1988, Rao et al., 1989, Sheu et al., 1993b, Jankowski et al., 1997). This method 
involves forcing a mixture of cells and gelling liquid (e.g. sodium alginate, shellac or pectin) 
through a small nozzle or a syringe needle (Smidsrød and Skja˚k-Br˦k, 1990) to form a 
droplet, which drops to a hardening solution e.g. calcium chloride (Hansen et al., 2002, Lee 
and Heo, 2000). Despite the applications of shellac in probiotic products, the encapsulation of 
cells in shellac beads by extrusion method has not been reported so far. 
 
The aim of the work described in this chapter was to encapsulate yeast cells in beads that 
maintain cell viability while protecting them from harsh environments. Several factors can 
influence the properties of the calcium pectinate (CaP) beads (and therefore cell viability) 
during the encapsulation process such as the concentration of cross-linking calcium chloride 
(CaCl2) solution to harden the encapsulated beads, the concentration of pectin as an 
encapsulating material and the freeze drying time. Entrapped yeast cells were surrounded by 
shellac and pectin in calcium crosslinked beads. The physical properties of calcium shellac 
and calcium pectinate beads obtained from the encapsulation process i.e. particle size, 
internal structure (Allan-Wojtas et al., 2008, Rosenberg et al., 1985) and water activity were 
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investigated. The number of viable cells in these beads was measured by colony plate 
counting (CPC) (Postgate, 1969) and a flow cytometry technique together with staining by PI 
and BOX (Hewitt and Nebe-Von-Caron, 2001, Boswell et al., 1998) and SYTO9 and PI 
(Tanja et al., 2013, Zhang and Fang, 2004, Stocks, 2004). Consequently encapsulation 
efficiency (EE) of yeast cells in CaP beads at different calcium chloride concentrations was 
measured based on the number of viable cells obtained from flow cytometry. Together with a 
calculation of cell viability based on CFU (%), the conditions that maximized cell viability 
were used to determine a formulation for subsequent compaction experiments in this chapter.  
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6.2 RESULTS AND DISCUSSION 
 
6.2.1 Encapsulation of yeast cells with shellac 
 
Encapsulation of yeast cells with shellac by an extrusion method using a Nisco encapsulation 
unit (model VAR J1, SPA-00195, Switzerland) was performed as described in section 3.11. 
The results obtained from measuring the properties (e.g., particle size; water activity and 
inner structure) of calcium shellac beads are introduced in this section.  
 
6.2.1.1  Morphology of calcium shellac beads 
 
Shellac was provided in a form of ammonium shellac solution. When a mixture of 
ammonium shellac and yeast was dropped into calcium chloride solution, there was an 
exchange of ions with ammonium ions replaced by calcium ions resulting in solid calcium 
shellac particles. Calcium shellac beads obtained from the encapsulation process and before 
freeze drying had yellowish hard outer shells that were almost spherical. Some beads before 
freeze drying had distinct tails which was due to the collective effects of surface tension, 
viscosity of the mixture and the collecting distance between the dripping tip and the gelling 
bath where the minimum was about 2 cm (Chan et al., 2009). In this study, the distance 
between a nozzle and a cross-linking solution was set at the minimum of 2 cm. Potentially, 
the distance could be adjusted, which might be done to obtain spherically shaped beads. 
However, since these beads were to be compacted into tablets by direct compaction, it was 
presumed that the shape of the beads was not critical, assuming the shape would not have a 
significant effect on the rearrangement and deformation of beads and MCC during tableting.  
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The particle sizes of prepared calcium shellac beads before freeze drying were in a range of 
3.5 to 4.5 mm (Figure 6-1a) and after freeze drying for 24 h, the size slightly reduced to a 
range of 2-3 mm (Figure 6-1b). This might be due to the removal of liquid content from the 
beads during freeze drying and thus reduction of particle volume (Velings and Mestdagh, 
1995). In addition, the size of calcium shellac beads was dependent on the encapsulation 
nozzle size and the co-axial air stream rate used to create droplets and consequently particles 
in the encapsulation process. 
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(a)  
 
(b)  
 
Figure 6-1 Calcium shellac beads containing yeast cells (a) before freeze drying (b) after 
freeze drying for 24 h 
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6.2.1.2  Particle size distribution 
 
As the particle size of calcium shellac beads may affect tablet compactibility, the size 
distribution of calcium shellac beads after freeze drying for 24 h was measured by QICPIC 
image analysis as described in section 3.12.5.1. In this experiment, the number of particles 
counted in three measurements ranged between 6,000 and 8,000 particles. As shown in 
Figure 6-2, dried calcium shellac beads had a very wide size distribution but the peak was 
between 2.55 and 3.09 mm with the average particle size of 2.9 ± 0.1 mm. This analysis 
indicated that the size of calcium shellac beads was significantly different to MCC particle 
size (mean size 0.19 ± 0.01 mm; as described in Chapter 5). 
 
 
Figure 6-2 Particle size distribution of dried calcium shellac beads measured by an image 
analyser (QICPIC). The density distribution is defined by Eq 3-3. 
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6.2.1.3 Water activity 
 
The previous chapter describes how non-encapsulated cells of FDY were sensitive to 
humidity demonstrating the importance of ensuring calcium shellac beads have low water 
activity (aw). The results in Figure 6-3 show the water activity versus drying time of calcium 
shellac beads subjected to (1) air drying and (2) freeze drying. Calcium shellac beads before 
drying had a very high water activity at 0.97 ± 0.02 because these solid particles were formed 
and immersed in an aqueous cross-linking solution for 15 min to allow ion exchange to take 
place (as described in section 3.11.2). After calcium shellac beads were dried for 12 h a 
significant drop of aw was obtained to 0.55 and 0.47 for air drying and freeze drying 
respectively. Since water activity has an effect on proliferation of microorganisms and also 
product stability (Hahn-Hägerdal, 1986, Harris, 1981), the aw value should be below 0.3 prior 
to storage (Dr Peter Jüsten, Lesaffre, France, Personal communication), thus improving the 
shelf life of probiotics in the tablet formulation. Hence, prolonging the drying time of calcium 
shellac beads was necessary.  
 
The aw of calcium shellac beads after freeze drying for 24 h was 0.12 ± 0.02 whereas air 
drying for 24 h produced aw of 0.4 ± 0.2. The former is desirable for long term storage 
stability (Dr Peter Jüsten, Lesaffre, France, Personal communication), whilst the latter may 
still be too high.  No significant changes of aw were observed after prolonging drying time up 
to 36 h. Therefore, freeze drying was preferable to air drying since a suitable aw value could 
be achieved within 24 h.  
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Figure 6-3 Water activity of calcium shellac beads that were either air dried or freeze dried. 
Data were measured every 12 h using a Pawkit water activity meter with standard errors 
(n=3). 
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6.2.1.4 SEM analysis 
 
The morphology of calcium shellac beads was characterized by scanning electron 
microscopy. SEM images of cross sections of calcium shellac beads after freeze drying are 
presented in Figure 6-4. As can be seen, the beads had a macroporous and slightly condensed 
internal structure, which might be due to bubbles created during the mixing step (as described 
in section 3. 11.2). To diminish these bubbles, the mixture could have been left longer than 
15 min before being extruded in the encapsulation unit. This finding is interesting since it 
may have an impact on the strength of tablets made with these beads. Moreover, it can be 
observed that embedded yeast cells were on the surface structure inside the microspheres.   
 
 
(a) 
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(b) 
 
(c) 
Figure 6-4 SEM images of cross-sectional areas of dried calcium shellac beads at different 
magnifications (a) 400x (b) 800x and (c) 3000x 
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6.2.1.5 Viability of cells in shellac beads 
 
To determine whether homogenisation time had the effect of releasing yeast cells from 
calcium shellac beads, dried beads were homogenised at 10,000 rpm for 3 to 12 min prior to 
serial dilution (as described in section 3.12.5.3). The CFU/g beads at different 
homogenisation times together with active dried yeast (ADY) suspension homogenised for 3 
min as a control are shown in Figure 6-5. It can be seen that longer homogenisation time 
resulted in higher CFU/g bead. However, it was observed that calcium shellac particles were 
very hard to break even by homogenisation. There was no significant difference in CFU/g 
bead when the beads were homogenised for 9 and 12 min. Despite this, it can be presumed 
that the total number of entrapped cells in the calcium shellac beads was not fully released by 
sufficient homogenisation or after 9 min homogenisation. “Shellac” actually comprises a 
mixture of shellac, water and ammoniumhydrogencarbonate, which has a pH that is more or 
less neutral. Therefore, it is likely that shellac itself has no effect on yeast cell viability. 
Approximately 1 log loss of CFU after 9 min homogenisation was observed when compared 
with the ADY control. This could be due to osmotic shock when the mixture of yeast 
suspension and shellac was dropped into the cross-linking solution (CaCl2). It also might be 
that not all yeast cells in calcium shellac beads were released after being homogenisation. 
Another possibility is that high concentration of 20% (w/v) of resinous shellac used might 
interfere with the transport of oxygen through the cell membrane (Stummer et al., 2010b). 
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Figure 6-5 Viability of cells released from calcium shellac beads after being homogenised for 
various times compared with ADY suspension (controlled experiment), n=3 with standard 
errors.  
 
 
The viability of cells released from calcium shellac beads after being homogenised at 10 000 
rpm for 3 min and stained with SYTO9 and PI was measured by fluorescent microscopy as 
described in section 3.12.9. It can be seen in Figure 6-6 that dead cells were clearly stained in 
red or dark orange and had spherical shapes. However, it was problematic to identify 
individual live cells, which appeared fluorescent green. The green particles appeared in 
distorted shapes where yeast cells might be embedded in non-breakable and insoluble shellac 
particles. This is thought to be due to an interaction of SYTO9 and some component in 
shellac which is highly variable depending on its origin and the way it has been refined (Buch 
et al., 2009). Therefore not only live cells, but also shellac particles were stained with green 
fluorescent SYTO9. This observation clearly indicates SYTO9 is not suitable for examining 
cell viability of encapsulated shellac beads. 
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Figure 6-6 Fluorescent microscopy image of calcium shellac bead suspension after being 
homogenised at 10,000 rpm for 3 min and stained with SYTO9 and PI at room temperature 
and protected from light for 15 min 
 
 
 
6.2.1.6 Dissolution study of tablets made with calcium shellac beads 
 
Due to the size and weight of calcium shellac beads, 1 g of calcium shellac beads was unable 
to fit in the die before direct compaction. Therefore, 0.5 g of calcium shellac beads without 
any filler were compacted into tablets as shown in Figure 6-7(a). It can be seen that calcium 
shellac beads have high compactibility, and did not require any binder, filler or lubricant for 
direct compaction. Based on Blanquet et al. (2004), they stated the physical transition time of 
ingested food from the stomach to the colon is 2-6 h. Figure 6-7(b) shows a tablet containing 
calcium shellac beads after being immersed in PBS (pH7.4) for 6 h. Although the tablet was 
immersed in neutral pH buffer for 6 h using the USP apparatus at a speed of 100 rpm 
operating at 37°C (as described in section 3.7.2), the tablets showed low solubility and poor 
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disintegration in simulated intestinal fluid. This slow dissolution of shellac in neutral pH 
buffer was also confirmed by Limmatvapirat et al. (2004) and Pearnchob et al.(2003a). As a 
result of poor dissolution of shellac, Pearnchob et al. (2004)  improved the disintegration of 
shellac coated capsules in simulated intestinal fluid by adding some plasticizers which 
remained unchanged at low pH in simulated gastric fluids and rapidly disintegrated in 
simulated intestinal fluid. In this study, however, it was thought that the ratio of shellac to 
cells for encapsulation could alter the release rate of entrapped cells from calcium shellac 
beads (Limmatvapirat et al., 2008). Using a low ratio of shellac to cells might overcome the 
problem of poor disintegration of calcium shellac beads by allowing more yeast cells to be 
released from the beads. 
 
Since, it proved difficult to break calcium shellac beads in order to fully release entrapped 
cells prior to viability determination. Moreover, calcium shellac beads had poor solubility in 
a neutral pH buffer (i.e. simulated intestinal fluid (SIF)). Therefore, further investigation of 
the encapsulation process focused on the use of pectin only. 
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(a) 
 
 
(b) 
Figure 6-7 (a) A tablet containing 0.5 g of calcium shellac beads compacted at a compaction 
pressure of 105 MPa (c.a. compaction force 14 kN) and (b) Tablet after being immersed in 
PBS solution for 6 h which showed low dissolution and poor disintegration in neutral pH 
solution 
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6.2.2 Encapsulation of yeast cells with pectin 
 
Another biodegradable material selected to encapsulate yeast cells was pectin. The 
encapsulation of yeast cells with pectin was performed by the extrusion method using a G23 
needle and a syringe pump according to section 3.12.2. The properties of calcium pectinate 
beads i.e. morphology, water activity and inner structure were examined. 
 
6.2.2.1 Morphology of calcium pectinate beads 
 
Calcium pectinate beads formed instantaneously after a mixture of cells and pectin was 
dropped to the gelling bath with calcium ions. The beads before freeze drying were white and 
fairly spherical shaped with a diameter of 2.3 ± 0.2 mm as shown in Figure 6-8(a). It was 
claimed by Chan et al. (2009) that the shape of the beads produced by the extrusion-dripping 
method was principally influenced by process conditions and the liquid properties. None of 
the calcium pectinate beads appeared with a distinct tail as found in calcium shellac beads. It 
is likely that the egg shape of calcium pectinate bead might be due to (1) the concentration of 
pectin used and (2) the distance of 7 cm between the G23 needle and the gelling bath of 
calcium chloride solution.  After freeze drying some beads became irregularly shaped and the 
colour changed to brown as shown in Figure 6-8(b). However, calcium pectinate beads 
produced from this encapsulation technique were generally spherical prior to tablet 
compaction.   
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(a) 
 
 
(b) 
 
Figure 6-8 Image of calcium pectinate beads with scale (a) before freeze drying and (b) after 
24 h of freeze drying 
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6.2.2.2 Particle size distribution 
 
Determination of the particle size distribution of calcium pectinate beads containing yeast 
cells after 24 h of freeze drying was performed using QICPIC image analysis (as described in 
section 3.12.5.1). The number of particles observed in three measurements ranged between 
7000 and 9000 particles. As shown in Figure 6-9, the distribution is in a narrow range with 
the average particle size of 2.1 ± 0.3 mm. Hansen et al. (2002) claimed that the particle size 
of encapsulated microspheres should be in the range of 100-1000 µm. However, particle size 
larger than 1000 µm obtained in this study did not affect the shape and quality of the CaP 
beads. 
 
 
Figure 6-9 Particle size distribution of calcium pectinate beads after 24 h freeze drying 
measured by an image analyser (QICPIC). The density distribution is defined by Eq 3-3. 
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6.2.2.3 SEM analysis 
 
The surface morphology and the inner structure of calcium pectinate (CaP) beads were 
examined using scanning microscopy electron (SEM) as described in section 3.10.7. An 
image of a calcium pectinate bead before freeze drying is shown in Figure 6-10, which was 
an egg shape and had smooth surface. The bead was cut through the centre by a blade to 
investigate a cross section (Figure 6-11). The SEM images showed that the internal structure 
of a calcium pectinate bead was porous and contained plenty of voids (Figure 6-11 c and d), 
which were probably caused by bubbles during the mixing step of the encapsulation process. 
A number of yeast cells embedded on the surface structure of microsphere can also be seen.  
 
 
 
Figure 6-10 SEM image of a calcium pectinate bead before freeze drying 
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(a)  
 
(b)  
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(c)  
 
(d)  
 
 
Figure 6-11 SEM images of a cross sectional area of a calcium pectinate bead before freeze 
drying at different scale (a) 1 mm (2) 100 µm (3) 10 µm (4) 10 µm 
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After 24 h of freeze drying, the bead size was smaller compared to those before freeze drying 
as a reduction of liquid content occurred with time. The structure of the dried bead was 
denser due to void spaces being removed during the freeze drying process. As shown in 
Figure 6-12(a), the bead had an irregular shape with a slightly rough surface consistent with 
the beads shown in Figure 6-8. With higher magnifications as shown in Figure 6-12(b) and 
(c), a large population of yeast can be seen on the surface. It can be noticed that the freeze 
drying time did not affect the shape and surface structure of the CaP bead. 
 
 
(a)  
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(b)  
 
(c)  
 
Figure 6-12 SEM images of a calcium pectinate bead after 24 h of freeze drying at different 
scale (1) 500 µm (2) 50 µm (3) 10 µm 
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6.2.2.4 Water activity 
 
Wet calcium pectinate beads obtained from the extrusion method before freeze drying (aw ̴ 
0.97) were dried with (1) air drying and (2) freeze drying. The water activity of beads dried 
with these methods were measured every 12 h as shown in Figure 6-13. The water activity of 
the calcium pectinate beads after freeze drying dropped dramatically in the first 24 h to 0.22 
± 0.02 which is lower (and more desirable) than the generally recommended range of 
between 0.25-0.3 for probiotic products (Chávez and Ledeboer, 2007, Manojlović et al., 
2010, Viernstein et al., 2005). The values gradually reduced to 0.15 and 0.11 at 36 and 48 h 
freeze drying respectively. Pertinent to this, Viernstein et al. (2005) noted that oxidation of 
membrane lipids may occur thus reducing the cell viability of probiotic products if aw is 
lower than 0.1.   
 
On the other hand, water activities of calcium pectinate beads after air drying for up to 48 h 
were considerably higher than those from freeze drying. High water activity indicates the 
extent of free water in probiotic products and excess free water could allow microorganisms 
to be active thus shortening product shelf life. It is also reported that encapsulated cells in 
probiotic products are not stable when water activity is high which generally results in cell 
viability reduction (Mathlouthi, 2001, Weinbreck et al., 2010). Only one previous study from 
Crittender et al. (2006) reported high cell survival of encapsulated Bifidobacterium infantis in 
film-foaming protein-carbohydrate-oil emulsion after 5 weeks storage at 25°C and 50% 
relative humidity. Consequently, freeze drying was considered preferable for drying calcium 
pectinate beads containing yeast cells in subsequent experiments.    
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Figure 6-13 Water activity of calcium pectinate beads dried by two methods: air drying and 
freeze drying 
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6.2.2.5 Viability of CaP beads under fluorescence microscopy 
 
Calcium pectinate beads (CaP) were immersed in PBS solution and stained with SYTO9 and 
PI before cell viability was examined under a fluorescence microscope (see section 3.12.9). 
The image in Figure 6-14 shows a high number of live cells stained in green and a few dead 
cells stained in red. It is clear that the components of SYTO9 had no interaction with pectin 
molecules. Therefore; flow cytometry together with SYTO9 and PI can be used to investigate 
viability of cells encapsulated in calcium pectinate beads and the data are comparable with 
BOX and PI stains.  
 
 
Figure 6-14 Fluorescent microscopic images of pectinate bead suspension after being stained 
with SYTO9 and PI (microscope magnification x40) 
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6.2.3 Optimizing calcium chloride concentration 
 
Viability of cells in CaP beads made in different CaCl2 concentrations and freeze dried for 24 
h was examined by CPC and FC. CaCl2 concentrations of 1%, 1.5%, 2% and 2.5% w/v were 
used in order to determine whether CaCl2 concentration had an impact on cell viability of 
encapsulated cells. The results in Figure 6-15 show that a maximum of 1.7×1010 ± 3×109 
CFU/g bead was observed in 1.5% CaCl2. A similar CFU/g result was obtained at 1% CaCl2 
but slightly less than that in 1.5% CaCl2. At higher CaCl2 concentrations of 2% and 2.5%, cell 
viability dropped dramatically by 1.5 log and 1.4 log which corresponded to 3.9×108 ± 3×107 
CFU/g bead and 4.6×108 ± 8×107 CFU/g bead respectively. 
 
Flow cytometric dot plots showing various states of yeast cells encapsulated in CaP beads 
made in different CaCl2 concentrations are shown in Figure 6-16. The determination of cell 
viability by FC was done using two dual stains: PI and BOX and SYTO9 and PI. The flow 
cytometric results correlated well with CPC method through which the maximum cell 
viability was found to be at a CaCl2 concentration of 1.5%. For PI and BOX stain plots, three 
population groups (i.e., healthy, injured and dead cells) can be clearly seen. Using a CaCl2 
concentration lower than 1.5% resulted in a higher number of viable cells (i.e., a higher 
number of healthy cells compared to injured cells). The percentage of live cells decreased 
with an increase of CaCl2. This can be explained by the fact that calcium is one of the 
important ions in eukaryotic cell function, involved in metabolic processes and cell 
replication and that at higher concentrations, this had a negative impact on cell viability 
(Trofimova et al., 2010, Walker, 1994, Walker, 1999). Accordingly, it was reported that high 
osmotic pressure from high calcium concentrations could cause cell dehydration in fungi 
(Chardonnet et al., 1999). Moreover, Cao et al. (2012) have previously shown that high 
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calcium ion used as a cross-linking solution in a biofabrication process can damage the cell 
membrane by disturbing cell electrolyte and subsequently cell functions. However, there are 
many degrees of cell damage at which some cells can either repair themselves or recover 
from an injury state.  
 
Figure 6-15 The number of healthy, injured and dead cells in 1 g of CaP beads made in 
different CaCl2 concentrations measured by FC stained with PI and BOX with CFU/g 
measured by CPC  
 
Pectinolytic enzyme - an enzyme used to simulate conditions found in the colon - 
considerably accelerated the release of cells from CaP beads and helped degrade pectin 
(Rubinstein et al., 1993, Ashford et al., 1994). It was previously reported that bovine serum 
albumin (BSA) encapsulated with pectin could maintain a controlled release in a pH 7.4 
buffer for 5 h and BSA was released in the presence of pectinolytic enzyme afterwards 
(Sriamornsak, 1998). In this study, it was noticed that CaP beads degraded within two hours 
in the presence of the pectinolytic enzyme. Given this, it is likely that all the entrapped cells 
would be released in the colon. It is also worth noting this enzyme did not interact with the 
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fluorescent dyes used in this study (data not shown), which helps to avoid misleading data in 
the analysis.  
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Figure 6-16 Flow cytometric dot plots showing various states of yeast cells in CaP beads 
made of CaCl2 concentration between 1 and 2.5% (w/v) and stained with PI and BOX (left) 
and SYTO9 and PI (right) 
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6.2.4 Encapsulation efficiency (EE)  
 
Encapsulation efficiency (EE) and encapsulation efficiency based on number of culturable 
cell (%) of CaP beads produced in different CaCl2 concentrations were measured (as 
described in section 3.12.6 and 3.12.7) as shown in Figure 6-17. Encapsulation efficiency was 
calculated based on the total number of cells entrapped in the beads before and after 
encapsulation whereby such cells could be either live or dead. It has been demonstrated that 
more than 60% of yeast cells were encapsulated into calcium pectinate beads depending on 
the concentration of calcium ion presented in the solution when ion exchange occurred. The 
relatively high EE of 93% at a CaCl2 concentration of 1% showed good efficiency of cell 
entrapment and 76% of entrapped cells were culturable. However, highest encapsulation 
efficiency based on culturable cells at 99% was observed at a CaCl2 concentration of 1.5%, 
suggesting that a high number of entrapped cells were able to grow on the agar and they had 
great culturability. Encapsulation efficiency based on number of culturable cells per gram of 
CaP beads, produced using 2% and 2.5% CaCl2, were very low which suggests that most 
entrapped cells at a higher calcium chloride concentration were not active and unable to form 
colonies onto the agar plates. In this study, cell loss during encapsulation by extrusion was 
very low due to the gentle method used whilst the high EE reflects the high number of cells 
that can be recovered after encapsulation. 
 
The encapsulation of yeast cells with pectin in calcium chloride concentrations of 1% and 
1.5% w/v proved to be effective as they showed relatively high EE and encapsulation 
efficiency based on number of culturable cells (%). The EE decreased with the increase of 
calcium chloride concentration, which might result from cell cytolysis (or cell bursting) in 
high concentrations of CaCl2 or the imbalance of osmotic pressure. As mentioned before, 
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calcium ion can have an impact on cell function so it is not surprising that high calcium ion at 
2% and 2.5% w/v resulted in low encapsulation efficiency based on culturable cells. Cell 
shrinkage during bead formation in the gelation process might occur and also be affected by 
cross-linking time. This is in agreement with Sriamornsak (1999) that encapsulation 
efficiency of CaP beads with lower concentrations of calcium ion and a cross-linking time of 
20 min was greater than using higher concentrations. Yeast cells exposed to calcium chloride 
solution for a long time might burst due to an osmotic imbalance, thus leading to cytolysis 
and increasing the number of dead cells. Such dead cells slightly affected EE presumably due 
to cell lysis and drastically affected encapsulation efficiency based on number of culturable 
cells (%).  
 
 
Figure 6-17 Encapsulation efficiency (EE) and EE based on number of culturable cells (%) of 
CaP beads prepared using different CaCl2 concentrations  
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6.2.5 Effect of freeze drying time on viability and aw of calcium pectinate beads 
 
Calcium pectinate (CaP) beads made with 5% (w/v) pectin and 1.5% (w/v) CaCl2 cross-
linking solution were used in this experiment. The impact of freeze drying time on 
encapsulated cells in respect of aw and cell viability is summarized in Table 6-1. It can be 
seen that after 12 h freeze drying time, CaP beads contained 1.8×1010 ± 3.7×109 CFU/g bead 
and had aw of 0.34 ± 0.02, which exceeded the long term storage stability of 0.3 (Dr Peter 
Jüsten, Lesaffre, France, Personal communication). Therefore, it is necessary to prolong the 
freeze drying time accordingly. After 24 h of freeze drying, CaP beads containing 1.7×1010 ± 
4.3×109 CFU/g bead and aw of 0.27 ± 0.02. CFU/g bead further reduced to 1.9×109 ± 6.8×108 
over 36 h and 1.4×109 ± 1.2×108 over 48 h of freeze drying whereas the aw decreased to 0.15 
± 0.02 and 0.13 ± 0.02 respectively. It can be seen that the prolonging drying time 
significantly affected water activity, which is consistent with those reported in literature 
(Hahn-Hägerdal, 1986, Harris, 1981, Vesterlund et al., 2012). 
 
Table 6-1 Cell survival and aw of entrapped S. cerevisiae in CaP beads at different freeze 
drying times 
Freeze drying time (h) CFU/g CaP aw 
12 1.8×1010 ± 3.7×109 0.34 ± 0.02 
24 1.7×1010 ± 4.3×109 0.27 ± 0.02 
36 1.9×109 ± 6.8×108 0.15 ± 0.02 
48 1.4×109 ± 1.2×108 0.13 ± 0.02 
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Flow cytometric results for CaP bead suspensions after being stained with PI and BOX are 
shown in Figure 6-18. It can be noticed that at 12 h freeze drying time the number of healthy 
cells was higher than injured cells. Contrarily, a freeze drying time between 24 and 48 h 
resulted in a higher number of injured cells than healthy cells. This indicates that removal of 
water during freeze drying (low aw) could change the physiological state of cells causing 
more cell injury and cell death and thus affecting the number of culturable cells, i.e. CFU/g 
bead. While freeze drying is considered a method that preserves cell viability, cell losses 
usually occur during the freezing process prior to drying (Uzunova-Doneva and Donev, 
2000). During the freeze drying process, ice crystal structures form on the surface of cells 
resulting in fragile cell membranes.  
 
Figure 6-18 Number of healthy, injured and dead cells obtained from FC, CFU/g bead of CaP 
beads and water activity versus freeze drying times. 
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Flow cytometric dot plots showing various physiological states of cells encapsulated in CaP 
beads at different freeze drying times are presented in Figure 6-19. For PI and BOX stain 
plots, it can be clearly seen that a population of healthy cells at 12 h freeze drying time 
became injured when prolonging freeze drying time to 24 h. It is possible that the change of 
cell physiological state occurred when large ice crystal structures formed onto cells resulting 
in fragile cell membranes as previously mentioned. However, when prolonging time from 24 
h up to 48 h, some injured cells became dead whereas the number of healthy cells remained 
almost the same. The results of SYTO9 and PI stain plots were also consistent with those 
stained with PI and BOX. Interestingly, two groups of dead cells were observed within the 
population after 12 h freeze drying which might correspond to debris having different sizes 
(marked in blue and purple in PI and BOX plot). This debris might occur during the 
encapsulation process and smaller size was thought to be due to cell shrinkage in CaCl2 
solution due to an osmotic imbalance. When CFU/g and aw values are taken into account with 
FC data, it was decided to dry CaP beads for 24 h which resulted in desirable CFU/g bead 
and aw and these beads were used in all subsequent experiments.  
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Figure 6-19 Flow cytometric dot plots showing various physiological states of yeast cells in 
CaP beads at various freeze drying times up to 48 h, which were stained with PI and BOX 
(left) and SYTO9 and PI (right) 
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6.2.6 Varying pectin concentration 
 
Calcium pectinate beads were produced with different pectin concentrations (3%, 4% and 5% 
w/v) and freeze dried for 24 h. Pectin concentration had no influence on the appearance of the 
beads (images not shown). However, it was observed that calcium pectinate beads did not 
have a spherical shape in the cross-linking solution when pectin concentration lower than 3% 
(w/v) was used. Figure 6-20 shows an image of dried calcium pectinate particles made using 
a pectin concentration of 2% (w/v), which are flat. This might be due to low amounts of 
negatively charged carboxyl groups of pectin that cannot completely cross-link even with an 
excess of divalent calcium ions during the gelation process.   
 
 
Figure 6-20 An optical image of calcium pectinate particles made of 2% pectin concentration 
and freeze dried for 24 h, scale bar 5 mm  
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Further investigation of cell viability for beads made of 3%, 4% and 5% pectin was 
undertaken. The beads were immersed in PBS solution for 2 h and cell viability in these 
suspensions was examined. No significant difference in cell viability across the three 
different concentrations was found (data not shown). The beads containing cells were then 
mixed with MCC in 50/50 (wt/wt) ratio and compacted into tablets at 90 MPa. Tensile 
strength and cell viability for tablets containing these beads made from different pectin 
concentrations were measured by CPC and FC together with PI and BOX and the results are 
presented in Figure 6-21. 
 
The pectin concentrations of 3% and 4% did not appear to have an impact on CFU/g tablet 
but with 5% (w/v) pectin, encapsulated cells were more protected from compaction pressure 
resulting in an increased CFU/g tablet. Tablet tensile strength increased with an increase of 
pectin concentration. Using 5% (w/v) pectin, a desirable tensile strength of 1.1 ± 0.1 MPa 
was obtained (meeting Lesaffre’s specification). It was also found that a mixture of WY and 
6% (w/v) pectin was too viscous and consequently was not suitable for extrusion through a 
G23 needle. This highlights that an optimal amount of pectin can provide good protection to 
yeast cells from compaction pressure. Therefore, 5% (w/v) pectin was considered as a 
suitable concentration to make CaP beads for further development of the probiotic tablet.  
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Figure 6-21 CFU/g tablet versus tablet tensile strength and the number of healthy, injured and 
dead cells in 1 g of calcium pectinate beads made using pectin concentration of 3%, 4% and 
5% mixed with MCC in 50/50 (wt/wt) ratio before compacting at 90 MPa  
 
 
Flow cytometric dot plots showing cell physiological states in tablets containing CaP beads 
made using different pectin concentrations and MCC in 50/50 (wt/wt) ratio are shown in 
Figure 6-22. In PI and BOX stain plots the percentage of injured cells was relatively low 
when 3% pectin concentration was used. However, the percentage of healthy cells remained 
constant at all pectin concentrations. SYTO9 and PI stain plots show no significant difference 
of live and dead cells between pectin concentrations of 4% and 5%. Therefore, flow 
cytometric data of two dual stains were consistent with CFU/g results and it is possible that 
the number of culturable cells (CFU/g) was related to the number of injured cells to some 
extent. Moreover, at low pectin concentration, encapsulated yeast cells were not well 
protected from compaction pressure resulting in a high number of dead cells. Moreover, 
tablets containing these beads were not rigid enough as shown by the low tensile strength. 
Chapter 6  Encapsulation of Yeast Cells 
___________________________________________________________________________ 
 
181 
 
Figure 6-22 Flow cytometric dot plots showing various physiological states of tablets 
containing calcium pectinate beads made using different pectin concentrations and MCC in 
50/50 (wt/wt) ratio before compaction at 90 MPa (c.a.12 kN): PI and BOX (left) and SYTO9 
and PI (right) 
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6.3 CONCLUSIONS 
 
Yeast cells were successfully encapsulated with shellac and pectin cross-linked with calcium 
ions in order to protect them from tablet compaction pressure and from harsh environments 
during storage. The physical properties of calcium shellac and pectinate beads characterized 
by particle size distribution, SEM and water activity were explained. It was found that 
calcium shellac beads after 24 h freeze drying resulted in desirable water activity (aw ̴ 0.12± 
0.02) as shown in Figure 6-3. Calcium shellac beads showed good compactibility during the 
tableting process because they were compacted to tablets without any filler. However, they 
did show low solubility and poor disintegration after they were immersed in neutral pH of 
SIF for 6 h as shown in Figure 6-7b. This finding highlights a strong interaction between 
shellac molecules and calcium ions in the cross-linking solution. Notwithstanding, the study 
also highlights a problem in the interaction between shellac and SYTO9, which makes it 
difficult to determine the viability of entrapped cells in calcium shellac beads (Figure 6-6). 
Therefore, yeast cells encapsulated with shellac might have limitations in probiotic 
applications.  
 
The results have demonstrated that freeze drying is a more effective and efficient method to 
remove water from CaP beads than air drying. Encapsulated yeast cells with 5% (w/v) pectin 
in 1.5% (w/v) calcium chloride solution after freeze drying for 24 h appeared to provide the 
best cell survival rate and desirable water activity (aw ̴ 0.27± 0.02). This combination created 
spherical beads with narrow particle size distribution that offered high encapsulation 
efficiency (99%) and high encapsulation efficiency based on number of culturable cells 
(65%) as explained in section 6.2.4. Freeze drying time did not affect the shape of CaP beads 
but did affect viability of encapsulated cells. Prolonging freeze drying times resulted in 
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decreasing of aw and hence, a population of healthy cells became injured and consequently 
died resulting in low CFU. Using pectin concentration less than 3% (w/v), spherical beads 
cannot be formed and thus, cells were not well protected from compaction pressure. High 
calcium chloride concentration might cause cell bursting due to an osmotic imbalance, thus 
leading to an increase in the number of dead cells. 
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CHAPTER 7 
 
EVALUATION OF CALCIUM PECTINATE (CAP) BEAD PROPERTIES 
AND COMPACTION OF CAP BEADS INTO TABLET FORM 
 
7.1 INTRODUCTION 
 
Results on calcium pectinate (CaP) beads made with 5% (w/v) pectin and crosslinked with 
1.5% (w/v) calcium chloride solution presented in Chapter 6 demonstrated that the cells 
encapsulated in CaP beads were protected to some extent from tablet compaction pressure. 
Moreover, they had a low water activity (aw ̴ 0.27± 0.02) after 24 h freeze drying, which may 
inhibit bacterial growth during storage and be desirable for long term storage stability. In 
order to understand the mechanism of the cell protection during compaction of CaP beads 
with MCC, it is essential to characterize and understand the mechanical properties of these 
beads.  
 
The diametrical compression test has been widely used to examine the material properties of 
pharmaceutical dosage forms (Fell and Newton, 1970, Stanley and Newton, 1977, Pitt et al., 
1988, Stanley, 2001). It measures the compressive force between two flat platens by allowing 
the load-applying machine to compress the material up to the point of failure (Kristensen et 
al., 1985, Bonollo et al., 1994, Soltesz et al., 1995). This method can be used to evaluate the 
mechanical behaviour of large particles (>200 µm) of brittle materials, which exhibit plastic 
deformation before fracture (Bonollo et al., 1994, Procopio et al., 2003). For smaller particles 
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than 200 µm e.g. calcium alginate microspheres with a diameter between 80 and 130 µm, 
Wang et al. (2005) used a micromanipulation technique to characterise their mechanical 
properties. Typical mechanical testing includes compression of single particles to a given 
deformation and then holding, compression of single particles at different speeds and loading 
and unloading in order to determine their elastic, viscoelastic or elastic-plastic properties.  
 
The aim of the work described in this chapter was to evaluate the material properties of CaP 
beads by diametrical compression testing in order to understand why they can protect cells 
during tableting. In addition, CaP beads made with 5% pectin and crosslinked with 1.5% 
CaCl2 were mixed with MCC in 50/50 ratio before compacted at different pressures. A 
storage stability test was undertaken to estimate the long-term shelf life of these tablets. Cell 
viabilities for the tablets before and after storage at 4°C were measured by colony plate 
counting (CPC) (Postgate, 1969) and flow cytometry (FC) together with some fluorescent 
dyes as described in method section 3.2 and 3.8 respectively (Boswell et al., 1998, Hewitt and 
Nebe-Von-Caron, 2001). The factors that affected tablet formulation and cell viabilities 
including water activity (Costa et al., 2002) and tablet tensile strength, were investigated.  
  
7.2 RESULTS AND DISCUSSION 
 
7.2.1 Diametrical compression test 
 
Single CaP beads made with 5% (w/v) pectin and 1.5% (w/v) CaCl2 crosslinking solution 
were compressed with a 100 N flat platen load at a speed of 0.01 mm s-1 using a Zwick/Roell 
machine (as described in section 3.13.1). At least ten beads were compressed at this velocity 
to obtain statistically significant results. The data of compressive force and displacement 
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recorded from a Zwick machine were plotted for typical examples in Figure 7-1 and Figure 7-
2. Within the ten beads, two kinds of material behaviours were observed. Figure 7-1 shows a 
fracture event at a force of 60 N suggesting the point at which the structure of a CaP bead 
was ruptured. After this point, the bead was irreversibly deformed and this was observed in 7 
out of 10 beads tested. Typical images of the fractured CaP beads after being compressed 
with a 100 N load cell are shown in Figure 7-2. The second material behaviour is shown in 
Figure 7-3 where no fracture event was observed during compression. The unloading curve 
shows the bead was plastically deformed since the force drops to zero before the 
displacement drops to zero. 
 
Figure 7-1 Force-displacement data of a single calcium pectinate bead (1.8 mm initial 
diameter) compressed with a 100 N load at a compression speed of 0.01 mm s-1  
 
 
Figure 7-2 Typical optical image of CaP bead fractured by a diametrical compression test 
after being compressed with a 100 N load cell 
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Figure 7-3 Force-displacement curve showing loading and unloading data of a single CaP 
bead (2.3 mm in diameter) at a compression speed of 0.01 mm s-1 
 
 
Figure 7-4 Stress-strain curve showing yielding point of a single CaP bead (1.8 mm in 
diameter)  
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7.2.2 Force relaxation 
 
Typical force relaxation data for compression of a single CaP bead made with 5% pectin and 
1.5% CaCl2 crosslinking solution having a diameter of 1.8 mm with no rupture event is 
shown in Figure 7-5. The bead was compressed to a deformation when the force reached 90 
N and this deformation was sustained for three minutes (as described in section 3.13.2). The 
force imposed on a CaP bead increased with displacement (deformation) and gradually 
decreased while the bead was held. It was thought that the force relaxation could be due to 
viscoelasticity of pectin or water loss causing a volume decrease. In this study, however, 
dried CaP beads were compressed and thus water loss was considered negligible and this 
assumption unlikely to be true. Therefore, force relaxation was probably caused by 
viscoelastic properties of CaP beads. 
 
 
Figure 7-5 Typical force relaxation data for compression of a single CaP bead (1.8 mm in 
diameter) at a compression speed of 0.01 mm s-1, and then holding 
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7.2.3 Mechanical property of CaP beads 
 
Although the beads were viscoelastic, as shown in Figure 7-5, the maximum force relaxation 
is about 20% of the peak force. Therefore, Hertz analysis was applied to fit the force versus 
displacement data, as adopted by Andrei D et al. (1996) and Wang et al. (2005). In section 
7.2.2, it was assumed that dried CaP beads had no changes in volume during compression, 
following Yap et al. (2008). Therefore, a Poisson’s ratio (ν) of 0.5 was used for the 
incompressible material of CaP beads. This value was supported by Wang et al. (2005) who 
worked on the mechanical behaviour of alginate microspheres. Using this assumption and 
Hertz equation (as explained in Eq.3-7), a summary of the Young’s modulus values and 
breakage behaviours of CaP beads is shown in Table 7-1. The mean Young’s modulus value 
for the three beads which did not show clear breakage under compression is 312 ± 28 MPa. 
 
The mean Young’s modulus value for the other seven CaP beads which showed breakage 
under compression is 162 ± 14 MPa. The average of nominal rupture stress of these beads 
was 14 ± 3 MPa which was less than the compaction pressure used in tableting (ranging 
between 75 and 105 MPa). The above results indicate that when the beads were compressed 
under high pressures, some might break. In a tablet, however, dried CaP beads were 
surrounded by many excipient particles of MCC. After compaction, the shape of the beads 
was slightly changed and small breaks appeared as shown in Figure 7-6. The image also 
shows some voids which might help to protect the cells inside the beads. Thus, it is likely that 
encapsulated cells in CaP beads were protected from compaction pressure and some cells 
within the beads remained intact to some extent. This was confirmed by a minor log loss of 
cell viability after compaction pressure was applied to the beads (Figure 7-8).   
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(a)  
 (b)     
Figure 7-6 SEM image of a tablet containing CaP beads and MCC compacted at 90 MPa 
showing some breakage and void between CaP bead and MCC at different scale (a) 100 µm 
(b) 10 µm 
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Table 7-1 Summary of the Young’s modulus values and breakage behavior of CaP beads (ten 
tested beads) 
 
Number of 
beads 
Average particle 
size (mm) 
Young’s modulus 
(MPa) 
Characteristics 
7 2.0 ± 0.2 162 ± 14 
Breakage point observed after 
pressure was applied 
3 2.2 ± 0.1 312 ± 28 No breakage point 
 
 
7.2.4 Compaction of CaP beads made in 1.5% CaCl2 into tablets 
  
7.2.4.1 Formulation of tablets containing CaP beads made in 1.5% 
CaCl2 
 
Preliminary results in Figure 6-21 show that CaP beads made of a 5% pectin concentration 
crosslinked with 1.5% CaCl2 and compacted at 90 MPa could produce a tablet with desirable 
tensile strength. Therefore, it would be interesting to produce tablets at different compaction 
pressures (75, 90 and 105 MPa) to determine whether which compaction pressure could 
produce the best tablet formulation in term of both tensile strength and an adequate number 
of culturable cells. A formulation containing CaP beads (made in 1.5% CaCl2) and MCC in 
50/50 ratio compacted into a tablet at 90 MPa is shown in Figure 7-7. The appearance of the 
tablets showed slight segregation but none of the CaP beads broke off.  
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Figure 7-7 Tablets containing CaP beads made in 1.5% CaCl2 mixed with MCC in 50/50 
(wt/wt) ratio compacted at 90 MPa (left: side view, right: front view) 
 
 
A summary of cell survival and tensile strength of tablets containing CaP beads made in 1.5% 
CaCl2 and MCC compacted in 50/50 ratio at different compaction pressure is shown in Table 
7-2. Tensile strength increased with the compaction pressure and it is also related to the 
porosity and relative density of the tablet (Wu et al., 2005). The authors also stated that 
tensile strength is independent of tablet diameter because they found similar tensile strengths 
for tablets where the diameter ranged between 8 mm and 13 mm.  
 
Table 7-2 Cell survival and loss in log scale of tablets containing CaP beads (1.5% CaCl2) 
and MCC in 50/50 ratio compacted at different pressures 
Formulation 
Compaction 
pressure 
(MPa) 
CFU/g tablet 
Tensile 
strength 
(MPa) 
Log 
loss Before 
compaction After compaction 
CaP beads* - 
 
2 ×1010 ± 8×109 
  
50/50 75 8×109 ± 8×108 9×108 ± 2×108 0.74 ± 0.07 0.97 
50/50 90 8×109 ± 8×108 9×108 ± 2×108 1.09 ± 0.03 0.97 
50/50 105 8×109 ± 8×108 5×108 ± 5×107 1.37 ± 0.06 1.21 
*CFU/g was calculated based on CFU after 24 h freeze drying 
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Cell viabilities and tensile strength of the tablets in the 50/50 formulations are shown in 
Figure 7-8. The formulation compacted at 90 MPa had a tensile strength of 1.09 ± 0.03 MPa 
which is a satisfactory value for a probiotic tablet with 13 mm diameter. In addition, cell 
viability of this formulation which contained 9×108 ± 2×108 CFU/g tablet exceeded the 
minimum probiotic requirement. Consequently, this formulation produces an adequate 
number of culturable cells that can be released and adhere in the intestine thus exerting 
probiotic effects. Therefore, these findings in terms of minimum CFU/g tablet and tensile 
strength could potentially be useful in industrial applications if the cells can survive long term 
storage. 
 
 
 
Figure 7-8 CFU/g tablet and tensile strength of tablets containing CaP beads made in 1.5% 
CaCl2 mixed with MCC in 50/50 (wt/wt) ratio and compacted at 75, 90 and 105 MPa. The red 
line demonstrates target CFU/g tablet (Lesaffre’s specification) whereas the
 
green line 
represents CFU/g of CaP beads before compaction. 
 
Chapter 7        Evaluation of Calcium Pectinate Bead Properties 
__________________________________________________________________________________________ 
 
194 
 
Figure 7-9 Flow cytometric dot plots showing the various cell physiological states of tablets 
made with CaP bead mixed with MCC in 50/50 (wt/wt) ratio and compacted at 75 MPa, 90 
MPa and 105 MPa 
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Figure 7-10 The number of healthy, injured and dead cells and CFU/g tablet versus pressure 
to compact CaP beads made in 1.5% CaCl2 and mixed with MCC in 50/50 (wt/wt) ratio 
 
 
Flow cytometric results showing various states of tablets containing CaP beads made in 1.5% 
(w/v) CaCl2 and mixed with MCC compacted at 75, 90 and 105 MPa are presented in Figure 
7-9. A slight decrease in the percentage of live cells in SYTO9 and PI plots was observed. 
The number of healthy, injured and dead cells and CFU/g tablet based on one tablet is shown 
in Figure 7-10. The CFU decreased with compaction pressure which might explain 
culturability of cells after being subjected to the stress of compaction pressure.  
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7.2.4.2 Storage stability of an optimized formulation 
 
The tablets in 50/50 formulation compacted at 75, 90 and 105 MPa were stored at 4°C and 
the storage stability test was performed after 3 and 6 months (as described in section 3.13.4). 
Flow cytometric results showing various physiological states of cells after being stained with 
PI and BOX and SYTO9 and PI are shown in Figure 7-11, Figure 7-12 and Figure 7-13. The 
initial water activity (aw) value of tablets before storage was 0.34 ± 0.02. After 3 months 
storage, a significant decrease in the number of healthy cells was observed at all compaction 
pressures. As a result, there was an increase of dead cells as their cytoplasmic membranes 
became permeabilised and consequently stained by PI. This might be caused by changes of 
cell structure and function resulting from external stresses i.e. oxygen and moisture in the 
storage place as the tablets were not stored in a desiccator (Kurtmann et al., 2009, Costa et 
al., 2002).   
 
Between 3 and 6 months, there were only slight changes in CFU/g tablet as shown in Figure 
7-14. The external stresses in the storage did not have significant impact on cell viability in 
tablets between 3 to 6 months and this might imply that encapsulated cells inside CaP beads 
were resistant from these stresses to some extent. Figure 7-15 shows the number of cells in 
each state from FC (i.e., healthy, injured, dead) of tablets containing CaP beads and MCC in 
50/50 (wt/wt) ratio at a compaction pressure of 90 MPa and the results correlated well with 
CFU data. It can be seen that the increase of dead cells in the first three months was greater 
than the following three months. During storage, the number of viable cells in the tablets 
remained constant but they had lower culturability after storage for longer. 
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Figure 7-11 Flow cytometry dot plots showing various physiological states of yeast cells 
stained with PI and BOX or SYTO9 and PI for tablets containing CaP beads and MCC in 
50/50 wt/wt ratio compacted at 75 MPa (c.a.10 kN) after 3 and 6 months storage at 4°C 
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Figure 7-12 Flow cytometry dot plots showing various physiological states of yeast cells 
stained with PI and BOX or SYTO9 and PI for tablets containing CaP beads and MCC in 
50/50 wt/wt ratio compacted at 90 MPa (c.a.12 kN) after 3 and 6 months storage at 4°C 
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Figure 7-13 Flow cytometry dot plots showing various physiological states of yeast cells 
stained with PI and BOX or SYTO9 and PI for tablets containing CaP beads and MCC in 
50/50 wt/wt ratio compacted at 105 MPa (c.a.14 kN) after 3 and 6 months storage at 4°C 
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Figure 7-14 CFU/g tablet of tablets containing CaP beads made in 1.5% CaCl2 mixed with 
MCC in 50/50 (wt/wt) ratio and compacted at 75, 90 and 105 MPa before and after 3 and 6 
months storage at 4⁰C 
 
 
Figure 7-15 Number of healthy, injured and dead cells and CFU/g tablet of tablets containing 
CaP beads made in 1.5% CaCl2 mixed with MCC in 50/50 (wt/wt) ratio and compacted at 90 
MPa after 3 and 6 months storage  
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The data of CaP beads before and after storage were plotted with the data in section 4.2.4 as 
shown in Figure 7-16, Figure 7-17 and Figure 7-18. It can be seen that the data of CaP beads 
before storage (symbol: red triangle) are in the same trend with a correlation in section 4.2.4. 
However, the number of viable, injured and healthy cells of storage data for 3 and 6 months 
(symbol: yellow triangle, outlined in red) could not corporate well with existing data and 
were plotted separately in the lower half of the figure and thus, it could weaken R2 of linear 
line. Therefore, it is suggested that the correlation found in section 4.2.4 could not be used to 
estimate cell culturability from total viable cell number determined by FC for storage stability 
data. 
 
 
Figure 7-16 Correlation between the number of healthy cells and CFU/g established in 
section 4.2.4 plotted with the storage data (3 and 6 months, outlined in red) of tablets 
containing CaP beads and MCC in 50/50 (wt/wt) ratio compacted at 90 MPa 
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Figure 7-17 Correlation between the number of injured cells and CFU/g established in section 
4.2.4 plotted with the storage data (3 and 6 months, outlined in red) of tablets containing CaP 
beads and MCC in 50/50 (wt/wt) ratio compacted at 90 MPa 
 
 
 
 
Figure 7-18 Correlation between the number of viable cells and CFU/g established in section 
4.2.4 plotted with the storage data (3 and 6 months, outlined in red) of tablets containing CaP 
beads and MCC in 50/50 (wt/wt) ratio compacted at 90 MPa 
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7.3 CONCLUSIONS 
 
The deformation behaviour of calcium pectinate beads made of 5% pectin and crosslinked in 
1.5% CaCl2 has been investigated using a diametrical compression test. The investigation 
revealed two material behaviours of CaP beads. Three beads out of ten behaved elastically at 
small deformation and had no fracture events and therefore, force relaxation (Figure 7-5) 
could be due to viscoelasticity of pectin. Seven beads showed fracture points and irreversibly 
deformed when compressed to large deformation. Using the Hertz equation and a Poisson’s 
ratio of 0.5 for incompressible material, the average Young’s modulus of seven beads was 
162 ± 14 MPa. Another three beads demonstrated viscoelastic property and Young’s modulus 
value of 312 ± 28 MPa (Table 7-1). 
 
Cells exposed to compression pressure resulted in a decrease in the number of healthy cells 
and caused more cell death by taking up more PI in FC analysis. Such decreased viable cells 
had lower culturability but were still viable. Additionally, when such injured cells were 
exposed to additional stresses during storage, their cytoplasmic membranes became 
permeabilised and thus resulted in cell death and PI up-take (Figure 7-11 to 7-13). Overall, 
cells encapsulated in CaP beads were resistant to external stresses in the storage. The 
encapsulation of yeast cells has created a favourable micro-environment, which protects the 
cells from being damaged by compaction to a certain extent and prolonged their storage 
stability. 
 
The correlations between the number of viable cells and CFU/g data as explained in section 
4.2.4 could be used to estimate the culturability of cells in tablets containing CaP beads and 
MCC before storage. However, these correlations could not be applied to the data of tablets 
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stored for 3 and 6 months, which implies there were different death mechanisms involved 
(Figure 7-16 to 7-18).  
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CHAPTER 8 
 
FINAL CONCLUSIONS AND FUTURE WORK 
 
8.1 FINAL CONCLUSIONS 
 
The objective of this study was to gain an understanding of the physiological state of 
probiotic yeast cells when they were incorporated in tablet dosage form produced by 
compaction. The factors (i.e. formulation, processing and environmental conditions) that 
affected cell viability were studied by colony plate counting (CPC) based on culturability 
(CFU/g) and by flow cytometry (FC) based on the applications of fluorescent probes.  
 
FC offered rapid data analysis of physiological states of microorganisms when used together 
with various fluorescent dyes. Cells stained with propidium iodide (PI) and Bis-oxonol 
(BOX) were classified into three different physiological states i.e. healthy cells with intact 
cytoplasmic membrane (PI-, BOX-), injured cells with no cytoplasmic membrane potential 
(PI-, BOX+) and dead cells with permeabilised cytoplasmic membrane (PI+, BOX+). Viable 
cells are defined as the summation of healthy and injured cells. The number of culturable 
cells was presented as CFU/g which was calculated based on the number of cell colony 
growing on agar plates.  
 
The study on yeast cell viability in simulated gastric and intestinal fluids with different pH 
values (pH 1 to 7) has shown that yeast cells (S. cerevisiae) maintained their viability in the 
fluid for pH greater than 2. Since the pH value in the gastric fluid during food digestion is 
rarely below 2, therefore the adverse effect of pH on cell viability at pH 1 was disregarded in 
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respect of formulation of a probiotic dosage form. This implies that probiotic yeast in tablet 
dosage form does not require enteric coatings. Active dried yeast (ADY) as received from 
Lesaffre in spherical granules (d50 = 1252 µm) resulted from being processed in a drum dryer 
at a relative low temperature between 40 and 42°C for 10-20 h. The FC results have shown 
that the drying process, in which 70% of residual moisture content was removed from yeast 
cells, caused the cell viability reduction by approximately 30%. Milled yeast (MY, d50 = 403 
µm) as received was produced from crushing of ADY with a comminutor before discharged 
through a 30 mesh screen to offer smaller particle sizes and thus, increased compactibility 
with other excipients for tableting. This process was found to have an additional adverse 
effect on cell viability by around 10%. All the dry yeast samples were suspended in PBS 
solution and then mixed by a laboratory homogeniser for 3 min prior to subsequent 
experiments. An optimized speed of the laboratory homogeniser used to prepare ADY 
suspension was found to be in the range between 8 000 to 12 000 rpm because at these speeds 
the maximum number of viable and culturable cells based on CFU/g data were released from 
the yeast granules. Moreover, active dry yeast (ADY) or milled yeast (MY) mixed with MCC 
were compacted into tablets using pressures ranging from 75 to 105 MPa but as the 
compaction pressure was increased, more dead cells and fewer healthy cells were found. In 
dissolution tests, the tablets produced using a Zwick machine disintegrated within 40 min 
after being exposed to a dissolution medium of PBS at 37°C. Therefore, if a tablet was 
ingested, the total number of cells in the tablet might be released in the GI tract. From FC and 
CFU data under the different conditions, a linear correlation between healthy and viable cells 
against CFU/g was applied. By considering the regression coefficient (R2), CFU/g and the 
number of healthy cells determined by FC showed a reasonably good linear relationship 
(Figure 4-16), whilst the correlation between CFU/g and number of injured cells was poorer. 
Therefore, healthy cells mainly contributed to those cells which were culturable, although 
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there could be more than one cell forming a single colony on agar plates. The slope of the 
regression line in Figure 4-18 which was less than 1 suggests that CFU/g data was typically 
underestimated in comparison with the number of viable cells detected by FC. This 
correlation might be useful to estimate cell culturability from the number of viable cells for 
other similar environmental and processing conditions.  
 
A freeze drying method was utilized to preserve yeast viability in order to produce probiotic 
tablets with a long shelf life. An attempt with an additional protectant of skimmed milk to 
WY was carried out but marginal improvement on yeast cell viability was observed. One 
important challenge for freeze dried yeast (FDY) is to obtain the desirable water activity ( aw 
< 0.3) in which prolonging freeze drying time was found to reduce water content but cause a 
reduction in cell viability. The flow cytometric results showed a declining trend of healthy 
cells in conjunction with an increase of injured and dead cells with freeze drying time. This 
reduction in cell viability might have been caused by a decrease in cell size due to 
dehydration, low temperature or absence of liquid in freeze drying process (Rault et al., 2007, 
Meng et al., 2008, Fu and Chen, 2011). These flow cytometric results consistently show a 
clear trend of declining CFU with freeze drying time. Those injured cells with membrane 
potential loss might be manifested by an inability to be able to form colonies on a solid 
medium, however they may restore and regain normal function under appropriate conditions 
or with enough nutrients (Mazur, 1965, Mazur, 1966, Novo et al., 2000). Even so, FDY 
particles after 24 h was mixed with microcrystalline cellulose (MCC) and compacted into 
tablets at different ratios and compaction pressures. However, the tablets containing FDY and 
MCC had a limitation in tablet compactibility which could be caused by a significant 
difference in particle size of FDY (d50 = 0.85 mm) and MCC (d50 = 0.19 mm) and thus 
resulted in low tensile strength. Another attempt was to improve tablet tensile strength by 
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increasing the amount of MCC as to enhance binding property in a tablet. Nevertheless, all 
formulations of tablets containing FDY and MCC did not meet the probiotic tablet 
requirements in term of CFU/g tablet ( ≥ 6.67×108 CFU/g tablet) and tablet tensile strength 
(≥1 MPa, Lesaffre’s specification, France). Overall, the reductions of cell viability were due 
to freeze drying time, tablet compaction pressure and stresses during storage to a certain 
extent. The numbers of healthy, injured and dead cells and CFU in tablets containing FDY 
and MCC before being storage were plotted in Figure 5-19 to 5-21 with the correlation 
explained in section 4.2.4 and they showed a good linear correlation. Nevertheless, this 
correlation could not be applied to the storage data of tablets as the correlation coefficient 
(R2) of linear line was weakened. The hypothesis for the storage data due to some external 
stresses requires further analysis.  
  
Encapsulation of yeast cells with some biodegradable materials (shellac and pectin) was 
investigated in order to provide a favourable micro-environment to cells, which is resistant to 
compaction pressure. WY containing high initial numbers of viable cells was selected for all 
experiments in the encapsulation process. First attempt on using shellac for encapsulating 
yeast cells with an extrusion method was made. Calcium shellac beads (d50 = 2.9 mm) 
containing yeast cells had desirable water activity value (aw ̴ 0.12) after 24 h freeze drying 
and offered good tablet compactibility without any binders. These beads had a macroporous 
internal structure caused by bubbles created during the mixing step. Nevertheless, such beads 
showed a low solubility and disintegration rate after exposure to simulated intestinal fluid 
(SIF) for 6 h and therefore calcium shellac beads were proven to have limitations in 
encapsulation of probiotic yeast. Second attempt on using pectin as encapsulating material 
was made. Yeast cells were successfully encapsulated with pectin crosslinked with CaCl2, 
which formed calcium pectinate beads (d50 = 2.05 mm). The effects of crosslinking solution 
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concentration, pectin concentration and freeze drying time on cell viability were investigated. 
During the dissolution test, a pectinolytic enzyme mimicking conditions in the colon was 
added to the dissolution media. WY mixed with 5% pectin, dripped in a 1.5% CaCl2 
crosslinking solution and freeze-dried for 24 h offered high encapsulation efficiency of 82%, 
encapsulation efficiency based on culturable cells of 65% and desirable water activity value 
of 0.27 ± 0.2. These beads were also mixed with MCC and compacted into tablets, which 
gave a desirable number of viable cells.  
 
Measurement of the mechanical properties of CaP beads by diametrical compression testing 
showed two material behaviours of CaP beads based on the analysis of ten tested beads. 
Seven beads showed a breakage point and three beads had no breakage point after diametrical 
compression. The internal structure of such beads contained pectin and some free volume. 
When the beads were compacted into tablets, MCC as an excipient could protect the beads 
from breakage. Therefore, this explained good tablet compactibility and resulted in a rigid 
tablet. A best achievable tablet formulation with desirable CFU/g and tensile strength 
contained an equal amount of CaP beads and MCC at 50/50 (wt/wt) ratio, which was 
compacted at 90 MPa. Cells entrapped inside the beads benefited from greater protection 
against external stresses than non-encapsulated cells (or FDY) by 0.77 log after 6 months 
storage. Overall the encapsulation of yeast cells has two significant benefits; firstly it reduced 
the amount of cells being damaged by tablet compaction, secondly it helped to prolong the 
product storage stability. The relationship between the number of viable, injured and dead 
cells and CFU of tablets containing CaP beads and MCC before storage was fitted with 
Figure 4-16 to 4-18 as explained in section 4.2.4. It has been found this correlation could be 
useful to predict cell culturability of cells after encapsulation. However, this correlation could 
not be applied to storage data (as shown in Figure 7-16 to 7-18) as it resulted in poor linear 
Chapter 8  Final Conclusions and Future work 
__________________________________________________________________________________________  
 210 
correlation coefficient which might be due to other external stresses affecting cell viability 
during storage i.e. oxygen or moisture.   
 
8.2 FUTURE WORK 
 
In this study, yeast cells were successfully encapsulated in calcium pectinate beads which 
may be useful to make probiotic tablet. However, more work is required to understand the 
protective mechanisms and improve the formulation developed thus far.  
 
Since adding skimmed milk to WY before freeze drying only improved the cell survival 
marginally, so other protective agents i.e. 10% trehalose could be added together with 
skimmed milk into WY before freeze drying in order to help maintain cell viability (Coutinho 
et al., 1988). Freeze drying at a high rate could be conducted to enable smaller ice crystals to 
form in order to minimize cell damage since large ice crystals can make cell membrane 
fragile and thus cause a reduction in cell viability (Morgan et al., 2006).  
 
A G23 standard needle was used to encapsulate yeast cells with pectin solution and the 
obtained beads after freeze drying appeared very big with an average particle size of 2.1 ± 0.3 
mm. Smaller beads with bigger surface area could enhance tablet compactibility and reduce 
the segregation of the tablets when mixing with other excipients. To obtain such beads, 
needles with smaller diameters (e.g. G24 or G25 standard needles) could be used. Moreover, 
if a Nisco encapsulation unit (model VAR J1) is used to generate droplets, air flow rate could 
be adjusted. Additionally, pectin concentration should be optimised. Therefore the viscosity 
of suspension would not be problematic to form the beads.  
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Storage stability studies could be carried out in a closure system with desiccator to examine 
whether the tablets are sensitive to moisture. Moreover, probiotic tablets could be stored 
under the accelerated condition (40 ± 2°C and 75%RH ± 5%RH) for 6 months to evaluate 
their thermal stability (Health and Services, 2003). For long term studies, the tablets should 
be stored at 20-25°C and 60%RH for a period of at least 12 months and the testing frequency 
should be every 3 months (Health and Services, 2003). 
 
FC can simultaneously measure the physiological state of cells and detect whether the cells 
are damaged due to either compaction pressure or other stresses during storage. However, 
this technique can only measure the sample in liquid form or suspension. Therefore, a 
technique using fluorescent dyes and confocal microscope by adjusting light at the 
wavelength of interest could be developed in order to gain better understanding and explore 
cell behaviours. This method could possibly measure how many cells are killed in solid form 
or tablet.  
 
Kawakita and Heckel equations have been validated in pharmaceutical powder compaction 
where they relate to material physical properties e.g. porosity and density. The primary 
particle data of CaP beads and MCC could be fitted into these equations and indicate the 
changes in the compaction mechanism. Since the relaxation force of some CaP beads might 
be due to viscoelastic property of pectin, modified Young’s modulus using viscoelastic model 
could be used to study viscoelastic behaviour. Moreover, adhesion force between cells and 
excipient particles using AFM could be measured to get a fundamental understanding of the 
interaction between materials.  
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The final product tests such as friability of uncoated tablet, uniformity of mass (weight) and 
resistance to crushing could be conducted through batch samples to conform to the tablet 
specification. The appearances of the tablets i.e. taste and colour could be adjusted to meet 
the needs of the consumer. If the in vitro studies are successful, the next step in in vivo whilst 
a scaled-up process including tablets for animal use could also be carried out to establish the 
effectiveness of probiotic tablets, and to enhance consumer confidence.  
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APPENDIX 1 
 
Serial dilution protocol from Lesaffre, France 
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APPENDIX 2 
 
Osmotic pressure (MPa) of different pH fluids was measured by a vapour pressure 
osmometer (Wescor 5500 XRS, Ontario, Canada). Error bars represent the range from the 
mean of triplicate measurements (n=3). 
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